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ABSTRACT 
 
J. Michael Ellis 
 
Approaches to the Marine-derived Polycyclic Ether Natural Products:  First Total 
Syntheses of the Asbestinins and a Convergent Strategy for Brevetoxin A 
(Under the direction of Professor Michael T. Crimmins) 
 
 Glycolate aldol reactions and glycolate alkylations, followed by ring-closing 
metatheses, are used to prepare medium ring ethers used as building blocks for 
polycyclic ether containing natural products.  Using the glycolate aldol/ring-closing 
metathesis strategy, an approach to a previously unprepared subclass of the C2–
C11 cyclized cembranoids known as the asbestinins is described.  An oxonene is 
efficiently synthesized and utilized as a manifold for an intramolecular Diels–Alder 
cycloaddition to form a hydroisobenzofuran moiety characteristic of the asbestinins.  
This tricyclic adduct represents the bulk of the framework of the asbestinins.  
Ultimately, the tricycle was progressed to two different natural products, 11-acetoxy-
4-deoxyasbestinin D and asbestinin-12, via a late-stage divergent route.  The 
completion of these natural products represented the first instance of preparing an 
asbestinin using chemical synthesis, and served to confirm the absolute 
configuration of the subclass. 
 Additionally, a glycolate alkylation/ring-closing metathesis strategy was used 
to prepare the B ring of brevetoxin A on multigram scale.  Novel reactivity was 
discovered and exploited along this route.  Namely, it was found that glycolate 
alkylation adducts can undergo direct Claisen condensation or reduction to the 
 iv 
aldehyde to provide useful synthons.  The B ring has been progressed to the BCDE 
tetracycle in a convergent fashion, and portions of this supply have been carried 
forward to provide possible coupling partners for the GHIJ fragment in hopes of 
completing brevetoxin A in a convergent manner. 
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Chapter I 
An Aldol/Ring-Closing Metatheis/Intramolecular Diels–Alder Approach to the 
Asbestinins:  Total Syntheses of 11-Acetoxy-4-deoxyasbestinin D and 
Asbestinin-12 
 
A.  Background 
 A wide array of C2–C11 cyclized cembranoid natural products have been 
isolated from marine sources.1  These diterpenes are grouped into four categories: 
the cladiellins (eunicellins), the briarellins, the asbestinins, and the sarcodictyins.  A 
biosynthetic pathway has been proposed by Faulkner relating each of these 
subclasses (Figure 1).2  Beginning with the cembrane skeleton, C2–C11 cyclization 
provides the cladiellin framework.  An intramolecular etherification of the cladiellin 
tricycle affords the tetracyclic framework of the briarellin subclass, and a 1,2-  
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Figure 1.  Proposed Biosynthesis 
 2 
suprafacial methyl shift on the briarellin structure is further predicted to deliver the 
asbestinins.   These speculations are corroborated by the isolation of a cembrane 
metabolite with cladiellin metabolites in Alcyonium molle and with asbestinin 
metabolites in Briareum steckii.3  The sarcodictyins are also proposed to arise from a 
C2–C11 cyclization of the cembrane skeleton; however, in these systems, the 
cyclization results in a fused cyclohexyl and oxonane in place of the 
hydroisobenzofuran of the cladiellins, briarellins, and asbestinins.  As a result of this 
significant structural variation of the sarcodyctins, the synthetic approaches to these 
molecules are quite different than those for the other three related subclasses.4,5   
 Eunicellin was the first reported member of the C2–C11 cyclized cembranoid 
natural products, isolated in 1968 by Djerassi and co-workers from the soft coral 
Eunicella stricta found off the coast of Banyuls-sur-Mer in France.6  Since this 
discovery, over one hundred unique secondary metabolites of gorgonian octocorals 
have been characterized, including the first asbestinin in 19802 and the first briarellin 
in 1995.7  The sum of these marine natural products provides a range of structural 
diversity.  The natural role of these cembranoids is proposed, based upon mollusk 
and fish lethality assays, to involve predation deterrence.7  Upon further 
investigation, several of the members of these subclasses have demonstrated 
remarkable pharmacological potential.7-13  Particularly, these diterpenes have been 
shown to possess in vitro cytotoxicity against various cancer cell lines, anti-
inflammatory properties, antimicrobial activities, and histamine and acetylcholine 
antagonism.  The fascinating molecular architecture of these cembranoids, as well 
as their potential as therapeutic agents, has sparked much interest in the synthetic 
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community over the past decade, resulting in a variety of approaches toward these 
challenging structural motifs and several total syntheses.   
 
B. Previous Total Syntheses of C2–C11 Cyclized Cembranoids  
1.  Prins–pinacol Condensation–rearrangement 
 The first total synthesis of a cembranoid natural product was completed by 
Overman and co-workers, who reported the total synthesis of (-)-7-
deacetoxyalcyonin acetate (1),14 a cladiellin, in 1995.15  The strategy relies upon the 
formation of the hydroisobenzofuran functionality via a Prins–pinacol condensation–
rearrangement approach, which had been previously employed in the Overman 
laboratory to stereoselectively form tetahydrofurans.16  (S)-Dihydrocarvone (2)17 was 
utilized as the starting material to prepare dienyl diol 3 suitable for the proposed 
transformation (Scheme 1).  Formation of the kinetic enol triflate,18 followed by 
iodination19 provided the dienyl iodide 4.20  Subsequent transmetalation and 
exposure to alkynyl aldehyde 5 (prepared in four steps from (S)-glycidyl pivalate)21 
provided diol 3 upon deprotection.22  With the stage set for the key Prins–pinacol 
condensation–rearrangement, diol 3 was combined with enal 6 in the presence of 
BF3·OEt2  to provide the hydroisobenzofuran 7 as a single diastereomer in 79% 
yield.  The stereochemical outcome of this transformation is predicted to arise from 
transition state 8 (Figure 2).  Following formation of the more stable (E)-
oxocarbenium ion,23 the molecule adopts the chair conformation necessary for the 6-
endo cyclization process.  Transition state 8 orients all substituents 
pseudoequatorially while also allowing the oxocarbenium ion to approach the diene 
 4 
from the opposite face of the bulky isopropyl substituent.16  The observed 
stereochemistry supports this model. 
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Scheme 1.  Prins–pinacol Condensation–rearrangement 
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Figure 2.  Transition States for Prins–pinacol Condensation–rearrangement 
With the cyclohexene and tetrahydrofuran in place, attention was turned 
toward formation of the oxonane (Scheme 2).  Removal of the primary silyl ether and 
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photochemical decarbonylation of the formyl group gave bicycle 10.24  The allylic 
alcohol was next exploited to achieve a Sharpless asymmetric epoxidation of the 
trisubstituted alkene,25,26 and the epoxide was regioselectively reduced using bis(2-
methoxy)aluminum hydride (Red-Al).27-29  Addition of water produced NaOH, which 
also effected desilylation in one-pot delivering diol 11.  A series of protections  
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Scheme 2.  Completion of (-)-7-Deacetoxyalcyonin Acetate 
followed by iodoboration of the alkyne provided the vinyl iodide,30  Reduction and 
oxidation revealed the aldehyde 13,31 which, following a one-carbon homologation, 
was utilized in an intramolecular Nozaki–Hiyama–Kishi coupling using NiCl2–
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CrCl2.32,33  Markedly, the resultant tricycle 15 was formed in 65% yield with high 
diastereoselection (>20:1 dr).  Selective acetylation of diol 15, with subsequent 
removal of the silyl ether, provided (-)-7-deacetoxyalcyonin acetate (1), marking the 
first successful total synthesis of a member of the C2–C11 cyclized cembranoid 
family. 
 The Overman laboratory next extended the Prins–pinacol condensation–
rearrangement approach to a cladiellin of potential pharmacological utility.  
Sclerophytin A (16) was characterized as a tetracyclic diether and showed promising 
in vitro cytotoxicity against the L1210 leukemia cell line (1 ng/mL).9,34,35  The strategy 
envisioned for sclerophytin A involved a Prins–pinacol approach, this time using a 
(Z)-α,β-unsaturated aldehyde as the nucleophile.  The synthesis would provide the 
opportunity to assess the viability of using an aldehyde of this sort without observing 
isomerization of the alkene configuration, while accomplishing the first total 
synthesis of this therapeutically intriguing natural product.  Utilizing diol 3 from the (-
)-7-deacetoxyalcyonin acetate synthesis15 and aldehyde 17 (prepared in four steps 
from 3-buten-1-ol),36 a two step condensation and rearrangement procedure was 
employed (Scheme 3).37,38  Condensation of the two components using acidic 
conditions provided an acetal that efficiently delivered bicycle 18 upon treatment with 
tin tetrachloride.  The (Z)-olefin remained in tact throughout the cyclization with no 
stereomutation observed.  Deformylation24 and deprotection of the silyl protecting 
groups gave the allylic alcohol 19, suitably poised for a substrate-controlled 
epoxidation.  Treatment with (t-BuO)3Al/t-BuO2H provided a separable 7:1 mixture of 
epoxides, favoring the desired diastereomer 20.39  Opening of the epoxide and 
 7 
sequential protection provided alkyne 21.  Refunctionalization to the Nozaki–
Hiyama–Kishi candidate as before completed a more efficient synthesis of vinyl 
iodide 14.15,30  Upon treatment with NiCl2–CrCl2, the oxonane was formed, delivering 
the desired isomer of allylic alcohol 15 in good yield.32,33  Deprotection of the tertiary 
silyl group and treatment with Hg(OAc)2 followed by NaBH4 provided diether 22 in 
moderate yield.40  Photoisomerization to the exocyclic olefin gave the reported  
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Scheme 3.  Overman's Completion of Sclerophytin A 
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structure of sclerophytin A (16).41,42  However, the data for the synthetic and natural 
material differed greatly.13  The C6 epimer of tetracycle 16 was also prepared via 
oxidation43 and reduction, but also failed to correlate with the natural product. 
 
2.  Claisen Rearrangement Strategy 
Simultaneously, the Paquette group had made efforts to synthesize 
sclerophytin A (16) via a unique route.13,34,35,44  Their strategy relied upon a Claisen 
rearrangement as the key step to provide the functionalized oxonane core of the 
natural product.45  The synthesis commenced with a Diels–Alder cycloaddition 
involving the Danishefsky diene (23) and chiral dienophile 24 (Scheme 4).46,47  The 
labile enolsilane was hydrolyzed48 and the resultant enone was reduced under 
Luche conditions49 to provide allylic alcohol 25 in good yield.  Ensuing silylation of 
the allylic alcohol and hydrolysis of the menthyl ether delivered lactone 26.  Allylation 
of lactone 26 afforded a 13:1 ratio of adducts, favoring the desired diastereomer.50  
Reduction, acetylation, and treatment of the derived oxocarbenium ion with 
trimethylsilyl cyanide gave a 1:1 mixture of nitriles 27 and 28.51,52  Efficient 
conversion of nitrile 27 to nitrile 28 was achieved under alkaline conditions.  Wacker 
oxidation53 and vinylation provided tertiary alcohol 29 in 75% yield for two steps.  
Mild hydrolysis of the nitrile provided an acid,54-56 which was used in a Yamaguchi 
lactonization to give the lactone.57,58  A Tebbe methylenation provided the target 
diene 30 for the key Claisen rearrangement.59  Gratifyingly, treatment of the mixture 
of dienes with sodium tetrafluoroborate in refluxing toluene provided the desired 
oxonene 31, but at two distinctly different rates.45  The noted variation in reaction 
 9 
rate can be explained by examining the transition states for each rearrangement 
(Figure 3).  The requisite chair conformations to access the desired rearranged 
product should both be accessible, however, transition state 30a suffers from  
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Scheme 4.  Claisen Rearrangement 
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Figure 3.  Claisen Rearrangement Transition States 
 
enhanced steric interactions over its corresponding epimer 30b, resulting in 
kinetically slower Claisen rearrangement.   
With the formation of the oxonene completed, attention was turned toward 
properly functionalizing the six- and nine-membered rings.  Diastereoselective 
alkylation of the ketone, protection of the resultant tertiary alcohol as a benzoate 
ester, removal of the silyl protecting group, and oxidation provided enone 32 
(Scheme 5).  Hydroxymethylation of the enone utilizing ytterbium triflate,60 followed 
by silyl protection of the resultant alcohol delivered the silyl ether.  
Diastereoselective conjugate addition of isopropyl Grignard reagent completed the 
diterpene skeleton of sclerophytin A (16).  A Luche reduction,49 formation of the 
thiocarbonyl imidazole, and reduction under radical conditions served to 
deoxygenate the cyclohexyl unit giving ester 34.  Reduction of the benzoate ester, 
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followed by oxymercuration and oxidative demercuration gave a 3:7 mixture of 
epimeric alcohols 35 in 54% yield, forming the final ring of the natural product.61  
Transient protection of the secondary alcohol as an acetate ester was followed by 
deprotection of the silyl ether and Grieco elimination.62  Reduction of the acetate 
ester provided the purported structure of sclerophytin A (16).  However, as expected 
based upon the Overman result, the spectroscopic data for this material differed 
significantly from that reported for the natural product.9  Oxidation31 and reduction of 
the secondary alcohol provided the C6 epimer 36, which still did not match the data  
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Scheme 5.  Paquette's Sclerophytin A Endgame 
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for the naturally isolated material.  Additionally, tetracyle 16 was much less polar 
than an authentic sample of the natural compound. 
Armed with the knowledge that the true structure of the natural product was 
not merely an epimer, the Paquette group performed extensive NMR and literature 
investigation and proposed a new structure for sclerophytin A (37).63  To access this 
material, in all of its C6 and C7 epimeric forms, alkene 34 was dihydroxylated using 
osmium tetraoxide to provide a nearly equal mixture of diastereomers (1.5:1 dr, 
Scheme 6).64,65  Oxidation66 and cleavage of the silyl ether with fluoride gave ketone 
39.  Greico elimination was next executed.62  Using one of three different reductive 
conditions, each of the four possible C6, C7 diastereomers of sclerophytin A (37) 
were accessed.  Gratifyingly, triol 37 matched the data for the natural product, 
serving to establish the true structure of sclerophytin A. 
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Scheme 6.  Paquette's Synthesis of Authentic Sclerophytin A 
 
3.  A Return to the Prins–pinacol Condensation–rearrangement 
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With knowledge of the reassignment of the structure by the Paquette group, 
the Overman laboratory had concurrently targeted authentic sclerophytin A (37) 
using an intermediate from their previous synthesis of the purported structure.37,38,64  
Hydroxyl-directed epoxidation of tricycle 15 gave 95% of the desired epoxide 
(Scheme 7).67  Reductive opening of the epoxide50 preceded cleavage of the silyl 
ether to give triol 40.  Finally, photochemical isomerization provided sclerophytin A 
(37), albeit in lower yield than the previous photoisomerization (vide supra, Scheme 
3).30 
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Scheme 7.  Overman's Synthesis of Authentic Sclerophytin A 
 
 In 2003, Overman applied the Prins–pinacol condensation–rearrangement 
approach to the synthesis of another cladiellin, alcyonin (41).68  Protection of 
epoxide 20 (previously prepared in the synthesis of sclerophytin A, Scheme 2)15,37,38 
as its acetate ester and treatment with aqueous trifluoroacetic acid prompted a 6-exo 
opening of the epoxide to provide diol 42 (Scheme 8).69-71  Reduction of the ester, 
selective protection of the primary alcohol as a pivalate ester, and protection of the 
resultant diol as silyl ethers provided alkyne 43.  Following iodoboration,30,72,73 
reduction of the ester, and oxidation31 to provide the alkenyl iodide 44, the Nozaki–
Hiyama–Kishi protocol was used to form the oxonane 45, again in excellent 
diastereoselectivity.32,33  Fluoride-promoted cleavage of the silyl ethers and careful 
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acetylation of the C4 hydroxyl provided the proposed structure of alcyonin (41).  
However, reminiscent of the sclerophytin A saga, the spectral data for the synthetic 
and natural material did not match.  A C6 peroxide analog 46 was proposed by the 
Overman group based upon the observed spectral data and reactivity of the 
synthetic and natural molecules,74-77 but no total synthesis of this reassigned 
compound has been achieved to date. 
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Scheme 8.  Attempted Synthesis of Alcyonin 
 
 The Overman laboratory next turned its attention to the briarellin subclass of 
the C2–C11 cyclized cembrane natural products.7,78,79  Again envisioning a Prins–
pinacol reaction as the key step in forming the characteristic hydroisobenzofuran 
portion of the molecule (Scheme 9),16 the synthesis commenced via protonolysis of 
the silyl ketene acetal of lactone 47 (prepared in two steps from (S)-(+)-carvone).80,81  
Reduction of the lactone gave diol 48, which was selectively protected as a silyl 
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ether and oxidized to the corresponding enone 49.82  Synthesis of the enol 
triflate18,83 preceded coupling with a tin reagent19 followed by iodination to give dienyl 
iodide 50.20  The lithiated diene was then treated with chiral aldehyde 51 and gave 
the diol 52 in 62% yield (3:1 dr) following methanolysis of the acetal.  The stage was 
set for the key Prins–pinacol condensation–rearrangement.  Treatment of diol 52  
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Scheme 9.  Forming the Hydroisobenzofuran of the Briarellins 
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with acid in the presence of aldehyde 53, followed by subjection of the condensed 
product to tin-catalyzed rearrangement conditions, provided the hydroisobenzofuran 
54 in 82% yield as a single detectable diastereomer.  Photolytic deformylation24 and 
selective basic hydrolysis of the t-butyldiphenylsilyl and trimethylsilyl protecting 
groups gave alcohol 55.  Stereoselective epoxidation84 and protection of the primary 
alcohol then allowed for acetate-assisted opening of the epoxide.69  In the event, 
treatment with aqueous acid, followed by acetylation of the resultant alcohol 
efficiently provided alkyne 57. 
With two of the rings of the tetracyle formed, epoxidation of the trisubstituted 
olefin proceeded with good stereoselectivity, and attention was turned to the 
formation of the oxepane of the briarellin core (Scheme 10).  Cleavage of the silyl 
ether and formation of the primary triflate under basic conditions triggered an 
intramolecular etherification, forming the third ring of the tetracyclic natural product.  
Next, to install the C12 carbinol, acid-catalyzed opening, followed by removal of the 
resultant C12 hydroxyl provided tricycle 59.  A two step procedure was next used to 
install the octanoyl side chain and provide ester 60.85  Stannylalumination–
protonolysis and a subsequent iododestannylation incorporated the vinyl iodide for 
the Nozaki–Hiyama–Kishi reaction.86  The acetate group was selectively removed 
using a tin reagent87 and oxidation provided the aldehyde.43  The cyclization again 
proceeded with complete stereoselection in 79% yield to provide briarellin E (62).32,33  
Oxidation of the allylic alcohol provided the enone, briarellin F (63).43   
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Scheme 10.  Total Syntheses of Briarellins E and F 
 
4.  [4+3] Annulation Strategy 
 The Molander laboratory has developed a [4+3] annulation strategy amenable 
to the construction of the hydroisobenzofuran of the cembranoids.88-90  (-)-7-
Deacetoxyalcyonin acetate (1), previously synthesized by the Overman group, was 
chosen as the initial target for their investigations.14,15  To prepare a dialdehyde 
surrogate, bis-acetal 64 was synthesized via a [2+2] cycloaddition of methoxy ketene 
and α-phellandrene (65),91,92 followed by photochemical rearrangement (Scheme 
11).93,94  Treatment of this bis-acetal 64 with a bis-nucleophile 66 in the presence of 
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titanium tetrachloride effected the formal [4+3] addition in a single step, establishing 
five of the seven stereocenters of their target molecule.  A diastereoselective methyl 
alkylation was followed by a Krapcho decarboxylation of the methyl ester, which also 
epimerized the newly-formed methyl stereocenter.95  Since the stereochemistry of 
the methyl substituent was crucial for the subsequent silyl enol ether formation, the 
stereocenter of the minor diastereomer was epimerized to the necessary 
configuration under basic conditions.  Formation of the silyl enol ether,96 selenation, 
and selenoxide elimination delivered enone 69.97  Conjugate addition98,99 and in situ 
formation of the vinyl triflate provided aldehyde 70 following hydrolysis.83  A Nozaki–
Hiyama–Kishi cyclization gave the cyclopentane in good yield as a mixture of 
diastereomers.32,33  After a Mitsunobu reaction that served to transform the 
undesired cyclopentanol into the desired,100 the merged material was progressed to 
the acetate ester 71.  The trisubstituted olefin was selectively protected as an 
epoxide, and the tetrasubstituted olefin cleaved under ozonolysis conditions, forming 
the nine-membered diketone 72.  The Sharpless tungsten reagent was used to 
reduce the epoxide and restore the trisubstituted olefin.101  Finally, selective 
protection of the C3 ketone as the enol silane, methylenation of the C7 ketone, and 
subsequent hydrolysis of the silyl enol ether provided the ketone.  Methylation 
provided (-)-7-deacetoxyalcyonin acetate (1)14 as a single detectable 
diastereomer.102 
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Scheme 11.  Molander's Approach to the Cladiellins 
 
5.  Intramolecular Amide Enolate Alkylation 
 Each of the previous syntheses have targeted cembranoids containing a (Z)-
olefin or lacking an endocyclic olefin within the nine-membered ring of the natural 
products.  In 2006, the Kim laboratory reported a route to the more sensitive (E)-
olefin containing cladiellins that are also ubiquitous in the isolation literature.103  The 
proposed approach would involve an intramolecular amide enolate alkylation, which 
has been well-documented within their group for the efficient formation of medium 
 20 
ring ethers.104-106  Upon forming the oxonene via this process, an intramolecular 
Diels–Alder cycloaddition analogous to that reported in  a previous synthesis by the 
Crimmins laboratory107-110 would be used to form the remaining two rings of several 
cladiellin natural products.  Their synthesis commenced with an asymmetric 
glycolate aldol reaction under Evans’s dibutylboron triflate conditions (Scheme 
12).111-113  Reduction of the chiral auxiliary and sequential protection of the diol 
provided alkene 75.  Oxidative removal of the p-methoxybenzyl ether114 and 
alkylation with an amide proceeded efficiently.  Selective allylic oxidation115 and 
chlorination of the resultant alcohol116 afforded amide 76 prepared for the key 
intramolecular alkylation.  In the event, treatment with lithium hexamethyldisilazide 
led to formation of the desired (E)-oxonene 77 in 92% yield as a single detectable 
diastereomer.104-106 
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Scheme 12.  Formation of (E)-Oxonene 
 
 Following formation of the medium ring ether 77, the functionalization to an 
appropriate Diels–Alder candidate commenced (Scheme 13).  Reduction of the 
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amide to the aldehyde117 and olefination by the Corey protocol gave an enal.118  
Methylenation and fluoride-promoted removal of the silyl ether gave alcohol 78.  
Oxidation43 and a stabilized Wittig reaction gave the intramolecular Diels–Alder 
substrate, which was treated with BHT in refluxing xylene to afford the desired 
tricycle 79 as a single detectable diastereomer via an exo-cycloaddition.  Alkylation 
of the ester and protection of the tertiary alcohol as an acetate ester set the stage for 
a dissolving metal reduction to deoxygenate the ester and remove the trityl 
protecting group.119  Oxidation43 and methylation provided a single diastereomer of 
the tertiary alcohol in 82% yield over two steps, completing the total synthesis of (-)-
cladiella-6,11-dien-3-ol (81),35,120 which represents the first total synthesis of an (E)-
olefin containing C2–C11 cyclized cembrane natural product. 
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Scheme 13.  Completion of First (E)-Olefin Containing Cladiellin 
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 Seeking to further illustrate the versatility of their synthetic material, three 
other cembranoid natural products were targeted.  Stereoselective dihydroxylation of 
tricycle 81 allowed access to (-)-cladiell-11-ene-3,6,7-triol (82) in 94% yield (Scheme 
14).121  A one-pot procedure was also developed involving oxymercuration of both 
olefins of (-)-cladiella-6,11-dien-3-ol (81) and demercuration to provide the tetracycle 
in 69% yield.122  Acetylation of the resultant tertiary alcohol provided (+)-polyanthellin 
A (83),78,123 marking the first total synthesis of this natural product.  Finally, following 
protection of the tertiary alcohol of (-)-cladiella-6,11-dien-3-ol (81), stereoselective  
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Scheme 14.  Versatile Syntheses of Several Natural Cladiellins 
 
dihydroxylation and acetylation of the secondary alcohol gave tertiary alcohol 84.  
Dehydration using Burgess salt provided the exocyclic olefin,124  and removal of the 
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silyl protecting group afforded (-)-7-deacetoxyalcyonin acetate (1),14,15,88 
representing the third total synthesis of this natural product. 
6.  Wittig Rearrangement/Intermolecular Diels–Alder Strategy 
 In 2007, the Clark laboratory reported another unique approach to cladiellin 
diterpenes, hinging upon a [2,3]-sigmatropic rearrangement that would be used to 
form the five- and nine-membered rings of the tricycle.  Following bicycle formation, 
an intermolecular Diels–Alder was envisioned to install the cyclohexyl moiety.125  
Vigulariol (85) was chosen as the initial target, a molecule possessing in vitro 
cytotoxicity against human-lung adenocarcinoma (IC50 = 18 nM).126  To begin, a 
Grignard reagent 86 was added to methacrolein (87) to give a secondary alcohol 
(Scheme 15).  The reported synthesis of vigulariol (85) is racemic due to the use of a 
racemic preparation of the secondary alcohol, but could be rendered 
enantioselective if a stereoselective method of preparing this alcohol was 
employed.127  O-alkylation with ethyl propiolate gave enoate 88.128,129  Deprotection 
and Swern oxidation130 gave the aldehyde.  A samarium-mediated reductive 
cyclization delivered the tetrahydropyran 89 diastereoselectively,131 and protection of 
the alcohol, followed by hydrolysis of the ester provided the acid.  The acid was 
converted to the corresponding anhydride and treated with diazomethane to give 
diazo ketone 90.  At this point, the copper carbenoid of diazo ketone 90 was formed 
and an ensuing oxonium formation and [2,3]-Wittig rearrangement occurred to 
deliver the oxonene 91 of the cladiellins.132,133  A 5:1 Z:E mixture of alkenes was 
obtained, but the material possessing the (E)-oxonene could be converted to the 
desired material using AIBN and ethanethiol.134,135  The ketone appended to the 
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tetrahydrofuran was converted to a vinyl triflate and a Stille coupling was used to 
form the diene 92.136  Intermolecular Diels–Alder cycloaddition with methyl vinyl 
ketone (93) gave a 2:1 exo:endo mixture of isomers, which were equilibrated to the 
desired exo-adduct 94 under basic conditions. 
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Scheme 15.  Intermolecular Diels–Alder 
 
With the tricycle elaborated, the ketone 94 was methylenated, and the enol 
ether was hydrolyzed under acidic conditions (Scheme 16).  Selective hydrogenation 
of the 1,1-disubstituted olefin was followed by methylenation of the ketone to give 
diene 95.  Deprotection of the silyl ether, oxidation to the ketone,43 and addition of 
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methyl Grignard reagent efficiently provided alcohol 96.  Finally, an epoxidation with 
m-CPBA delivered the epoxide, which was opened intramolecularly by the tertiary 
alcohol to afford (±)-vigulariol (85).126   
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Scheme 16.  Completion of (±)-Vigulariol 
 
7.  Miscellaneous Strategies 
 A variety of approaches leading to partial syntheses of cladiellins have been 
reported.  Among these, some unique strategies have been elucidated adding to the 
methods for the synthesis of C2–C11 cyclized cembranoid natural products.  Though 
none of the following attempts have resulted in a total synthesis, they provide 
valuable insight into several approaches that have shown promise in the setting of 
cladiellin, briarellin, and asbestinin syntheses, as well as some routes that have 
proven to be less amenable to these natural products. 
 Some of the earliest reported work involving cladiellins employed an 
annulation–fragmentation strategy for the formation of the five- and nine-membered 
rings of these cembranoids.  The Hoffmann laboratory began with symmetrical 
ketone 97137 and performed a diastereoselective allylation in high yield (Scheme 
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17).138  Hydrobromination provided the alkyl bromide, which was uneventfully 
converted to the alkyl iodide 98 under Finkelstein conditions.  A samarium-mediated 
Barbier-like cyclization provided the cyclopentanol,139 which was fragmented using 
cerium(IV) ammonium nitrate to provide bicycles 99 and 100 in 27% yield and 7% 
yield, respectively.140  No further efforts have been reported within the past decade 
utilizing this strategy. 
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Scheme 17.  Annulation-Fragmentation Strategy 
  
 The Clark group reported an approach to a similar oxabicycloundecane core 
of the cladiellins in 2000.  Their strategy featured a novel rearrangement to form the 
five- and nine-membered rings of these natural products.  Beginning with (R)-γ-
butyrolactone-γ-carboxylic acid (101),141 acid-catalyzed ring opening of the 
lactone142 was followed by allylation of the resultant secondary alcohol (Scheme 
18).143  Hydrolysis and acetylation afforded anhydride 102.  Treatment with 
diazomethane regioselectively opened the ring and formation of the rhodium 
carbenoid provided furanone 103 in 50% yield.134,135,144  A diastereoselective 
methylation145 preceded acetylation and hydrolysis to give acid 104.  Again, 
treatment with diazomethane followed by formation of the copper carbenoid set the 
stage for a spontaneous [2,3]-Wittig rearrangement to give bicycle 105.132,133  As the 
key step of the synthesis, bicycle 105 was treated with phenylselenyl chloride, which 
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triggered a rearrangement to yield oxabicycloundecane 106 in 78% yield.  
Additionally, treatment of ketone 105 with phenylselenyl trifluoroacetate gave tricycle 
107, albeit in lower yield.  Recently, in a separate publication, the Clark group 
reported that reduction of tricycle 107, protection of the resultant secondary alcohol, 
and oxidative elimination o the selenide gave bicycle 108, which represents a 
framework that could be used to complete a cladiellin natural product. 
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Scheme 18.  Clark's Rearrangement Approach 
 
 The McIntosh laboratory has developed two strategies for the synthesis of the 
hydroisobenzofuran of the C2–C11 cyclized cembranoids.  The first report relied 
upon a cycloaldol approach to form the furan portion of these molecules.146  
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Beginning with (S)-carvone (109), an aldol reaction147 with methacrolein and 
Williamson etherification of the resultant alcohol provided ester 110 (Scheme 
19).82,148  An intramolecular aldol reaction delivered bicycle 111 in 87% yield.  
Oxidation gave the enone,149 which was converted to the tosylhydrazone 112.  
Reduction with catecholborane and heating the reaction gave the cis-fused 
isobenzofuran 113.150-152  A similar route was also developed to access natural 
products containing oxygenation at C13.107,108,120,153  To this end, ester 111 was 
reduced to the primary alcohol, protected as a silyl ether, and allylic oxidization 
afforded the enone 114 (Scheme 20).  Rubottom oxidation154 gave predominantly 
the undesired configuration of the C13 alcohol 115 (7:1 dr), and formation of the 
tosylhydrazone proceeded smoothly.  Reduction with catecholborane again and in 
situ allylic diazene rearrangement gave the trisubstituted olefin 116,150-152 and a 
Mitsunobu reaction gave the correct C13 configuration for bicycle 117.100  No further 
efforts utilizing this route have been reported since 2003. 
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Scheme 19.  Cycloaldol Route to the Isobenzofuran 
 29 
1. TsNHNH2, AcOH
2. catecholborane,
NaOAc
111
1. LiAlH4
2. TIPSOTf, 2,6-lut.
3. PCC, celite
O
H
Me
O
Me
Me
114
OTIPS
1. KHMDS, TMSCl
2. m-CPBA, NaHCO3
O
H
Me
O
Me
Me
115
OTIPS
HO
O
H
Me
Me
Me
116
OTIPS
HO
1. DIAD, PPh3,
p-NO2C6H4CO2H
2. LiAlH4
O
H
Me
Me
Me
OTIPS
HO
Me
Me
Me
O
EtO2C
OH
H
(70%)
(75%)
(70%) (75%)
H
H
117
 
 
Scheme 20.  C13 Oxidized Isobenzofuran 
 
 The second route recently reported by the McIntosh group involves an 
Ireland–Claisen rearrangement (Scheme 21).  The approach commenced with ester 
118 (available in three steps from (S)-carvone).155,156  Treatment with base in the 
presence of triisopropylsilyl triflate triggered the rearrangement to give acid 119 
following deprotection.157  Lactonization158 set the stage for installation of an 
additional oxygen substituent via SN2’ addition of an alkoxy methyl copper 
nucleophile159 and formation of the methyl ester 120.  Selective hydrogenation and 
cleavage of the methoxymethyl ether gave alcohol 121.  A Swern oxidation130 and a 
Horner–Wadsworth–Emmons reaction provided sulfone 122.  Dihydroxylation160 and 
oxidation130 gave ketone 123.  Allylic alcohol transposition161,162 preceded formation 
of the tetrahydrofuran 124 via subjection to alkaline conditions.  Formation of the 
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tosylhydrazone and reduction triggered an allylic diazene rearrangement once again 
to give bicycle 125,150-152 characteristic of the cladiellin subclass. 
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Scheme 21.  Rearrangement Approach to the Cladiellins 
 
 In 2003, the Jung group reported efforts toward the initially reported structure 
of sclerophytin A (16).9,34,35,163  Formation of the silyl enol ether of ketone 126 using 
a chiral base164 and subsequent alkylation gave bicycle 127 (Scheme 22).165  A 
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second alkylation using a palladium mediated coupling gave alkene 128 in 83% 
yield.166,167  Hydroboration and oxidation of the terminal olefin168 preceded protection 
of the resultant alcohol as an ester functionality.  A Baeyer–Villiger oxidation 
provided the lactone,169 from which the ester was removed170 and the alcohol was 
protected as a silyl ether to give bicycle 130.  A Tebbe olefination proceeded in good 
yield,59 however, the trisbustituted olefin 131 was isolated rather than the desired 
exocyclic olefin.  The original synthetic plan involved a [3+2] cycloaddition reaction, 
but the inability to access the exocyclic olefin in good yield precluded this prospect, 
so the group redirected their strategy taking advantage of the alkene 131.  
Hydrolysis of the enol ether provided the ketone, and the diol was bis-protected as 
silyl ethers.  Selective removal of the primary silyl ether gave ketone 132.  Oxidation 
of the primary alcohol to the aldehyde31 provided a substrate that was proposed to 
be suitable for a pinacol coupling.171  However, no productive reaction could be 
achieved with the dicarbonyl.  In an attempt to overcome this inactivity and form the 
nine-membered ring, methylenation of both carbonyls gave a diene 133 that was 
treated to the Grubbs second generation catalyst to attempt a ring-closing 
metathesis,172 but again this was met with no success.  Frustrated by the numerous 
roadblocks, this program was abandoned. 
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Scheme 22.  Fragmentation Approach to the Furan 
 
 As alluded to earlier, the Holmes laboratory reported a route to cladiellin 
natural products that employed an intramolecular Diels–Alder cycloaddition (Scheme 
23).110  Their efforts were published shortly after the Crimmins laboratory divulged 
their synthesis of ophirin B.107  The Holmes group has developed a Claisen 
rearrangement for accessing medium ring lactones.173,174  Their synthesis 
commenced with the acid-catalyzed glycosidation of 2-deoxy-D-ribose (134),175 
followed by protection of the diol as silyl ethers.  The acetal was demethylated176,177 
and treatment with a Grignard reagent gave diol 135.  Formation of the dioxepane178 
preceded oxidation of the selenide, which triggered a Claisen rearrangement to give 
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lactone 136.179  With an efficient route to lactone 136, attention was turned toward 
preparing an appropriate Diels–Alder candidate.  Methylenation180 and selenation 
gave selenide 137.  Oxidation of selenide 137, Pummerer rearrangement, and loss 
of methoxide gave aldehyde 138 as a single diastereomer.181  A stabilized Wittig 
reaction gave the enal, and methylenation delivered triene 139.  Selective removal of 
the primary protecting group and oxidation gave the aldehyde,31 which upon 
treatment with a stabilized Wittig reagent182 formed the enone and spontaneously 
cyclized.  Upon deprotection, tricycles 140 and 141 were isolated.  However, the 
endo-adduct 140 was the major product of this cyclization (3:1 dr).  This reversal of  
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Scheme 23.  Cycloaddition Approach of Holmes 
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selectivity from the cladiellin and asbestinin syntheses from the Crimmins laboratory 
demonstrates the crucial nature of the C3 configuration and protecting group.107-109  
When the opposite configuration at C3 is employed, the endo-adduct is the dominant 
product, whereas the exo-adduct is favored when using the C3 epimer.  The 
undesired result of the Diels–Alder cycloaddition brought an untimely end to this 
project.  
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Scheme 24.  Samarium-mediated Cyclization to Polyanthellin A Diastereomer 
Finally, the Molander group has reported a second route to the cladiellins that 
extends the [4+3] annulation strategy discussed earlier (Scheme 11).88-90  Using 
tricycle 67 from their earlier synthesis (vide supra), an alkylation and Krapcho 
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decarboxylation gave the ketone 142 as a mixture of epimers (3:1 dr),95 which could 
be epimerized to the desired configuration under basic conditions (Scheme 24).  
Selective hydroboration and oxidation of the terminal olefin168 was followed by 
chorination to give alkyl chloride 143.183  A three step sequence installed the tertiary 
acetate,184-187 and the alkyl chloride was transformed into alkyl iodide 144.188  At this 
point, a key samarium iodide-mediated cyclization provided tetracycle 145.189  
Dehydration124 and ozonolysis gave the cladiellin skeleton 146.  Chemoselective 
methylenation was followed by alkylation.102  At this point, oxymercuration and 
reduction190 gave the 3,7-epimer of polyanthellin A 147.78 
 
C. Medium Ring Ether Synthesis via Ring-closing Metathesis 
1.   Catalyst Development 
 The olefin metathesis reaction is recognized as an efficient method for the 
construction of carbon–carbon bonds.  Early efforts in this field utilized poorly 
defined catalyst systems that were difficult to employ and featured a narrow 
substrate scope due to functional group compatibility issues.191  However, in 1990, 
the Schrock laboratory divulged a highly efficient catalyst system using molybdenum 
alkylidene complex 148, which showed broader functional group than its 
predecessors (Figure 4).192,193  As a result, this catalyst became widely-used among 
synthetic chemists for the formation of olefins, including medium ring ethers.  
However, the catalyst is not ideal due to its oxophilicity, rendering it highly air and 
moisture sensitive, as well as the difficulty in synthesizing the active catalyst.  
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Despite these drawbacks, the efforts of Schrock represent a major step forward in 
the history of olefin metathesis. 
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Figure 4.  Olefin Metathesis Catalysts 
 
 Concurrently, the Grubbs laboratory focused efforts toward ruthenium-based 
alkylidene complexes they hoped to apply to olefin metathesis reactions.194,195  
Notably, catalysts 149 and 150 showed similarly high reactivity when compared to 
the Schrock system (Figure 4).  Additionally, these catalysts demonstrated high 
thermal stability and broad functional group tolerance.  Further, the ruthenium-based 
catalysts 149 and 150 showed lower air and moisture sensitivity than the Schrock 
systems.  With the advent of a new catalyst species, featuring a 4,5-dihydroimidazol-
2-ylidene ligand and coined the Grubbs second generation catalyst (151), the scope 
of potential products grew dramatically as the reactivity of the catalyst increased.172  
Di-, tri-, and tetrasubstituted olefins could efficiently be formed using catalyst 151.  
Within the past decade, other novel ruthenium-based catalysts have been developed 
that have found great success in the ring-closing, ring-opening, and cross 
metathesis reactions.196,197 
 Early reports documented efficient formation of five-, six-, and seven-
membered rings using the ruthenium-based catalyst systems, while the formation of 
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eight- and nine-membered rings remained more elusive due to unfavorable 
transannular interactions and entropic difficulties.  To combat these challenges 
encountered in medium ring synthesis, extra rigidifying elements, such as cyclic 
constraints, have been employed successfully.198-200  Grubbs demonstrated that 
such cyclic constraints greatly improve the efficiency of the formation of medium 
rings, due to the decreased rotational freedom of these dienes (Table 1).201  
However, the employment of these synthetic tactics greatly minimizes the utility of 
this reaction since the cyclic constraints are often not desired in the target molecule.  
In 1995, Grubbs reported the successful ring-closing metathesis of an eight-
membered dipeptide lacking a cyclic constraint (Scheme 25).201  The following year, 
the Hoveyda laboratory divulged the ring-closing metathesis of an even more 
simplified medium ring.202  The success of these reactions is credited to the steric  
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Table 1.  Cyclic Constraints for Ring-closing Metathesis 
 
 38 
and electronic requirements of the substituents on the respective dienes producing a 
rotamer that places the dienes in close proximity, favoring ring-closing metathesis.  
At the time, these served as very rare, but promising, examples of eight-membered 
ring formation via these processes.   
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Scheme 25.   Early Ring-closing Metathesis Lacking Cyclic Constraint 
 
2.  Aldol/Ring-closing Metathesis in the Crimmins Laboratory 
 Around the same time that olefin metathesis was becoming more practical for 
target-directed synthesis, the Crimmins laboratory was developing auxiliary-based 
methodology for the synthesis of subunits of polyketide-containing natural products.  
Seeking to apply these reactions to the synthesis of medium ring ethers, efforts 
focused on the development of two distinct approaches to these cyclic units, namely 
a glycolate aldol or glycolate alkylation reaction, followed by ring-closing metathesis 
using the Grubbs catalysts.  This approach was predicated on the expected gauche 
effect present in dienes derived from aldol adducts (Figure 5).203  As demonstrated, 
the stabilizing interaction involving donation of the C-H σ orbital into the C-O 
σ* οrbital places the two olefins in a favorable conformation for ring-closing 
metathesis to occur.  Alternatively, the dipole minimized conformation also leads to a 
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more favorable orientation for ring-closing metathesis.  These acyclic conformational 
constraints were proposed to deliver medium ring ethers efficiently. 
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Figure 5.  Acyclic Conformational Constraint via Gauche Effect 
 
 To synthesize the desired dienes, glycolate aldol reactions were utilized, 
allowing access to a variety of ring sizes by varying the chain length of the 
respective glycolate or aldehyde (Figure 6).  Initially, the conditions developed by 
Evans using dibutylborontriflate for enolization were exploited in the asymmetric 
aldol additions.111  Eventually, the Crimmins laboratory developed more cost efficient 
conditions using titanium tetrachloride, diisopropylethylamine, and later N-methyl 
pyrrolidinone for these additions, which proved to be applicable to a plethora of 
simple and complex oxazolidinone and oxazolidinethione glycolates to deliver the 
corresponding Evans-syn adducts in good yield and excellent diastereoselectivity.204 
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Figure 6.  Aldol/Ring-Closing Metathesis Strategy 
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 A systematic study examining the formation of six-, seven-, eight-, and nine-
membered rings via ring-closing metathesis reactions of various aldol adducts was 
undertaken.205  A variety of dienes accessible via Evans-syn glycolate aldol 
reactions were prepared and treated to Grubbs catalyst 150 in refluxing methylene 
chloride (Table 2).  The results confirmed the hypothesis that the gauche effect 
present within these 1,2-dioxygenated compounds was sufficient to orient the olefins 
proximally and allow for small and medium ring ether formation.  The desired 
unsaturated products were formed in less than two hours and were isolated in 73-
95% yields.   
Table 2.  Small and Medium Ring Ether Formation 
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 These findings concerning the glycolate aldol addition and the ring-closing 
metathesis reaction have been applied repeatedly in the setting of natural product 
synthesis in the Crimmins laboratory.  The improved syn glycolate aldol conditions 
were applied to form two small rings in the total synthesis of gigantecin (152, 
Scheme 26).206  The chlorotitanium enolate of complex glycolate 153 reacted with 
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ynal 154 to provide the desired Evans-syn adduct 155 in 93% yield (>19:1 dr).  
Standard transformations prepared a diene 156 that served as a ring-closing 
metathesis candidate.  Upon subjecting the diene 156 to the Grubbs second 
generation catalyst 151 in refluxing methylene chloride, the furan 157 was formed in 
nearly quantitative yield.  Further manipulations afforded gigantecin (152). 
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Scheme 26.   Total Synthesis of Gigantecin 
 
 In 2000, the Crimmins laboratory applied this aldol/metathesis approach to 
the synthesis of a medium ring ether natural product, prelaureatin (158, Scheme 
27).207  The use of titanium tetrachloride and diisopropylethylamine to form the 
corresponding enolate of glycolate 159, followed by addition of 3-butenal (160), led 
to the desired aldol adduct 161 in good yield and good diastereoselectivity.  
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Protection of the secondary alcohol and treatment with catalyst 151 provided the 
oxocene 162 in 95% yield, which was carried on to prelaureatin (158).  The 
aforementioned total syntheses represent a fraction of the natural products prepared 
in the Crimmins laboratory via the aldol/ring-closing metathesis strategy. 
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Scheme 27.  Prelaureatin Total Synthesis 
 
3.  Alkylation/Ring-closing Metathesis in the Crimmins Laboratory 
 The Crimmins laboratory has also developed a useful extension to the Evans 
asymmetric alkylation which involves the formation of the sodium enolate of 
oxazolidinone glycolates and addition to a variety of electrophiles.208  Most often, 
allylic iodides serve as electrophiles in the reaction, but other halides, such as 
propargylic bromides and benzyl iodomethyl ether have also been shown to deliver 
useful handles for natural product total synthesis.  Silyl, benzyl, allyl, and alkyl 
protected glycolates perform well under these conditions providing the desired 
alkylation adducts in good yield and high diastereoselection.  This alkylation strategy 
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has also been utilized to arrive at dienes useful for ring-closing metathesis to give 
small and medium ring ethers. 
 In 2003, the Crimmins laboratory divulged the total synthesis of rogioloxepane 
A (164) using the glycolate alkylation and ring-closing metathesis reactions as key 
steps (Scheme 28).209  Alkylation of glycolate 165 with allyl iodide provided diene 
166 in 86% yield as a single detectable diastereomer.  Using Grubbs catalyst 150, 
diene 166 underwent facile ring-closing metathesis to give the corresponding 
oxepene 167 in high yield.  A series of manipulations provided rogioloxepane A 
(164). 
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Scheme 28.  Total Synthesis of Rogioloxepane A 
 
 Crimmins and co-workers have also employed the alkylation/ring-closing 
metathesis strategy in the total synthesis of a medium ring ether-containing natural 
product, isolaurallene (168, Scheme 29).210  The sodium enolate of complex 
oxazolidinone glycolate 169 was alkylated with allylic iodide 170 to give diene 171.  
Several steps gave ring-closing metathesis candidate 172, which was treated with 
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Grubbs catalyst 150 to efficiently deliver oxonene 173.  Medium ring ether 173 was 
carried on to isolaurallene (168). 
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Scheme 29.  Isolaurallene Total Synthesis 
 
4.  Total Syntheses of Eunicellin Diterpenes via Alkylation/Ring-closing 
Metathesis in the Crimmins Laboratory 
As detailed, the Crimmins laboratory has extensively demonstrated the ability 
to form medium ring ethers209,211-214 via the ring-closing metathesis reaction172,195 of 
dienes generated by glycolate alkylation208 and glycolate aldol reactions.204,213,215,216  
As an extension of these methods, a novel strategy was envisioned for the 
cembranoid natural products involving initial formation of the oxonene ring prior to 
the hydroisobenzofuran moiety.  This would represent the first total synthesis at the 
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time to form the nine-membered ring prior to formation of either of the other two 
rings.  The synthesis of these final two rings hinged upon an intramolecular Diels–
Alder approach that would form the tricycle while concomitantly establishing the C1, 
C10, C13, and C14 stereocenters.  Ophirin B (174)120 was first targeted, 
representing the first C13, C18 oxygenated cladiellin to be prepared via total 
synthesis.107,108  The synthesis commenced with the methylenation of (S)-
benzylglycidyl ether (175)217 followed by proection as a p-methoxybenzyl ether 
(Scheme 30).  Wacker oxidation provided ketone 176 in 80% yield over three 
steps.218,219  Chelation-controlled stereoselective alkylation and protection of the  
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Scheme 30.  Ophirin B Oxonene Formation 
 
resultant alcohol as a benzyl ether preceded deprotection of the secondary alcohol 
under acidic conditions.  Standard formation of the corresponding glycolic acid and 
glycolate provided imide 178, prepared for a glylcolate alkylation.  The sodium 
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enolate of imide 178 was alkylated with methyallyl iodide in 93% yield to provide a 
single detectable diastereomer of the diene.208  Reduction of the chiral auxiliary and 
ring-closing metathesis efficiently provided the oxonene 179.172 
With the nine-membered ring 179 in hand, careful ordering was necessary for 
the installation of the diene and dienophile for the key Diels–Alder cycloaddition.  To 
this end, an oxidation43 and stabilized Wittig reaction provided the enoate, which was 
reduced to the allylic alcohol and protected as a tetrahydropyranyl ether to provide 
oxonene 180 (Scheme 31).  Dissolving metal reduction of the benzyl ethers provided 
the diol, and the primary alcohol was oxidized43 and treated with a stabilized Wittig 
reagent to give the enoate, which would be employed as the dienophile in the 
pending Diels–Alder reaction.  The tertiary alcohol was protected as a triethylsilyl 
ether.  The pyran was then removed under acidic conditions and the resultant 
alcohol was oxidized to the aldehyde.31  Treatment with benzyloxymethyl-
enetriphenylphosphorane gave tetraene 181 as a 3:1 mixture of E:Z isomers.  Under 
ambient conditions, tetraene 182 underwent a spontaneous, highly exo-selective 
Diels–Alder cycloaddition.  The minor isomer from the Wittig reaction could be 
photochemically recycled to the reactive tetraene 182, providing an overall 78% yield 
of tricycle 183.220  The observed stereochemistry from the cycloaddition can be 
rationalized using transition states 182a and 182b, which demonstrate the 
importance of the C3 protecting group (Figure 7).  Namely, the bulk at C3 has a 
significant steric interaction with the C14 proton and carbon in the endo case which 
is mitigated for the exo transition state.  This hypothesis has been corroborated by 
varying the size of the C3 protecting group and observing the diastereoselectivity of  
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Scheme 31.  Intramolecular Diels–Alder Cycloaddition 
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Figure 7.  Diels–Alder Transition States 
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the cycloaddition.  Additionally, the work of Holmes using C3 epimers (vide supra, 
Scheme 23) supports these selectivity models.110 
With the tricyclic core formed, alkylation of ester 183 delivered the tertiary 
alcohol (Scheme 32).  A careful acetylation sequence was required to preclude 
formation of tetracycle 184.  Removal of the silyl ether provided the diol, and the C18 
hydroxyl was selectively acetylated under basic conditions.44  The C3 hydroxyl was 
then converted to its acetate ester 185 in the presence of a Lewis acid.87,221  Finally, 
cleavage of the benzyl ether, and acetylation under basic conditions provided ophirin 
B (174), which possessed identical spectroscopic properties in all respects to the 
natural material. 
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Scheme 32.  Completion of Ophirin B 
 
During the course of the synthesis of ophirin B (174),107,108 the Crimmins 
group pursued the synthesis of a biologically active cadiellin, astrogorgin (186).120,153  
Identical to ophirin B (174), except for an additional oxygenated stereocenter at C6, 
it was believed that astrogorgin (186) could be constructed utilizing a different 
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electrophile for the glyclolate alkylation reaction.208  This electrophile would possess 
a latent synthetic handle that could be used to install the C6 stereocenter following 
construction of the tetracyle (Scheme 33).  Alkylation, reduction and ring-closing 
metathesis each proceeded in greater than 90% yield to provided oxonene 188 
(Scheme 33).172  An identical sequence was utilized to install the diene and 
dienophile as was applied in the ophirin B (174) synthesis,107,108 and the key  
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Scheme 33.  Synthetic Approach to Astrogorgin 
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intramolecular Diels–Alder cycloaddition again proceeded under ambient conditions 
to provide tricycle 192 as a single diastereomer. 
Upon completion of the tricycle 192, methylation and acetylation of the C18 
tertiary alcohol proceeded uneventfully, followed by careful hydrogenation of the 
benzyl ether (Scheme 34).  Acetylation and deprotection of the allylic triisopropylsilyl 
protecting group provided an alcohol that was utilized in an allylic transposition to 
provide the epimeric C6 hydroxyl for astrogorgin (186).222,223  An oxidation23 and 
Luche reduction49 delivered the desired C6 alcohol stereoselectively.  Esterification, 
deprotection, and installation of the fourth and final acetate group was accomplished 
to provide astrogorgin (186), which was identical in all regards to the naturally 
isolated material.120,153 
O
Me
H
HH
H
H
OTES
Me
BnO
O
MeH
HH
H
H OAc
Me
AcO
MeMe
OAc
OTIPS
OAc
1 . MeMgCl
2. NaHMDS, Ac2O
3. H2, Pd/C
O
MeH
HH
H
H
OTES
Me
HO
MeMe
OAc
OTIPS
1. Ac2O, DMAP, Et3N
2. n-Bu4NF
3. o-NO2C6H4SeCN, n-Bu3P
4. H2O2, C5H5N
Oi-Pr-O
O
Me
H
HH
H
H
OTES
Me
AcO
MeMe
OAc
OH 1. TPAP, NMO2. NaBH4, CeCl3, MeOH
3. Ac2O, DMAP, pyr.
O
Me
H
HH
H
H
OTES
Me
AcO
MeMe
OAc
OAc 1. n-Bu4NF
2. Bi(OTf)3, Ac2O
(89%)
(86%) (82%)
(21%)
192 193
194
195 astrogorgin (186)
1
3
10
6
13
14
 
 
Scheme 34.  Total Synthesis of Astrogorgin 
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D.  Total Syntheses of 11-Acetoxy-4-deoxyasbestinin D and Asbestinin-12 
1.  Background 
 The asbestinins represent the farthest evolved subclass from the original 
cembrane skeleton of the C2–C11 cyclized cembranoids (Figure 1).  The first 
asbestinin was discovered and its structure elucidated in 1980.2  For 25 years, no 
total synthesis of any member of this subclass had been reported.  A diverse array 
of structures have been found within the asbestinins, which differ from the cladiellins 
and briarellins in that C12, C13, and C15 are never oxygenated and there is never a 
lactone moiety at C16.1  This subclass features a range of biological activity, 
including antimicrobial, acetylcholine antagonism, and antitumor properties.  Though 
an X-ray diffraction study of asbestinin-1 confirmed the relative stereochemistry of 
this subclass, some discrepancy exists in the literature regarding the absolute 
configuration of this family of natural products.1,2  The biosynthetic hypothesis would 
suggest that the stereochemistry would correlate to that of the cladiellins and 
briarellins, but the isolation literature consistently portrays the enantiomer as the 
natural configuration. 
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Figure 8.  Targeted Asbestinins 
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 11-Acetoxy-4-deoxyasbestinin D (196) was isolated in 1990 by Rodríguez 
and co-workers from Briareum asbestinum off the coast of Puerto Rico (Figure 8).11  
The title compound represented 0.072% of the dry weight of the isolated sponge.  
The natural product features a fascinating molecular structure, with nine contiguous 
stereocenters and a fully-substituted tetrahydrofuran.  Further, 11-Acetoxy-4-
deoxyasbestinin D (196) demonstrates strong antimicrobial activity against Klebsiella 
pneumoniae and cytotoxicity against CHO–K1 cells (ED50 = 4.82 µg/mL).  A related 
member of this subclass, asbestinin-12 (197), features a similar structure with an 
additional stereocenter at C4,224  which is more ubiquitious within the asbestinins.  
The sum of the biological benefits and structural intrigue, as well as the lack of a 
total synthesis of any member of this subclass piqued our interest in these two 
natural products.  We set out to apply a strategy similar to that employed in the 
cladiellin syntheses in our laboratory,107,108 this time targeting members of the 
asbestinin subclass, in hopes of verifying the viability of our plan and confirming the 
absolute configuration of the asbestinins.   
2.  Retrosynthetic Analysis 
 Strategically, ketone 198 was targeted as a point of divergence for the 
syntheses of 11-acetoxy-4-deoxyasbestinin D (196) and asbestinin-12 (197) 
(Scheme 35).  The desire to apply the previously developed Diels–Alder strategy 
used for the cladiellins to complete the first total synthesis of a member of the 
asbestinin subclass of natural products resulted in selection of tetraene 199 as the 
Diels–Alder substrate. Tetraene 199 was an attractive Diels–Alder substrate in that it 
would incorporate the required stereochemistry of the C15 methyl group prior to the 
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Diels–Alder reaction.  While the 2,3-substitution on the diene was viewed as a 
potential liability with regard to the possibility of the diene to adopt the required s-cis 
conformation, and the electronic character of the dienophile was less than optimal, 
the facility of the Diels–Alder reaction in the ophirin B (174) synthesis107 provided 
optimism for the success of the Diels–Alder reaction of tetraene 199.  Thus, we set 
out to prepare tetraene 199 and investigate its performance in the designed 
cycloaddition.  Tetraene 199 would be prepared from diene 200 by ring-closing 
metathesis followed by further functionalization.  While construction of the diene 
metathesis substrate for the ophirin B and astrogorgin syntheses was accomplished  
asbestinin-12 (197)11-acetoxy-4-deoxyasbestinin D (196)
O
Me
AcO
Me
Me
H
HH
H
H
H
O
12
11
10
9
32
114
15 Me
O
Me
AcO
Me
Me
H
HH
H
H
H
O
12
11
10
9
32
114
15 Me OAc
O
Me
MeO
Me
Me
H
HH
H
H
O
H
OMOM
198
199
200
O
Me
H
H
OMe
H
Me
MOMO
MeH
TBSO
O
TBSO
Me
OBn
TBSO
HH
H
Me
O
BnO
N O
SO
Bn BnO OH
201
202
H
 
 
Scheme 35.  Retrosynthetic Analysis 
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through the use of an asymmetric glycolate alkylation as the key step,107,108,208 the 
strategy for the synthesis of diene 200 hinged upon the development and application 
of an asymmetric glycolate aldol reaction to establish the ether linkage 
stereochemistry of the oxonene precursor.204,205  The required thioimide 201 for the 
aldol reaction would be prepared from (R)-benzyl glycidyl ether (202). 
 
3.  Oxonene Formation 
 An initial goal of this project was to probe the effectiveness of 
oxazolidinethione glycolate 201 and oxazolidinone glycolate 203 in the glycolate 
aldol reaction to determine which substrate was more useful for this transformation.  
The preparation of each of these glycolates commenced with a copper iodide-
mediated propenyl Grignard addition to commercially available (R)-benzyl glycidyl 
ether (202).225,226  A quantitative yield of the desired secondary alcohol 204 was 
routinely obtained, and alcohol 204 was transformed into the corresponding glycolic 
acid (Scheme 36).  For this alkylation, three solvent systems were examined, 
tetrahhydrofun, N,N-dimethylformamide, and an equal mixture of the two 
aforementioned solvents.  As has been previously observed, a 1:1 ratio of 
tetrahydrofuran and N,N-dimethylformamide provided the highest yields of acid 
205.107,108  Attention was next turned to formation of the targeted glycolates 201 and 
203 to probe the glycolate aldol reaction.  The oxazolidinethione 201 was formed by 
either in situ acylation of the intermediate acid chloride with auxiliary 206 or standard 
peptide DCC coupling conditions.  The latter method provided a higher yield of the 
glycolate 201 and also allowed for recovery of unreacted acid 205, which was not 
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possible using the acid chloride route.  Alternatively, for the oxazolidinone glycolate 
203, the mixed anhydride of acid 205 was formed and treated in situ with lithiated 
oxazolidinone 207, providing glycolate 203 in high yield.  It was also discovered that 
the oxazolidinethione glycolate 201 could be hydrolyzed to again provide glycolic 
acid 205 under basic conditions if a change of chiral auxiliary was desired following 
glycolate formation.   
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Scheme 36.  Formation of the Glycolates 
 
 For the preparation of 4-pentenal (208), the aldehyde necessary for the 
proposed glycolate aldol reaction, we chose to utilize an oxidative cleavage of 5-
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hexene-1,2-diol (209).  To that end, racemic glycidol (210) was treated with 
allylmagnesium chloride to provide diol 209 (Scheme 37).  Diol 209 was then 
subjected to sodium periodate to provide 4-pentenal (208) in good yield following 
purification via distillation.  It was discovered that using unpurified aldehyde 208 led 
to poor results in the glycolate aldol reaction.   
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Scheme 37.  4-Pentenal Synthesis 
 
 The glycolate aldol reactions of thiomide 201 and imide 203 with 4-pentenal 
(208) were probed using three different enolization conditions (Table 3).  Initially, the 
conditions that had previously been optimized for glycolate aldol reactions within the 
Crimmins laboratory were used;207 namely, 1.0 equivalents of titanium tetrachloride 
were added to the cooled glycolates 201 and 203, followed by 2.5 equivalents of 
N,N-diisopropylethylamine to form the chlorotitanium enolate.  Also, the use of 1.0 
equivalent of (-)-sparteine for enolization followed by the addition of 1.0 equivalent of 
N-methyl pyrrolidinone ten minutes prior to aldehyde addition were tested, but with 
limited success.  Both methods exhibited higher reactivity and selectivity for the 
oxazolidinethione glycolate 201 when compared to the oxazolidinone glycolate 203.  
Still, the results left room for improvement.  Concurrently, more general conditions 
were being developed within our laboratory for use in the aldol addition of complex 
glycolates.204  As part of this program, these modified conditions, involving initial 
enolization with N,N-diisopropylethylamine followed by the addition of 1.0 equivalent 
of N-methyl pyrrolidinone ten minutes prior to addition of the aldehyde, were tested 
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with glycolates 201 and 203.  The results obtained were very encouraging, providing 
a higher yield and selectivity for the desired adducts 211 and 212.  These conditions 
have proven general for a range of glycolates to give reproducibly higher yields and 
selectivities compared with previous methods.  Though the oxazolidinone adduct 
212 was obtained in higher yield than the corresponding thioimide 211, for our 
purposes, we chose to proceed with the oxazolidinethione variant due to the higher 
diastereoselectivity obtained and resultant ease of purification of alcohol 211.   
Table 3.  Base Screening for Glycolate Aldol Reaction 
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O
208
TiCl4,
base, CH2Cl2,
-78 oC to -40 oC
Me
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OHH
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HH
 
Base 211 Yield 211 dr 212 Yield 212 dr 
i-Pr2NEt 59% 90:10 18% not measured 
i-Pr2NEt, NMP 70% >95:5 78% 90:10 
(-)-sparteine, NMP 18% 85:15 16% not measured 
 
 With the α,ω-diene 211 in hand, the key ring-closing metathesis to complete 
the oxonene was probed.  Treatment of aldol adduct 211 with the Grubbs second 
generation catalyst (151)172 led mostly to recovered starting material and unidentified 
side products (Scheme 39).  Protection of the secondary alcohol as the t-
butyldimethylsilyl ether gave diene 213, which did undergo ring-closing metathesis 
using the Grubbs second generation catalyst 151 in refluxing dichloromethane to 
form oxonene 214 (Scheme 38, 39).  However, conversion was low, and loss of the 
protecting group was observed during the course of the reaction and purification.  
Other ring-closing metathesis candidates were also tested, including the reduced 
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product of silyl ether 213, as we hoped to investigate whether the sulfur atom in the 
chiral auxiliary was poisoning the catalyst, as has been previously observed.  
Treatment of alcohol 215 with ring-closing metathesis conditions led to a 98% yield 
of oxonene 216.  With this result in hand, we prepared diol 217 by reduction of aldol 
adduct 211.  However, under identical conditions, this substrate gave only dimer 
218.  Finally, diol 217 was bis-protected as t-butyldimethylsilyl ethers and treated 
with the Grubbs second generation catalyst 151.  Excellent conversion to oxonene 
219 was observed.  Additionally, it was found that the concentration of the ring-
closing metathesis of diene 200 could be increased from the traditionally-used 2 mM 
up to 10 mM.  Though a seemingly small improvement, this finding paid dividends as 
throughput was greatly improved when processing material on larger scale as the  
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Scheme 38.  Ring-closing Metathesis Candidates 
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project progressed.  Following this modification, oxonene 219 could be isolated in 
99% yield when 5 mol% of the catalyst 151 was used in refluxing dichloromethane. 
Two-dimensional 1H NMR analysis (COSY, nOeSY) were performed on the bis-
acetate version 219b of oxonene 219.  This data corroborated that the desired 
configuration for the three stereocenters installed to this point was present, as strong 
nOe interactions were observed between the hydrogens on C2 and C9, and C2 and 
C3.  The completion of oxonene 219 represents the first successful formation of a 
nine-membered ring in the Crimmins laboratory via the glycolate aldol/ring-closing 
metathesis strategy that resulted in a natural product total synthesis. 
The sum of the results from the ring-closing metathesis studies can be 
rationalized via a conformational analysis of some of the possible rotamers of the 
diene (Figure 9).  It is apparent from the data that the substituent at C3 is of utmost 
importance for the ring closure to proceed successfully.  As previously described, 
gauche conformations place the olefins proximally allowing ring-closing metathesis 
to occur.  In the case where C3 is a hydroxyl substituent (R = H, 217), it is possible 
that the anti conformation is the least sterically encumbered, placing the two olefins 
distally.  However, when C3 is a silyl ether (R = TBS, 200, 215), the steric interaction 
between the silyl ether and the ether linkage of the diene becomes more 
pronounced in the anti conformation, and the gauche conformations, particularly the 
dipole minimized conformation, become more readily accessible, leading to 
productive oxonene formation.   
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Scheme 39.  Ring-closing Metatheses 
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Figure 9.  Conformational Analysis of Oxonene Formation 
 
4.  Synthesis of the Diels–Alder Candidate 
 Attention was next turned to installing the diene and dienophile necessary for 
the key intramolecular Diels–Alder cycloaddition.  We chose to install the diene first.  
To that end, the cleavage of the benzyl ether was examined.  Dissolving metal 
reductions of oxonene 200 using sodium naphthalene or sodium and liquid ammonia 
proved successful in accessing alcohol 221 in good yield (Scheme 40).  Care had to 
be taken to ensure that the primary silyl group was not cleaved due to prolonged 
reaction times with these reductions producing diol 222.  A six step method for 
recycling diol 222 to the desired alcohol 221 was devised involving formation of the 
triol and protection of the 1,3-diol as an acetonide to give alcohol 223.  Protection of 
the primary alcohol 223 as a pivalate ester and deprotection of the acetonide 
afforded diol 224.  Bis-protection as t-butyldimethylsilyl ethers and reduction of the 
ester functionality intercepted alcohol 221.  Oxidative cleavage of the benzyl ether 
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was also attemped using DDQ, but it was difficult to maintain the primary silyl ether 
within the slightly acidic reaction media.  When using a basic buffer, such as sodium 
bicarbonate, the oxidation ceased to occur, and only starting material 200 was 
recovered.  In the end, a sodium ammonia reduction became the most reproducible 
and scaleable method for transforming oxonene 200 into alcohol 221. 
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Scheme 40.  Benzyl Ether Cleavage 
 
          Oxidation of alcohol 221 was accomplished using Swern conditions130 or n-
Pr4NRuO4/NMO (Scheme 41).31  The Swern oxidation was the most reproducible, 
regardless of scale.  Dess-Martin periodinane was not useful in forming aldehyde 
225.43  With aldehyde 225 in hand, a one-step procedure for installing the diene 226 
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was attempted.  1-Alkyoxyallylphosphonium salts have been reported in the 
literature as useful substrates to effect a Wittig transformation, however, care must 
be exercised to maintain low temperatures to preclude allylic 1,3-rearrangement to 
afford 3-alkoxyphosphonium salts.  However, if the salt is prepared from the 
corresponding acetal using a Lewis acid and triphenylphosphine at low temperature, 
it can be deprotonated in situ to form the ylide, and the aldehyde can be added to 
this solution to afford the Wittig adduct.  This approach was reported by Kim and co-
workers using similar acetals to the one we desired to employ, and the enol ether 
products were hydrolyzed to the corresponding enones.227  The E:Z selectivity for 
the Wittig reactions were not reported due to the immediate hydrolysis of these 
adducts.  With knowledge of this precedent, we prepared the dimethyl acetal 227 of 
methacrolein (228), and used the reported conditions in hopes of generating our 
desired diene 226.  However, all attempts to isolate the desired Wittig adducts using 
simple aliphatic or aromatic aldehydes, as well as complex aldehyde 225 proved 
fruitless.  Though other methods exist in the literature for generating α-
alkoxyallylphosphonates and phosphine oxides,228 our concern with E:Z selectivity of 
these processes led us to try a two step method for installing the diene.  The use of 
1-methoxy-1-(triphenylphosphoranylidene)acetone (229) as a stabilized Wittig 
reagent had been reported to give excellent yield and complete E selectivity with 
aromatic aldehydes.229  We prepared this reagent in three steps from pyruvic 
aldehyde dimethyl acetal (230).  Formation of the α-chloro ketone was followed by 
displacement of the chloride with triphenylphosphine.  Deprotonation of the resultant 
salt provided stabilized ylide 229.  Productive Wittig reaction was observed with a 
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Scheme 41.  Diene Installation 
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simple aliphatic aldehyde using ylide 229.  Gratifyingly, treatment of aldehyde 225 
with ylide 229 in refluxing toluene led to an 84% yield of the desired enone 231 with 
complete E selectivity observed.  Methylenation of enone 231 gave desired diene 
226 in good yield. 
Installation of the dienophile required selective deprotection of the primary 
silyl ether, oxidation of the resultant alcohol, and another olefination reaction to join 
the two pieces.  Selective deprotection of diene 226 proved quite difficult.230  A 
number of buffered hydrogen fluoride conditions were employed, but all attempts 
that led to selective deprotection also resulted in hydrolysis of the enol ether to yield 
enone 232 (Scheme 42).  PPTS in protic solvent gave identical results.  Tetrabutyl- 
Table 4.  Selective Deprotection Attempts 
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Conditions 226 232 233 234 
PPTS, MeOH, CH(OMe)3, CH2Cl2  ▲   
HF:CH3CN, CH3CN, -20 oC  ▲   
HF:pyr., pyr., THF  ▲   
Et3N(HF)3, CH3CN, 0 oC  ▲   
n-Bu4NF, THF, 0 oC   ▲  
NaOH, EtOH, 78 oC   ▲  
K2CO3, MeOH, 65 oC ▲    
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ammonium fluoride at low temperature resulted in unselective deprotection to 
provide diol 233.  Sodium hydroxide in refluxing ethanol also gave diol 233.  Milder 
alkaline conditions, potassium carbonate in refluxing methanol, gave only recovered 
starting material 226.  The inability to access alcohol 234 led us to pursue initial 
installation of the dienophile prior to diene formation using alcohol 216. 
It was most expedient to use alcohol 216 (accessed in six steps from (R)-
benzyl glycidyl ether (202)) to probe dienophile installation.  Oxidation of alcohol 216 
was accomplished using Swern conditions130 to provide aldheyde 235 in high yield 
(Scheme 42).  A Wittig reaction was targeted for dienophile formation.  To that end, 
phosphonium salt 236 was prepared from Roche ester 237 in six steps.  Protection 
and reduction of ester 237 gave alcohol 238.231  The alcohol 238 was then 
transformed into bromide 239 through the intermediate mesylate.232  Finally, 
deprotection of the silyl ether gave the commercially available bromohydrin, which 
was converted to phosphonium salt 236 prepared for Wittig reaction.  Kozikowski 
and co-workers have reported the use of phosphonium salt 236 to provide a 
Schlosser modified-type Wittig adduct favoring the E olefin due to the intramolecular 
alkoxide present during the reaction.233  Since we desired the E olefin geometry as 
well, we attempted using this phosphonium salt with aldehyde 235.  Although the 
salt was effective in providing the E isomer when reacted with simple aldehydes, no 
olefination product 240 was observed using aldehyde 235.  Though we predicted a 
salt lacking the free hydroxyl would favor Z alkene formation, we still attempted 
using other protected Wittig substrates to investigate whether the free hydroxyl was 
leading to unproductive side reactions (Scheme 43).  Transient in situ protection as 
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a silyl ether was attempted,234 as well as use of the methoxymethyl ether variant 241 
of phosphonium salt 236, but none of the desired product 240 or 243 was obtained 
in any attempt.   
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Scheme 42.  Wittig Olefination Attempts 
A modified Julia olefination was next investigated for installation of the dienophile, 
due to the efficiency and high E selectivity these reactions have displayed in the 
literature.235  To that end, sulfone 244 was prepared in two steps from previously 
synthesized bromide 245 (Scheme 44).  However, treatment of aldehyde 235 with 
the potassium anion of benzothiazole 244 did not provide any of the desired diene 
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243.  Though discouraged by these results, we chose to attempt a cross-metathesis 
reaction, since this has found prior success in the Crimmins laboratory for joining 
two olefinic fragments.236 
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Scheme 43.  Protected Wittig Attempts 
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Scheme 44.  Modified Julia Attempt 
 
 The two desired cross-metathesis coupling partners were prepared in a 
straightforward manner.  Methylenation of aldehyde 235 gave diene 246 in 81% 
yield (Scheme 45).  Alcohol 238 was oxidized130 and methylenated to give alkene 
247.  Homodimerization of alkene 247 with the Grubbs second generation catalyst 
151 provided dimer 248 in good yield.172  Unfortunately, combining alkene 248 and 
diene 246 in refluxing dichloromethane in the presence of catalyst 151 was not 
efficient in providing dienophile 249.237  At this point, we speculated that the steric 
bulk of the t-butyldimethylsilyl ether protecting group at C3 was impeding addition of 
the olefination reagents, precluding dienophile formation.  We chose to install a less 
sterically encumbering protecting group at C3 to reattempt dienophile installation. 
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Scheme 45.  Cross-Metathesis Attempt 
 
 A p-methoxybenzyl ether was installed at C3 in place of the t-
butyldimethylsilyl ether present in aldehyde 235 (Scheme 46).  Our synthesis of 
aldehyde 250 began with deprotection of the silyl ether of alcohol 216 (accessed in 
six steps from (R)-benzyl glycidyl ether (202)).  The p-methoxyphenyl acetal 251 
was formed under acidic conditions in 84% yield, and the acetal was reduced with 
complete regioselectivity to form the secondary p-methoxybenzyl ether.  Oxidation 
under Swern conditions130 delivered desired aldehyde 250.  Following preparation of 
the tetrazole 252 from bromide 235 in two steps, a Julia–Kocienski olefination was 
 71 
attempted with aldehyde 250, as was a modified Julia reaction using benzothiazole 
244.  Each of these reactions led to productive olefination to give diene 253, with the  
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Scheme 46.  Successful Julia Olefination 
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modified Julia substrate 244 performing better than the tetrazole 252.  These results 
support our hypothesis that it was indeed the bulk of the C3 protecting group 
preventing effective dienophile installation.  With the dienophile installed, we 
targeted an installation of the diene that would allow us to test the viability of our 
intramolecular Diels–Alder strategy for the asbestinins. 
 Lithium di-t-butylbiphenylide was employed to selectively deprotect the benzyl 
ether of diene 253 in the presence of the p-methoxybenzyl ether (Scheme 47).  
Swern oxidation130 of the resultant alcohol provided aldehyde 254.  The previously 
investigated two step procedure for diene installation was next utilized.  First, a 
stabilized Wittig reaction using ylide 229 gave enone 255,229 which was 
methylenated to provide tetraene 256, prepared for intramolecular Diels–Alder 
reaction.  Unfortunately, subjection of oxonene 256 to conventional thermal as well 
as microwave conditions in an attempt to effect cycloaddition were unsuccessful 
(Scheme 48).  At least two possible sources were postulated for the observed low 
reactivity.  First, the 2,3-disubstituted diene hinders the rotation of the C11–C12 
carbon–carbon bond due to the eclipsing interaction present in the necessary s-cis 
conformation of the diene.  Second, the dienophile is significantly reduced in 
reactivity (compared to the dienophiles in the cladiellin series Diels–Alder reactions) 
because of the absence of an electron withdrawing group.107,108  Since changes to 
the C11–C12 substitution seemed less straightforward to implement into our 
synthetic plan, we set out to revise our strategy utilizing a more activated dienophile 
still possessing the C11–C12 substituted diene.  We postulated that this change in 
 73 
electronics should allow for more facile cycloaddition, providing a substrate that 
could be converted into an asbestinin. 
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Scheme 47.  Synthesis of the Diels–Alder Candidate 
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Scheme 48.  Attempted Cycloaddition 
 
Rather than spend time optimizing our route to an activated Diels–Alder 
candidate, we chose to proceed in the most expedient fashion possible toward a 
proof of concept.  So, previously prepared alcohol 258 was protected as a silyl ether, 
and the benzyl ether was reductively removed in the presence of the p-
methoxybenzyl ether to give alcohol 259 in only 40% yield due to loss of some of the 
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primary silyl ether during the course of the reaction and workup (Scheme 49).  
Oxidation130 and a Wittig reaction with ylide 229 provided enone 260.229  Diene 
formation and deprotection proceeded uneventfully to provide alcohol 261, which 
upon oxidation gave aldehyde 262.130  With the stage set to attempt the Wittig 
reaction to prepare a more activated Diels–Alder candidate, two ylides were utilized 
for the olefination reaction.  When ylide 263 was employed,238 enoate 264 was 
isolated after refluxing in benzene for one hour.  However, using 
(acetylmethylene)triphenylphosphorane (265),182 intramolecular Diels–Alder 
cycloaddition ensued under the conditions of the Wittig reaction, presumably via 
intermediate enone to provide the desired tricycle 266 (76%, 4:1 dr) favoring the 
exo-diastereomer.  This successful cycloaddition result served to confirm our 
hypothesis regarding the unfavorable electronics precluding reaction of the 
unactivated Diels–Alder candidate (Scheme 48).  We rationalize the stereochemistry 
observed in this cycloaddition in an analogous manner to the cladiellin transition 
states (Figure 7, Figure 10).108  Again, the exo-adduct is the favored product, but we 
hoped to improve the selectivity of this process by increasing the steric bulk at C3.  
This had been shown to be effective in the cladiellin case where the 
diastereoselection increased as the steric demand of the C3 substituent increased 
(Figure 11).  Particularly, the selectivity obtained when C3 was a p-methoxybenzyl 
ether in the asbestinin case (4:1 dr) closely mirrored that obtained when C3 was a 
benzyl ether in the ophirin B synthesis (4.5:1 dr).  Therefore, we chose to revise our 
approach to the asbestinins, ensuring a silyl ether was present at C3 in our modified 
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plan, since a silyl ether had demonstrated complete exo diastereoselection in the 
ophirin B case. 
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Scheme 49.  Revised Synthesis of Cycloaddition Candidate 
 
O
Me
PPh3
O
EtO
PPh3
C6D5CD3, 100 oC,
76%, 4:1 dr
C6D6, 80 oC,
90%
O
Me
MeO
Me
Me
H
HH
H
H
O OPMB
H
O
PMBO
Me
H H
H
Me
OMe
O
EtO
O
PMBO
Me
O
H H
H
Me
OMe
263
262 264
265
266
 
Scheme 50.  Successful Intramolecular Diels–Alder Reaction 
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Figure 10.  Asbestinin Cycloaddition Transition States 
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Figure 11.  C3 Protecting Group Effects in the Ophirin B Synthesis 
 
5.  Revised Retrosynthesis 
 Armed with the knowledge gained from our investigations to this point, we set 
out to apply the activated Diels–Alder strategy to complete the synthesis of the 
asbestinins.  Ketone 267 was targeted as a useful substrate for accessing the 
functionality of the five-, six-, and nine-membered rings of 11-acetoxy-4-
deoxyasbestinin D (196) and asbestinin-12 (197).  Triene 267 also features a handle 
that we envisioned to be useful for establishing the C15 stereochemistry of the 
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oxepane.  An intramolecular Diels–Alder cycloaddition of tetraene 268, with a silyl 
ether in place at C3 would be exploited to prepare the tricyclic framework.  And, 
oxonene 268 would be constructed via a ring-closing metathesis of previously 
synthesized diene 200, which was accessed via our glycolate aldol addition of 
thioimide 201, derived from (R)-benzyl glycidyl ether (202). 
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Scheme 51.  Revised Retrosynthesis 
 
6.  Synthesis of the Revised Diels–Alder Substrate 
 Utilizing previously prepared triene 226, accessible in 11 steps from 
commercially available material, the issue of selectively deprotecting the primary silyl 
ether was revisited (Table 4, Scheme 52).  After attempting several of the previously 
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examined conditions once again, it was finally found that ammonium fluoride in 
methanol promoted highly efficient selective deprotection, providing alcohol 234 in 
79% yield, with the remainder of the material representing recovered starting 
material 226 and diol 233 (which was able to be reprotected and recycled).239  
Following this important result, oxidation gave aldehyde 269 in high yield.130   
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Scheme 52.  Selective Deprotection and Improved Cycloaddition 
Utilizing ylide 265, the aldehyde 269 underwent a Wittig reaction and again cyclized 
to the desired tricycle 270, this time with a single isomer observable by NMR 
spectroscopy.  This result is in agreement with our previous observations involving 
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the importance of the C3 protecting group, further supporting our transition state 
models (Figure 10). 
 
7.  Refunctionalization of the Six- and Nine-membered Rings 
 With an efficient, fourteen step route to tricycle 270, attention was turned to 
refunctionalizing the six- and nine-membered rings with the substitution present 
within the asbestinin subclass.  First, the ketone of cycloadduct 270 was 
methylenated to provide a handle for a hydroboration/oxidation protocol that would 
be used to provide the proper configuration at C15 at a later point (Scheme 53).  
Triene 271 was then deprotected and oxidized to give ketone 264, the targeted point 
of divergence for the syntheses of 11-acetoxy-4-deoxyasbestinin D (196) and 
asbestinin-12 (197).43  Two-dimensional 1H NMR analysis (COSY, nOeSY) was 
performed at this point, since none of the previous substrates were amenable to 
confirming the stereochemistry obtained in the cycloaddition (Figure 12).  Strong 
support was gleaned from this data that the desired configuration was the product of 
the Diels–Alder reaction.  Namely,  a nOe was observed between the hydrogens of 
C1 and C10 and C2 and C9.  Further, the hydrogen of C2 was a singlet in the 1H 
NMR, indicating that it does not couple with any other hydrogens.  Via the Karplus 
equation, it can be deduced that it has a 90o relationship with the C1 hydrogen, 
indicating a trans relationship between those two protons.  The C14 configuration 
could not be definitively established from these data.  However, ketone 264 was a 
solid, white compound following purification, and some time later, a suitable crystal 
was obtained for X-ray crystallographic analysis (Figure 13).  The data obtained 
 80 
confirmed that the desired configurations for the C1, C2, C9, C10, and C14 
stereocenters were each as expected, definitively proving that the Diels–Alder 
cycloaddition proceeded to give the desired exo-adduct.  Each of the five 
stereocenters matched the desired configuration for the asbestinin subclass.  
Additionally, this data corroborated speculation gained from previous two-
dimensional analysis of asbestinin and cladiellin intermediates that the oxonene was 
oriented in a bowl shape with the top face (as drawn) representing the concave face.  
This conformational feature was present in the solid state, and we hoped to exploit 
this to execute a substrate-controlled diastereoselective reaction with the convex 
face of the oxonene. 
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Scheme 53.  Synthesis of the Ketone 
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Figure 12.  Two-dimensional NMR Data 
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Figure 13.  X-ray Crystallographic Data of the Ketone 
 A substrate-controlled diastereoselective methylation served to complete the 
functionalization of the oxonene (Scheme 54).  As hoped, a single isomer of tertiary 
alcohol 272 was obtained, presumably via attack on the convex face of the oxonene.  
This stereochemical outcome was supported by two-dimensional 1H NMR analysis 
(COSY, nOeSY), which showed a nOe between the newly installed methyl protons 
at C3 and the proton at C2 of the ring juncture, suggested a cis relationship between 
these two substituents. 
 Attention was then turned to functionalization of the cyclohexene (Scheme 
54).  Hydrolysis of the enol ether provided a 96% yield of a 10:1 mixture of α-methyl 
ketone diastereomers 273 and 274, favoring the undesired configuration.  Again, 
nOeSY spectroscopy was used to reveal a nOe interaction between the C12 methyl 
protons and the C10 proton in ketone 273, while ketone 274 showed a similar nOe 
between the C12 proton and the C10 proton.  Facile epimerization was achieved 
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under alkaline conditions to provide a 1:1.2 mixture of diastereomers at equilibrium, 
favoring the undesired configuration.  Two recycles allowed isolation of 83% of 
ketone 274 from enol ether 272, along with 13% of ketone 273 remaining.  Ensuing 
reduction of the ketone using sodium borohydride provided alcohol 275 in  good 
yield with good diastereoselectivity (>4:1 dr) for the desired C11 stereocenter.  
However, using a bulkier hydride source, L-selectride, provided a single isomer of 
diol 275 in 94% yield.  Selective acetylation of the secondary alcohol was trivial and 
proceeded in nearly quantitative yield to deliver alcohol 276.   
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Scheme 54.  Refunctionalization of the Six-membered Ring 
 
8.  Oxepane Formation to Complete 11-Acetoxy-4-deoxyasbestinin D 
 83 
 As previously mentioned, we had envisioned using a hydroboration/oxidation 
protocol to install the C15 stereocenter, hoping for a substrate-controlled 
diastereoselective reaction.  The X-ray of ketone 264 revealed that, in the solid 
state, the 1,1-disubstituted olefin is oriented such that the face upon which we hoped 
to selectively operate appears unencumbered, while the undesired face of reactivity 
is shielded by the oxonene portion of the tricycle (Figure 13).  We were hopeful that 
a similar low energy conformation would be operational in solution for diene 276.  
Numerous substrate-controlled highly diastereoselective hydroborations exist in the 
literature involving the reaction of a variety of 1,1-disubstituted olefins with 9-
BBN.240-242 When diene 276 was treated with 9-BBN under ultrasonic conditions in 
THF, the starting material was consumed, and upon oxidation, alcohol 277 was 
isolated (Scheme 55).  To our delight, chemoselective and regioselective 
hydroboration had been achieved, however, an equal amount of each C15 epimer 
was obtained.  After attempting similar hydroborations on ketone 264, alcohol 272, 
and ketone 274 with no success, we turned our attention toward improving the 
reaction with diene 276.  Namely, we hoped to install a protecting group on the C3 
alcohol that would impede addition for one face of the alkene by altering the 
energies of each transition state for the hydroboration step.  A trimethylsilyl group 
was installed uneventfully.  Hydroboration and oxidation of this substrate 278 did 
demonstrate modest diastereoselection (1.7:1 dr), but certainly left room for 
improvement.  A triethylsilyl variant 280 was prepared, and provided a 2.2:1 dr under 
the hydroboration/oxidation conditions.  A t-butyldimethylsilyl ether 282 was also 
formed, but exhibited identical diastereoselection to the triethylsilyl substrate 280 
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Scheme 55.  Hydroboration Studies 
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(2.2:1 dr) under the reaction conditions.  Formation of t-butyldimethylsilyl ether 282 
proceeded slowly due to the orientation of the C3 alcohol within the concave face of 
the oxonene.  Predictably, a triisopropylsilyl ether could not be formed at a useful 
rate.  Since this strategy seemed to have a modest ceiling of diastereoselectivity, we 
hoped to improve the ratio via epimerization of the corresponding aldehyde. 
 Diastereoenriched alcohol 277, prepared via deprotection of alcohol 281, was 
oxidized to the aldehyde 284 under Swern conditions (Scheme 56).130   
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Scheme 56.  Reductive Etherification Strategy 
  
Unfortunately, during the course of the reaction, the material epimerized to an equal 
ratio of C15 epimers.  Despite this undesired result, we attempted to proceed via 
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aldehyde 284 to form the oxepane using a ketal cyclization/reductive etherification 
strategy that had found use in our approach to brevetoxin A.214,243,244  To that end, 
the dimethyl ketal was formed.  A solvent switch and heating of the dimethyl ketal 
gave mixed methyl ketal 285.  Unfortunately, reductive etherification of mixed ketal 
285 resulted in isolation of aldehyde 284, rather than natural product 196, most likely 
due to adventitious water intercepting the oxocarbenium ion faster than hydride.  
Use of i-Bu2AlH led only to reduction of the acetate ester. 
A revised route to install the C15 methyl stereocenter diastereoselectively 
was devised envisioning hydrogenation of an exocyclic C15 1,1-disubstituted olefin 
following oxepane formation (Figure 14).  It was proposed that the concave nature of 
the tetracycle would allow selective reaction from the convex face, providing the 
desired C15 configuration.  To install the olefin and form the oxepane, we hoped to 
open the epoxide 286 of tricycle 276 with lithium diethylamide (Scheme 57).245  The 
diol would then undergo an intramolecular etherification, and hydrogenation would 
provide 11-acetoxy-4-deoxyasbestinin D (196).  Unfortunately, attempts to 
chemoselectively epoxidize the disubstituted olefin of diene 276 were unsuccessful, 
as the trisubstituted olefin reacted faster with m-CPBA to give epoxide 287.  Another 
method for installing the disubstituted epoxide was devised utilizing the Johnson–
Corey–Chaykovsky reaction.246,247  However, none of the desired epoxide 288 was 
isolated under these conditions.  Finally, we envisioned using a modified dienophile 
for the intramolecular Diels–Alder reaction that would allow exocyclic olefin 
formation, while also providing a handle for oxepane cyclization.  Again, our efforts 
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were thwarted as Wittig reaction with ylide 289 led to none of the desired tricycle 290 
under the same conditions that were successful using ylide 265.248 
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Figure 14.  Hydrogenation Strategy 
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Scheme 57.  Hydrogenation Strategy 
 
With the previous routes for diastereoselectively installing the C15 
stereocenter proving fruitless, we returned to the hydroboration/oxidation strategy.  
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Although chiral hydroborating agents generally give poor results for 
diastereoselectively hydroborating 1,1-disubstituted olefins, our lack of success with 
achiral variants led us to attempt using diisopinocampheylborane.249  Much to our 
delight, treatment of diene 280 with (+)-diisopinocampheylborane, followed by 
alkaline oxidation gave diol 281 as a single detectable diastereomer (Scheme 58).  
This represents only the second example of the successful application of 
diisopinocampheylborane for the diastereoselective hydroboration of a 1,1-
disubstituted alkene (Scheme 59).250  Formation of the corresponding mesylate 291 
was followed by deprotection of the silyl ether with fluoride, which we hoped would 
result in etherification via the intermediate alkoxide following deprotection.  However, 
fluoride 292 was instead isolated from the reaction mixture.  Alternatively, mesylate 
291 could be deprotected at lower temperature, to provide alcohol 293.  But, upon 
treatment with a variety of bases (sodium hydride, 2,6-lutidine, 4-
dimethylaminopyridine, collidine), only elimination product 276 was isolated.  
Overman has previously reported the formation of an oxepane in an analogous 
system for the total syntheses of briarellin E and F using an etherification that 
proceeds through the intermediate primary triflate (Scheme 10).80  Application of the 
same conditions to diol 277 delivered 11-acetoxy-4-deoxyasbestinin D (196) in 66% 
yield, with the remainder of the material representing elimination product 276.  
Whereas the Overman example required four days for complete reaction, the 
primary triflate of diol 277 took only four hours to cyclize, likely due to the extra 
rigidifying element present in our system of the closed oxonene.  The synthetic 
material corresponded to the natural material in all regards.11  Additionally, though 
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the optical rotation of the synthetic material ([α]26D; CHCl3 = -15) differed from the 
reported literature value ([α]29D; CHCl3 = -2.29), we were able to obtain a sample of 
the natural product from the Rodríguez laboratory at the University of Puerto Rico,  
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Scheme 58.  Completion of 11-Acetoxy-4-deoxyasbestinin D 
 
Río Piedras.  Submission of the natural material to polarimetry under the same 
conditions used for the synthetic material provided a matching optical rotation ([α]26D; 
 90 
CHCl3 = -15) to our synthetically prepared compound, further confirming the 
synthetic material was indeed 11-acetoxy-4-deoxyasbestinin D (196).  This 26 step 
sequence from (R)-benzyl glycidyl ether (202) represents the first total synthesis of a 
member of the asbestinin subclass.  Further, the optical rotations obtained for the 
synthetic and natural materials serve to confirm the absolute configuration of the 
asbestinin subclass, verifying that the biosynthetic proposal gives the proper 
configuration, rather than the enantiomer featured in the isolation literature.1,2,11 
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Scheme 59.  Masamune's Chiral Hydroboration 
 
9.  Total Synthesis of Asbestinin-12 
 For the synthesis of asbestinin-12 (197),224 we again hoped to exploit the 
inherent concavity of ketone 264 to perform a diastereoselective transformation.  
This time, an α-hydroxylation of the potassium enolate of ketone 264 using Davis 
oxaziridine provided the alcohol 294 as a single diastereomer (Scheme 60).251-253  
When a greater number of equivalents of the Davis reagent were employed, 
overoxidation was observed via epoxidation of the C11–C12 tetrasubstituted enol 
ether to provide a mixture of hydroxy epoxides 295 (1.3:1 dr).  However, use of just 
more than stoichiometric oxaziridine and careful monitoring of the reaction could 
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preclude formation of this undesired byproduct 295.  There was some concern that 
the presence of the C4 alcohol would adversely impact the diastereoselectivity of the 
subsequent alkylation via chelation of the carbonyl and hydroxyl to provide the 
epimeric C3 diol.  Fortunately, this phenomenon was never observed.  However, the 
conversion for this methylation was poor, perhaps due to competitive enolization of 
the C3 ketone, and prolonged reaction led to an unidentified byproduct.  Attempted 
use of methyllithium (with or without sodium tetrafluoroborate) did not improve the 
yield of this reaction.44,88,103  However, using a large excess of the Grignard reagent 
(20.0 eq), provided diol 296 as a single diastereomer in 84% yield.   
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Scheme 60.  Hydroxylation and Grignard Reactions 
 
Hydrolysis of enol ether 296 again provided the undesired C12 configuration 
of ketone 297 as the major product, in a similar ratio to that previously observed 
(Scheme 61).  Epimerization was again facile under alkaline conditions and gave 
some of the desired C12 methyl configuration 298.  A single diastereomeric triol was 
obtained upon reduction of ketone 298 with L-Selectride, whereupon selective 
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protection of the secondary alcohols was accomplished in the presence of the 
tertiary alcohol providing diacetate 300. 
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Scheme 61.  Formation of the Hydroboration Candidate 
 
At this point, we hoped to examine the role of the C3 protecting group in the 
diastereoselectivity of the hydroboration.  Earlier, the triethylsilyl ether 280 was 
ultimately employed as the hydroboration substrate for monitoring purposes 
(Scheme 58), but this was not necessary for diacetate 300.  Treatment of diene 300 
with (+)-diisopinocampheylborane and oxidation provided the desired diol 301 as a 
single diastereomer in good yield,249 confirming that the reagent controls the 
selectivity (Scheme 62).  Oxidation with the milder sodium perborate conditions 
proved useful in this case to prevent hydrolysis of the labile C4 acetate.73  Using 
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triflic anhydride and 2,6-lutidine,80 asbestinin-12 (197) was obtained in good yield, 
with the remainder of the material representing elimination product 300.  All data 
reported for the natural material again corresponded well with the data for the 
synthetic material.224 
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Scheme 62.  Completion of Asbestinin-12 
 
E.  Summary 
 In summation, highly stereoselective syntheses of 11-acetoxy-4-
deoxyasbestinin D (196) and asbestinin-12 (197) have been completed in 26 and 25 
steps respectively.  The strategy for completing these two molecules hinged upon 
the formation of an oxonene ring using an asymmetric gylcolate aldol reaction and 
subsequent ring-closing metathesis.  This oxonene was used as a manifold for an 
intramolecular Diels–Alder cycloaddition to form the hydroisobenzofuran moiety.  An 
α-hydroxylation was utilized to diverge the two routes.  A chiral hydroborating 
reagent proved crucial in establishing the stereocenter at C15.  These syntheses 
 94 
stand as the first molecules of the asbestinin subclass to be prepared by chemical 
methods and serve to confirm the absolute configuration of the asbestinins. 
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Scheme 63.  Summary for 11-Acetoxy-4-deoxyasbestinin D 
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Scheme 64.  Summary for Asbestinin-12 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter II 
A Convergent Strategy for the Total Synthesis of Brevetoxin A 
 
A.  Background 
 In addition to the previously described C2–C11 cyclized cembranoids, marine 
sources also provide an assortment of trans-fused polycylic ethers (Figure 15).254  
These molecules, generally produced by algae called dinoflagellates, make up a 
class known as the ladder toxins, due to their ladder like structure and often toxic 
biological effects.  In 1981, brevetoxin B became the first member of this class to be 
characterized.255  Since this time, a number of other ladder toxins have been 
isolated and their structures elucidated.  Each of the identified ladder toxins feature 
cylic ethers composed of five- to nine-membered rings, joined in a repeating 
trans/syn/trans pattern.  The total number of rings within each molecule varies 
greatly, from hemibrevetoxin B (302)256 possessing only four cyclic ethers and ten 
stereocenters, to maitotoxin, which features an impressive 32 ether rings and 98 
stereocenters.257  
 Beyond the fascinating complexity and uniformity of the structures of this 
class, the ladder toxins also display a range of biological properties.  Many of the 
observed effects are harmful to humans, including strong ichthyotoxicity255,258,259 and 
ciguatera poisoning.260,261  These properties have been implicated as the potent 
component of the red tides, resulting in massive fish kills and human sickness upon 
 98 
consumption of infected sea life.262  Additionally, cases have been reported of some 
ladder toxins becoming aerosolized during red tides, resulting in respiratory irritation 
for those in the area.  Despite these often harmful effects, some of the polycyclic 
ethers also feature beneficial biological effects, including antifungal properties263 and 
tumor cytotoxicity, with IC50 values as low as 0.5 nM.264,265 
 Due to the molecular intrigue, as well as the biological and ecological effects 
of trans-fused polycyclic ethers, a number of research groups have devoted effort 
toward the preparation of members of this class.  Several total syntheses of these 
daunting natural products have resulted from these endeavors.254,266  As part of this 
work, new synthetic strategies have been developed.  The large number of steps  
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generally required to prepare these molecules demand high throughput, and 
strategies for decreasing the total, and longest linear, number of steps have been 
described.   
B.  Approaches to Polycyclic Ether Synthesis 
1.  Iterative Ring Formation 
 The most straightforward method for forming polycyclic ethers involves 
applying approaches to medium ring ether formation in an iterative fashion to 
construct each ring of the ladder toxins sequentially.  Clearly, this strategy requires 
highly efficient formation of each ring, since there is no convergency to reduce the 
longest linear sequence.  One of the most effective methods of forming polycyclic 
ethers in a linear fashion was developed by the Rainier laboratory, centered upon C-
glycoside synthesis.267  The strategy has been applied to the preparation of the 
ABCD 306268 and FGH269 subunits of gambierol, a natural product that causes 
ciguatera (305).270  Namely, an enol ether–olefin ring-closing metathesis route was 
exploited to build each of these subunits.  Beginning with pyran 307, an epoxidation 
and subsequent Grignard addition delivered the tertiary alcohol, which was acylated 
to provide alkene 308 in 51% yield over two steps (Scheme 65).  The theme of 
opening enol ether epoxides with nucleophiles was repeatedly utilized to build 
handles for establishing the subsequent rings.  Methylenation271 and treatment with 
the Grubbs second generation catalyst (151)172 gave the AB ring unit 309, again 
possessing an enol ether ready for oxidation.  Nine steps delivered ester 310, which 
was again methylenated271 and subjected to a ring-closing metathesis172 to provide 
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the ABC ring system 311.  Epoxidation, in situ reduction, and cyclodehydration gave 
the ABCD fragment 306268.  Similar methods were employed to complete the FGH 
unit of gambierol (305).269 
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Scheme 65.  Iterative Ladder Toxin Synthesis 
 
2.  Biomimetic Epoxide Opening 
 Nakanishi has proposed a biosynthetic pathway for the formation of polycyclic 
ethers involving a cascade of epoxide openings, with each epoxide opening 
simultaneously forming a new ring of the ladder toxins.258  This sequential approach 
to the construction of marine ladder toxins has been examined by several research 
groups to test the probability of this hypothesis of origins.272,273  One of the more 
refined approaches has been reported by the Jamison group.  They have used a 
cascade opening of polyepoxides to form a tetrad of tetrahydropyrans, a unit which 
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is present in several of the ladder toxins.274  Their strategy relies upon the use of 
trimethysilyl substituents on the epoxide, which serve to direct the cyclizations to 
favor the generation of tetrahydropyrans (6-endo) over the general bias for 
tetrahydrofuran formation (5-exo).  Exemplary of their strategy is the formation of 
tetracycle 312 in one step from pyran 313 (Scheme 66).  Pyran 313 was constructed 
using several iterations of the Shi epoxidation protocol to give the desired 
stereochemistry of each epoxide.275  In the event, treatment with cesium carbonate 
and cesium fluoride in methanol at 65 oC provided the tetracycle, which was 
acylated to provide ester 312.  During the course of the reaction, the trimethylsilyl 
groups served to direct the epoxidation to form the desired ring size; these directing 
groups are also cleaved following cyclization, a feature absent in other biomimetic 
routes.  Although the yield for this transformation is low (20% overall), three new C–
O bonds and three new C–H bonds are formed in this example, translating to an 
average of 80% yield per bond formation.   
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Scheme 66.  Biomimetic Approach 
 
3.  [X + 1 + X] Approach 
 As previously mentioned, convergent strategies have gained popularity within 
the synthetic community for the construction of polycyclic ethers to shorten the 
longest linear sequence and thereby increase throughput.  An example of this 
strategy was described by Sasaki in his synthesis of brevenal (304).266,276,277  
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Interestingly, brevenal (304) acts to competitively displace brevetoxin A (303) in rat 
brain synapses and antagonizes the toxic effects of its ten-ring counterpart.  Due to 
this intriguing activity, as well as its potential utility for the treatment of cystic fibrosis, 
brevenal (303) has quickly garnered interest as a synthetic target.  The Sasaki 
laboratory has applied their B-alkyl Suzuki strategy to couple two fragments and 
form the central ring of the natural product.278  To that end, phosphate 314 and the 
hydroborated variant of alkene 315 were coupled under palladium-catalyzed 
conditions to afford tetracycle 316 (Scheme 67).  A second hydroboration and 
oxidation of the B ring enol ether, followed by further oxidation of the resultant 
secondary alcohol, gave ketone 317 in good yield.   
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 Installation of a secondary alcohol was next achieved in two steps (Scheme 
68).279  Protecting group manipulations and adjustment of the oxidation states of the  
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Scheme 68.  Completion of the ABCDE Rings 
alcohols on the B and D rings proceeded uneventfully.  The triethylsilyl ethers were 
concomitantly cleaved under conditions used to form the dithioketal, and the alcohol 
spontaneously cyclized to form the mixed thioacetal.280  Protection of the remaining 
secondary alcohol gave pentacycle 320.  Oxidation of sulfur and in situ alkylation of 
the resultant oxocarbenium ion provided polycycle 321 in 92% yield.  All that 
remained was installation of the A and E ring sidechains, which was completed to 
achieve the first total synthesis of brevenal (304).266,281 
 
4.  [X + 2 + X] Strategy 
 The final convergent approach developed to date involves the coupling of two 
fragments and subsequent formation of two rings between the previously 
independent moieties.  An example of this can also be found in the synthesis of 
gambierol (305) by Rainier.282  After iterative formation of the ABC 322 and FGH 323 
fragments,268,269 the group sought to join the two fragments and complete the E ring, 
followed by formation of the D ring to complete the octacycle.  To that end, acid 322 
was esterified with alcohol 323 under Yamaguchi conditions (Scheme 69).  Takai–
Utimoto conditions were modified for direct formation of enol ether 324 from the 
ester in 60% yield.283  With the E ring formed, attention was turned to installing the D 
ring to complete the octacyclic core.  Epoxidation and in situ reduction of ketone 324 
gave the alcohol, which was oxidized to provide ketone 325.  Deprotection, 
formation of the thioacetal,280 and radical reduction completed the D ring, to give the 
framework 326 for gambierol (305).  Eight more steps installed the side chains to 
complete the total synthesis of gambierol (305).   
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Scheme 69.  Formation of the D and E Rings 
 
C.  Brevetoxin A 
1.  Characterization and Biological Activity 
 Brevetoxin A (303) was isolated in 1975 by Alam and co-workers from the 
dinoflagellate Gymnodinium breve.284  This algal bloom has been implicated as the 
toxic component of the red tides in the Gulf of Mexico, causing massive fish kills.  
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The structure of brevetoxin A (303) was determined in 1986 via X-ray 
crystallographic analysis of its dimethyl ketal derivative.285  The following year, 
extensive NMR and MS analyses were reported which corroborated the previous 
structural assignment.286  Brevetoxin A (303) features a decacyclic structure with 22 
stereocenters and four methyl substituents, two of which are angular.  As with all 
ladder toxins, each ring is trans-fused.  Interestingly, brevetoxin A (303) is the only  
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Scheme 70.  Biosynthetic Hypothesis for Brevetoxin A 
 
 polycyclic ether that possesses five-, six-, seven-, eight-, as well as nine-
membered rings within the same molecule.  The Nakanishi proposal for the 
biosynthesis of the ladder toxins is demonstrated below for the natural formation of 
brevetoxin A (303).258  The decacycle is derived from a polyolefin via stereoselective 
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epoxidation of the nine E-olefins in the chain (Scheme 70).  The polyepoxide is then 
opened in cascade fashion, initiated by cyclization of the five-membered lactone and 
concluding with protonation of the J ring. 
In depth studies have been undertaken to elucidate the mode of action for 
brevetoxin A (303) within humans.  The brevetoxins bind strongly with neurological 
sodium ion channels.287  This binding causes the sodium channels to remain open, 
allowing a harmful influx of sodium ions.  As a result, the parent organism is 
eventually asphyxiated, causing death.  Based upon extensive calculations and 
binding studies with brevetoxin derivatives, the Baden laboratory has gained much 
insight into the binding of brevetoxin A (303) within the cell.  Calculations have 
determined that two B ring conformers, five D ring conformers, three E ring 
conformers, and five G ring conformers are possible, giving a total of 48 possible 
conformations of the natural product within 6 kcal/mol of the global minimum.288  
Additionally, the F ring serves as a hinge point for the entire molecule, allowing the 
decacycle to fold nearly in half on itself.  These calculations, as well as a number of 
synthetic manipulations on the natural material have elucidated which portions of 
brevetoxin A (303) are most crucial for binding.  The sum of these results suggest 
that brevetoxin A (303) is a cigar-shaped molecule, about 30 Å in length, which 
binds primarily via hydrophobic and nonpolar solvation forces, potentially facilitated 
by hydrogen bond donors near the A ring lactone.289  This greater understanding of 
the mode of action of the brevetoxins should prove useful in attempting to deal with 
this serious ecological concern. 
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2.  Nicolaou’s Total Synthesis of Brevetoxin A 
 Naturally, the intriguing structure and biological properties of brevetoxin A 
(303) have sparked interest within the synthetic community.  This molecule is clearly 
quite daunting, and some inherent question as to whether or not a molecule of this 
size and complexity could even be prepared via purely synthetic means existed from 
the outset.  Undeterred, or possibly inspired by these challenges, the Nicolaou 
laboratory initiated a program targeting the brevetoxins in the 1980’s.  The group 
hoped to apply methods that they had developed specifically for the construction of 
oxygen-containing heterocycles to the total syntheses of the ladder toxins. 
 The Nicolaou group reported the total synthesis of the related undecacycle 
brevetoxin B in 1995,145,290-295 and utilized a similar strategy for the preparation of 
brevetoxin A (303).296-300  Strategically, the polycycle was envisioned to arise in a 
convergent [X + 1 + X] sense from the union of two fragments of similar complexity, 
the ABCD portion 327 and the FGHIJK fragment 328 (Scheme 71).  The E ring was 
proposed to be formed via the coupling of these two fragments using a Wittig 
reaction and subsequent dithioketal cyclyization.  For the ABCD fragment 327, the B 
and D rings would be formed via a bis-lactonization of the C ring, derived from D-
glucose (329).  A late-stage lactonization would provide the A ring.  The FGHIJ 
portion 328 would arise from a series of epoxide openings beginning with the J ring, 
derived from D-mannose (330), building the I and H rings in an iterative fashion.  
Wittig coupling and dithioketal cyclization would be exploited to establish the G and 
F rings. 
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Scheme 71.  Nicolaou's Retrosynthetic Analysis 
 To begin, tetrahydrofuran 331 was accessed in seven steps from D-glucose 
(329) via protection, oxygenations, deoxygenation, and alkylations (Scheme 72).  
Three steps delivered lactol 332, which was converted in three steps to the C ring 
333.  Fourteen steps were performed to prepare CD phosphonium salt 334, to be 
used as a probe for the E ring formation.  Similarly, F ring aldehyde 335 was 
synthesized in 24 steps from known diol 336.301  Union of fragments 334 and 335 
was accomplished using a Wittig coupling to provide the diene in 82% yield.  
Deprotection provided the D ring alcohol 337.  However, upon subjecting the 
dithioketal 337 to the cyclization conditions developed in their laboratory, no E ring 
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Scheme 72.  Attempted E Ring Formation Model 
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Scheme 73.  Nicolaou’s Revised Retrosynthesis 
 
was formed.280  Instead, elimination 339 and hydrolysis 340 products were isolated 
in 87% combined yield.  Due to this setback, a new approach to brevetoxin A was 
envisioned that would involve formation of the F ring as the point of convergence 
(Scheme 73).  It was thought that the smaller size of the F ring, an oxocene 
compared to the E ring oxonene, would facilitate the dithioketal cyclization.  To that 
end, BCDE phosphonium salt 341 was targeted along with GHIJ aldehyde 342. 
To model the revised coupling strategy, E ring 343 was prepared in 20 steps 
from 2-deoxy-D-ribose (344, Scheme 74).  Analogously, 16 steps delivered GH 
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aldehyde 345 from 2-deoxy-D-ribose (344).  Again, Wittig coupling was effective in 
joining the two fragments and gave the diene in 77% yield.  Deprotection provided a 
candidate for cyclization 346, and this time, the conditions developed within the 
Nicolaou laboratory were effective for giving pentacycle 347.280  Radical reduction of  
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Scheme 74.  Model of F Ring Formation 
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the mixed thioacetal delivered the EFGH fragment 348 in 80% yield as a single 
diastereomer. 
With confidence in the main disconnection point chosen for brevetoxin A 
(303), the group set out to prepare BCDE fragment 341 and GHIJ aldehyde 342 to 
complete their total synthesis.  Previously described C ring 333 was converted in five 
steps to diacid 349 (Scheme 75).  A bis-lactonization closed the B and D rings and 
four more steps gave dilactone 350.  Six further steps were exploited to vary the 
oxidation states of the B and D rings and deliver triol 351.  Protecting group 
manipulations proceeded for the subsequent six steps to give alcohol 352, and the 
lactone was formed to close the E ring and give access in four steps to lactone 353.  
Four steps were utilized to prepared diene 354, and alcohol 355 was accessed in six 
additional steps.  Finally, the targeted phosphonium salt 341 was realized in four 
steps from alcohol 355. 
For the GHIJ aldehyde 342, seven previously elucidated steps gave access to 
alkene 356 from D-mannose (330, Scheme 76).293  Six further transformations 
delivered epoxide 357, which was altered in four additional steps to give alkene 358.  
Epoxide 359 was arrived upon in five steps from alkene 358, and four more steps 
gave alkene 360 with the H ring in tact.   Five manipulations gave acetonide 361, 
and eight further steps provided the aldehyde 362.  The G ring was formed via a 
dithioketal cyclization and four additional steps to provide pentacycle 363.  Five 
steps delivered alcohol 364, and four more transformations delivered targeted 
aldehyde 342.   
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Scheme 76.  GHIJ Aldehyde Synthesis 
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 With each of the desired coupling partners in hand, attention was turned to 
the union of these units and formation of the F ring.  Unfortunately, unlike in the 
model system (Scheme 74), the Wittig reaction was unsuccessful in delivering the 
desired olefinic product 365 (Scheme 77).  The methyl substituent of the GH ring 
juncture was implicated as the culprit, as it had been omitted in the successful model 
system (Scheme 74).  The steric interactions of the ylide of phosphonium salt 341 
and the aldehyde 342 precluded productive olefination.  As a result, a less bulky 
ylide was targeted, and alcohol 355 was transformed into phosphine oxide 366 in 
four steps (Scheme 78).  It was predicted via extensive modeling that a small, 
chelating protecing group, in this case methoxypropyl, would be necessary to obtain 
good Z selectivity for the olefination. 
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Scheme 77.  Attempted Wittig Coupling 
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Scheme 78.  Phosphine Oxide Formation 
 
 A Horner–Wittig coupling was employed to join the BCDE phosphine oxide 
366 and GHIJ aldehyde 342 (Scheme 79).  Base-induced elimination of the resultant 
adduct provided diene 367 in 56% yield over the two steps.  Mild acidic conditions 
were useful in cleaving the ketal protecting group, and subjection to Nicolaou’s 
hydroxyl dithioketal cyclization conditions resulted in formation of mixed thioacetal 
368.280  Earlier investigations had revealed that radical reduction was not useful in 
removing the thioether, so a two-step oxidation and reduction protocol was exploited 
to deliver the fully functionalized F ring 369.  With the BCDEFGHIJ portion of 
brevetoxin A (303) constructed, formation of the A ring and the J ring sidechain were 
next targeted.  The trityl protecting group had been cleaved during the reduction of 
the mixed thioacetal, so the primary alcohol was oxidized to the aldehyde43 and then 
the acid, followed by formation of the methyl ester 370 (Scheme 80).  Acidic removal 
of the silyl protecting groups also resulted in lactonization of the A ring.  Careful 
oxidation of the primary alcohol on the J ring was carried out in the presence of the 
secondary alcohol,43 and the resultant aldehyde was treated with Eschenmoser’s 
salt to provide brevetoxin A (303),302 which was identical in all regards to the natural 
material.284 
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Scheme 79.  Formation of the BCDEFGHIJ Portion 
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Scheme 80.  Completion of Brevetoxin A 
 
 
D.  Previous Work in the Crimmins Laboratory Toward Brevetoxin A 
1.  Seminal Efforts Toward the BCDE Fragment 
 In 2000, the Crimmins laboratory began investigating the syntheses of the B 
and E rings of brevetoxin A (303).  The original intent was to probe the efficiency 
with which the glycolate alkylation/ring-closing metathesis strategy would allow 
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access to subunits of the ladder toxins.  In time, it was decided to pursue a total 
synthesis of this complex natural product.  An [X + 1 + X] strategy highly analogous 
to the Nicolaou laboratory’s endgame would be exploited to form the F ring (Scheme 
81).  This completion strategy was selected for at least two reasons; first, it divides 
the molecule into two fragments of very similar complexity, and second, the final 
steps worked out by the Nicolaou group have been demonstrated to be highly  
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Scheme 81.  Retrosynthetic Analysis of Brevetoxin A 
 
efficient.300  The required BCDE 371 and GHIJ 372 fragments would arise from a 
novel, convergent [X + 2 + X] strategy to form the CD and HI rings from their 
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respective peripheral rings.  The overall strategy hinged upon initial formation of the 
B 373, E 374, G 375, and J 376 rings via methods developed in our laboratory. 
Dr. Kyle A. Emmitte initiated these efforts, developing a 20 step approach to 
oxonene 377, as well as providing seminal results for the B ring synthesis.  
Following these findings, Dr. Patrick J. McDougall took on the task of improving 
routes to modified B and E rings, and developing a convergent [X + 2 + X] coupling 
strategy for the synthesis of the BCDE portion.244  For the E ring, Dr. Emmitte 
utilized a glycolate alkylation to initiate the synthesis (Scheme 82).208  Two steps 
transformed alkylation adduct 379 into aldehyde 380, which was used in a 
thiazolidinethione propionate aldol reaction to give alcohol 382.215  Four further 
transformations provided glycolate 383, which was alkylated with prenyl iodide to 
yield alkene 384.  Five further steps, including an asymmetric Brown allylation to set 
the C21 stereocenter,303 delivered diene 385, which was efficiently closed using the 
Grubbs catalyst 150 to provide oxonene 386.195,201  Five steps gave E ring 377, 
which could be utilized in a coupling reaction with the B ring.   
Dr. McDougall next developed two possible pathways to form the E ring of 
brevetoxin A (303).  The second route to the E ring was predicated upon the anti-
glycolate aldol methodology that Dr. McDougall had previously developed in the 
Crimmins laboratory (Scheme 83).304  Using glycolic acid 387 from the previous E 
ring route, oxazolidinethione glycolate 388 was prepared and subjected to the 
optimized conditions for anti-aldol reaction with 3-butenal.  This approach led to an E 
ring β-keto phosphonate 390, which proved useful in a Horner–Wadsworth–Emmons 
reaction to couple to the B ring.305,306  However, diene 390 was a truncated version 
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of the E ring, missing C24.  It was determined that a homologated version of the E 
ring would be more amenable to the desired [X + 1 + X] convergent coupling 
strategy for the F ring formation.  To that end, glycolate 391, differing from previously  
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Scheme 82.  Dr. Emmitte's E Ring Synthesis 
 
prepared glycolate 383 only in the protecting group for the C16 hydroxyl moiety, was 
alkylated with bromoacetonitrile to afford nitrile 384 (Scheme 84).  Thirteen steps 
provided diene 393, prepared for ring-closing metathesis.195,201  In the event, the 
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oxonene was formed, delivering phosphonate 394.  Both diene 389 and oxonene 
394 were utilized for a convergent coupling with the B ring to form variants of the 
BCDE portion of brevetoxin A (303, vide infra). 
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Scheme 83.  Dr. McDougall's First Generation E Ring Synthesis 
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Scheme 84.  Dr. McDougall's Second Generation E Ring Synthesis 
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 For the B ring, Dr. McDougall built upon initial results obtained by Dr. Emmitte 
to develop an efficient strategy for oxocane 395 (Scheme 85).  The approach 
commenced with an anti-glycolate aldol reaction of thioimide 396 with 3-methyl-3-
butenal.  Six steps provided glycolate 398, a candidate for an asymmetric alkylation.  
Treatment of the sodium enolate of glycolate 398 with benzyl iodomethyl ether 
prepared in situ gave adduct 399.  Three steps delivered diene 400, which upon 
treatment with the Grubbs second generation catalyst 151 yielded oxocene 401.172  
Five further transformations led to B ring oxocane 395, prepared for Horner–
Wadsworth–Emmons coupling. 
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Scheme 85.   Dr. McDougall's B Ring Synthesis 
 
E.  Prepartion of the BCDE and GHIJ Fragments 
 125 
1.  A Revised Route to a Homologated B Ring 
 The aforementioned B ring 395 was also truncated by one carbon (analogous 
to E ring 390).  Upon joining the effort toward brevetoxin A (303), my initial task was 
to develop an efficient, revised route to a homologated B ring, including C1, based 
upon Dr. McDougall’s efforts.  It was chosen to incorporate C1 at an early stage, 
essentially intercepting the previous route for the majority of the synthesis.  To that 
end, a one-carbon homologated variant of glycolate 398 was targeted.  A glycolate 
alkylation strategy was selected to replace the anti-glycolate aldol reaction used to 
initiate the previous route (Scheme 85).  Alkylation of glycolate 402 with methallyl 
iodide provided the desired adduct in 78% yield (Scheme 86).208  Reduction and 
oxidation130 delivered aldehyde 404, which was utilized in an aldol reaction with t-
butyl acetate to give alcohol 405 as a mixture of C3 epimers.  Reduction was 
accomplished using lithium aluminum hydride to provide diol 406.  In an effort to 
shorten the synthesis of diol 406, and further examine the versatility of glycolate 
alkylation adducts, we investigated other useful transformations using imide 403.  
After some optimization, it was found that very efficient Claisen condensation was 
possible using the lithium enolate of t-butyl acetate or ethyl acetate and imide 403 to 
yield β-keto ester 408 or 411 (Scheme 87).  Additionally, it was discovered that i-
Bu2AlH reduction of alkylation adduct 403 allowed for direct access to aldehyde 404.  
We propose that these manipulations are facilitated by the inductive effect of the 
ether oxygen, which increases the electrophilicity of the adjacent carbonyl.  Since 
this discovery, these reactions have found use in other settings within our laboratory.  
The most direct route to the B ring involved use of β-keto ester 407.  Reduction 
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provided diol 406, this time in three steps from glycolate 402 as opposed to the 
previous five step route (Scheme 88). 
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Scheme 86.  Homologated Diol Synthesis 
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Scheme 87.  Novel Glycolate Transformations 
 
Selective protection of the primary alcohol of diol 406 was followed by 
oxidation to give ketone 409 (Scheme 88).130  Chelation-controlled reduction 
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provided alcohol 410 in 79% yield (>15:1 dr).307  It was not possible to effect direct  
diastereoselective reduction on β-keto ester 407, likely due to favored formation of 
the zinc enolate.  Alcohol 410 represents a one-carbon homologated variant of an 
intermediate from the previous B ring route.  Formation of the glycolic acid and 
corresponding acylation to realize glycolate 411 proceeded uneventfully.  Alkylation 
with benzyl iodomethyl ether afforded alkene 412.208  Reduction and oxidation 
served to deliver aldehyde 413.130  Direct reduction to the aldehyde was not possible 
in this case, presumably due to either the increased steric demand of the alkylation 
adduct or counterproductive participation of the benzyl ether oxygen.  Vinyl Grignard 
addition gave a 3:1 inseparable mixture of diastereomers, favoring the desired C8 
configuration.  Although this center would later be oxidized, the configuration of the 
C8 alcohol had previously been demonstrated to be crucial for the impending 
hydrogenation to establish the C6 stereocenter.  Ring-closing metathesis delivered 
oxocenes 414 and 415.  At this point, the C8 epimers were separable, and the minor 
diastereomer 415 could be recycled via a Swern oxidation130 and Luche reduction 
(Scheme 89).49   
With the oxocene in hand, the merged material was subjected to 
hydrogenation with Crabtree’s catalyst at low temperature (Scheme 90).308  Since 
hydrogenations of allylic alcohols with Crabtree’s catalyst often proceed via direction 
from the hydroxyl group, it may appear counterintuitive that the C6 methyl and the 
C8 hydroxyl are cis to one another.  However, there are examples of 
cyclopropanations and epoxidations of cyclooctenes proceeding to provide the  
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Scheme 88.  Oxocene Synthesis 
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Scheme 89.  Recycling the C8 Epimer 
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newly-formed ring trans to the alcohol.309  As a probe of the role of the C8 oxygen, 
alcohol 414 was protected as a silyl ether and subjected to Crabtree’s 
hydrogenation.  In the event, no reaction was observed, even after several hours at 
ambient temperature.  Whether responsible for a conformational or directing effect, 
the C8 hydroxyl is clearly important in this transformation.  Oxidation130 provided a 
ketone, which delivered a single diastereomer of tertiary alcohol 419 upon alkylation 
with methylmagnesium chloride (Scheme 91).  Selective cleavage of the benzyl 
ether could be accomplished using lithium di-t-butylbiphenylide reduction or Raney 
nickel hydrogenation,310 with the latter proving more amenable to larger scale.  
Dess–Martin oxidation provided aldehyde 420,43 a one-carbon homologated variant 
of aldehyde 395.  Aldehyde 420 was prepared in 18 steps and 9.8% overall yield,  
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Scheme 90.  Diastereoselective Hydrogenation 
 
compared to 17 steps and 8.8% overall yield for aldehyde 395.  Highlights of this 
route include the discovery of novel reactivity for glycolate alkylation adducts, use of 
the more economical Swern oxidation130 in place of Dess–Martin periodinane at two 
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points,43 and more practical conditions for removal of the benzyl ether on large 
scale.310  The practicality and efficiency of this route is underscored by the 
preparation of 3.8 grams (7.2 mmol) of the B ring 420 in a single pass. 
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Scheme 91.  Completion of the Homologated B Ring 
 
2.  Formation of the BCDE Fragment  
After preparing multigram quantities of B ring aldehyde 420, this material was 
passed on to Dr. Patrick J. McDougall, who progressed the B ring aldehyde 420 and 
the E ring phosphonate 394 to BCDE fragment 421.  The route utilized was based 
upon previous success forming BCDE fragment 422 in eleven steps from truncated 
B ring 395 and truncated E ring 390.  The homologated cyclic ethers 420 and 394 
were joined via a Horner–Wadsworth–Emmons olefination using aqueous barium 
hydroxide (Scheme 92).305,306  Cyclodehydration was accomplished using 
Wilkinson’s catalyst, followed by heating with acid to give tricycle 424 in a single 
pot.311  Oxidation, ketalization, and reduction led to diol 422 in five steps.214  This 
route provided the BCDE tetracycle in four fewer steps from the B and E rings than 
the previous strategy for the truncated fragments.244 
 131 
O
Me
H
Me
PMBO
TIPSO H
H B OH
O1
420
Me
O
H
H
OBn
H
H
ETBSO
394
O
P
OMeO
MeO OBn
24
Ba(OH)2, THF, H2O
96%
O
Me
H
Me
PMBO
TIPSO
H
H
B
OH
423
O
O
H H
H OBn
OBn
Me
RO
R = TBS
(Ph3P)3RhCl, Me2PhSiH;
PPTS, PhMe, 50 oC
92%
O
Me
H
Me
PMBO
TIPSO H
H B OC
TBSO
O
H
H H
H
OBn
OBnMe
424
5 steps
E
O
O O
MeH
H
Me
H
Me
B C D
HO
HO
HH
421
OH
H
E
OBnH
H
OBn
1
24
O
O O
MeH
H
Me
H
Me
B C D
HO
TIPSO HH
422
OH
H
E
OHH
H
OH
E
 
 
Scheme 92.  Dr. McDougall's BCDE Formation 
 
 
3.  Formation of the GHIJ Fragment 
 The approach to the other half of brevetoxin A (303) was executed by J. 
Lucas Zuccarello, Dr. Pamela A. Cleary, and Dr. Jon D. Parrish.  Dr. Cleary 
designed a first generation synthesis of the G ring,312 while Dr. Parrish formed the J 
ring in an expedient fashion.  With these results, Luke Zuccarello progressed these 
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fragments, while optimizing each step, to the GHIJ fragment 425 (Figure 16).243  A 
similar Horner–Wadsworth–Emmons olefination/cyclodehydration approach was 
successful in forming the tetracycle 425.  Additionally, tetracycle 426 was accessed 
to provide a substrate with less robust protecting groups on the J ring, for more facile 
removal at a later stage.  Efforts are also underway to intercept Nicolaou’s silyl 
variant 342.296,297 
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Figure 16.  GHIJ Fragments 
  
F.  Model Studies of F Ring Formation 
 Upon attempting to model Wittig and Horner–Wittig strategies for the 
formation of the F ring using E and G ring fragments, a plethora of obstacles were 
encountered.  Oxidation of alcohol 427,43 an intermediate from the G ring 
synthesis,243 provided hemiketal 428, with concomitant loss of the p-methoxybenzyl 
protecting group, instead of the desired ketone 429 (Scheme 93).  To impede this 
cyclization so that we could access the ketal, we chose to install a cyclic constraint 
on the opposite side of the G ring.  Triol 430 was accessed by acidic deprotection of 
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both the silyl and p-methoxybenzyl protecting group, or by oxidative deprotection of 
the aryl ether, followed by fluoride-mediated removal of the silyl ether.  The latter 
route was more reproducible, as the acidic conditions gave a ring-opened product 
431 upon extended reaction time.  Treatment of triol 430 with p-toluenesulfonyl  
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Scheme 93.  G Ring Aldehyde for Model 
 
chloride caused spontaneous cyclization to give bicycle 432.  Oxidation provided the 
ketone, which was ketalized under acidic conditions to give dimethyl ketal 433.  Care 
had to be taken when handling ketal 433, as some slightly acidic solvents caused 
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elimination to occur.  As a result, all NMR’s were taken in d6-benzene.  Finally, the 
benzyl ether was cleaved under hydrogenolysis conditions, and oxidation provided 
aldehyde 434,43 which we hoped to use in a Wittig or Horner–Wittig reaction. 
The E ring model proved more difficult to work with.  Diol 435, an intermediate 
from the E ring 394 synthesis, was obtained from Dr. McDougall.214  Ring-closing 
metathesis afforded oxonene 436 (Scheme 94).195,201   We hoped to install a good 
leaving group on the primary alcohol, then protect the secondary alcohol.  However, 
tosylation of the primary alcohol of diol 436 led only to furan 437.  The diol was bis-
protected as triethylsilyl ethers and the primary silyl group was removed under acidic 
conditions.  Formation of the primary iodide led to facile cyclization to the previously 
observed furan 437, despite precedent in ladder toxin synthesis forming analogous 
silyl protected 1,4-halohydrins in high yield.254  We returned to diol 436 and 
protected the primary alcohol as an ester, followed by protection of the secondary 
alcohol as a silyl ether.  Methanolysis of the acetate group was followed by formation 
of the iodide 442, which also formed furan 437, though slower than the triethylsilyl 
variant 440.  Attempts to form the phosphonium salt 443 led to mixtures of 
cyclization and deprotection products.  These undesired cyclizations served to 
thwart our efforts at a phosphonium salt for the time being, so we pursued a 
phosphine oxide variant for a Horner–Wittig olefination.  To that end, mesylation and 
subsequent phosphine oxide formation delivered oxonene 444 in 88% from alcohol 
441 (Scheme 95).  Unfortunately, the lithium enolate of phosphine oxide 444 and 
aldehyde 434 did not react with one another, likely due to the size of the silyl ether 
on the E ring 444.  So, ester 446 was protected with a methoxymethyl ether, and 
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Scheme 94.  Attempted Phosphonium Salt Formation 
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Scheme 95.  Attempted Horner–Wittig Olefinations 
 
deprotection of the acetate gave alcohol 447.  Formation of the phosphine oxide 448 
proceeded as before, and again, the subsequent Horner–Wittig reaction was 
unsuccessful.  Discouraged by the time we had invested into these models that were 
diverging more and more from our complex system, we set out to prepare the BCDE 
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phosphine oxide with a methoxypropyl protecting group and the GHIJ aldehyde, 
fitted with a dithioketal, to mimic Nicolaou’s olefination (Scheme 79).296 
 
G.  Progressing the BCDE Fragment 
1.  Preparation of the BCDE Coupling Partner 
 Following the attempted modeling of the F ring formation, I undertook the task 
of progressing the BCDE fragment 421 to some possible coupling partners for the 
GHIJ tetracycles 342, 425, and 426.  After some deliberation, it was decided that p-
methoxybenzyl ethers would serve as useful protecting groups for the B ring diol 
during the formation of the F ring.  Bis-protection of diol 421, and reduction of the 
more electron poor benzyl ethers provided E ring diol 450 (Scheme 96).  In order to 
install a methoxypropyl protecting group on the secondary alcohol, it was necessary 
to transiently protect the primary alcohol.  To that end, the primary ester was 
accessed, followed by preparation of the desired ketal 451.  Alkaline solvolysis of the 
primary acetate and subsequent formation of the mesylate proceeded uneventfully.  
Formation of the phosphine oxide was successful; however, the oxidative workup 
also effected some hydrolysis of the acetal.  Although the material could be 
reprotected, it was difficult to separate alcohol 452 from the excess 
diphenylphosphine oxide used in the reaction.  To temporarily circumvent this 
difficulty, it was decided to form the acetal following synthesis of the phosphine 
oxide.  
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Scheme 96.  Unprotected Phosphine Oxide Synthesis 
 
 To access the desired phosphine oxide 453 using one additional step, the bis-
silyl ether was prepared, followed by selective acidic deprotection of the primary silyl 
ether to give alcohol 454 (Scheme 97).  Synthesis of the phosphine oxide 455 
proceeded in quantitative yield over the two steps.  This intermediate 455 represents 
a potential coupling partner for the GHIJ aldehydes 342, 425, and 426.  At this point, 
the silyl ether could be cleaved using fluoride, and the resultant alcohol could be 
used without purification and delivered desired phosphine oxide 453 in good yield.  
Additionally, as a potential coupling partner for a Wittig reaction rather than a 
Horner–Wittig olefination, phosphonium salt 456 was accessed in two steps from 
alcohol 454.  With each of the BCDE coupling partners 453, 455, and 456, the stage 
was set to probe the most efficient method for accessing the F ring olefin. 
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Scheme 97.  BCDE Phosphine Oxide Formation 
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Scheme 98.  Phosphonium Salt Formation 
 
2.  Analog Syntheses 
 Beyond the total synthesis of brevetoxin A (303), a second goal of this project 
involves accessing a variety of fragments and analogs of the brevetoxin structure 
that could provide further insight into the structure–activity relationships of this 
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molecule.  To facilitate these efforts, a collaboration was established with the Baden 
laboratory at the University of North Carolina at Wilmington.  The Baden group has 
examined the biological properties of the ladder toxins for over two decades.289,313  
As an initial group of molecules to assay, we hoped to pass along several BCDE 
fragments.  Oxidation of diol 421 delivered the A ring lactone, serving to form the 
pentacycle 457 useful for assays, as well as model the late-stage A ring formation 
(Scheme 99).31  Oxidative deprotection of the benzyl ethers of pentacycle 457 was 
unsuccessful.  Reduction of the benzyl ethers of diol 421 proceeded in high yield to 
give tetraol 458.  With these preliminary fragments in hand, diol 421, pentacycle 457, 
and tetraol 458 were sent to the Baden laboratory for testing, along with several 
GHIJ analogs.  Although these compounds have not delivered results of high 
importance to date, they have paved the way for further collaboration in the hope of 
better understanding the ladder toxins. 
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Scheme 99.  Analog Syntheses 
 
H.  Union of the BCDE and GHIJ Fragments and Completion of Brevetoxin A 
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 For the first attempt at coupling the BCDE and GHIJ fragments, phosphine 
oxide 453 and aldehyde 426 were chosen as substrates (Scheme 100).  Use of n-
butyllithium for the deprotonation of phosphine oxide 453 was difficult on small scale, 
as the resultant ylide was typically quenched by adventitious water prior to or during 
addition of aldehyde 426.  Since the use of superstoichiometric n-butyllithium would 
result in undesired alkylation and epimerization of aldehyde 426, we chose to 
investigate the use of excess lithium diisoproplyamide for the deprotonation event.  
To ensure that the ylide of fragment 453 was indeed formed, lithium 
diisopropylamide was added to the substrate resulting in a yellow solution; the ylide 
was quenched with deuterium oxide, and 1H NMR analysis of the resultant product 
provided evidence for incorporation of deuterium in the phosphine oxide, confirming 
that the ylide had been realized.  Pushing forward, deprotonation of phosphine oxide 
453 with lithium diisopropylamide followed by addition of a solution of aldehyde 426 
provided a complex mixture of products.  Inspection of the 1H NMR spectrum of each 
of these adducts led us to speculate that addition had occurred, however a 
significant portion of the material featured free hydroxyls resulting from benzoate 
ester cleavage.  Elimination of each of the coupled alcohols provided a very low 
yield of what we believe to be alkene 459.  However, the difficulties encountered 
with the esters in the initial addition caused us to pursue this strategy using a GHIJ 
fragment with more robust protecting groups on the J ring, namely aldehyde 425, 
possessing benzyl ethers in place of benzoate esters (Scheme 101).  
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Scheme 100.  Attempted Union of the Fragments 
 
Future work will involve attempting the union of phosphine oxide 453 and 
aldehyde 425, which we hope will allow the completion of the total synthesis of 
brevetoxin A (303) (Scheme 101).  Following formation of diene 460, we hope to 
effect deprotection of the acetal protecting group and form the mixed methoxyketal 
in one pot.  These types of ring formations have previously been achieved with 
smaller rings.314  Reduction of the resultant ketal should also result in deprotection of 
the p-methoxybenzyl ethers to provide nonacycle 461.  Removal of the benzyl ethers 
would then be followed by careful oxidation of the tetraol to deliver the A ring lactone 
and J ring aldehyde in one step.  Finally, treatment with Eschenmoser’s salt should 
provide brevetoxin A (303)302 
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Scheme 101.  Proposed Completion of Brevetoxin A 
 
I.  Summary 
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 In summary, a novel approach to the B ring 420 of brevetoxin A (303) has 
been devised and executed to prepare multigram quantities of the oxocane.  Novel 
reactivity was discovered and exploited along this route, and several improvements 
were made on the previous strategy.  This material has been progressed to 
tetracycle 421, and portions of this supply have been carried forward to the 
phosphine oxides 453 and 455 and the phosphonium salt 456 (Scheme 97, 98).  
Current efforts are directed at union of the BCDE and GHIJ fragments and the 
ultimate completion of brevetoxin A (303). 
  
 
Chapter III 
 
Experimental 
 
A.  Materials and Methods 
Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform 
infrared spectrometer.  Proton and carbon nuclear magnetic resonance (1H and 13C 
NMR) spectra were recorded on the following instruments:  Bruker 400 (1H at 400 
MHz; 13C at 100 MHz) and Bruker 500 (1H at 500 MHz; 13C at 125 MHz).  Optical 
rotations were determined using a Jasco P1010 polarimeter.  Thin layer 
chromatography (TLC) was conducted on silica gel F254 TLC plates purchased from 
Scientific Adsorbents, Inc.  Flash column chromatography was carried out using 
silica gel (32 to 63 µm) purchased from Scientific Adsorbents, Inc.  Diethyl ether 
(Et2O), tetrahydrofuran (THF), dichloromethane (CH2Cl2), and toluene were dried by 
being passed through a column of neutral alumina under nitrogen immediately prior 
to use.  Alkylamines and benzene were distilled from calcium hydride immediately 
prior to use.  Chloroform was washed and distilled over phosphorous pentoxide 
immediately prior to use.  Dimethyl sulfoxide (DMSO) was distilled from calcium 
hydride under reduced pressure and stored over 4 Å molecular sieves. Anhydrous 
N,N-dimethylformamide (DMF) was purchased from Aldrich chemical company in 1L 
Sure/SealTM bottles.  Acetic anhydride was distilled and stored under a blanket of 
argon.  Trifluoromethanesulfonic anhydride was distilled over phosphorous 
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pentoxide immediately prior to use.  All other reagents and solvents were used as 
received from the manufacturer.  All air and water sensitive reactions were 
preformed in flasks flame dried under positive flow argon and conducted under an 
argon atmosphere.  Davis oxaziridine was prepared via the condensation of 
benzaldehyde and benzenesulfonamide, followed by oxidation according to literature 
precedent.  Pivaloyl chloride was distilled and stored over 4Å molecular sieves.  Zinc 
borohydride was prepared by stirring a solution of zinc chloride (1.0 M in Et2O) with 
NaBH4 for two days in Et2O to prepare a 0.14M solution.  Dess-Martin periodinane 
was prepared according to literature procedures and stored at -20 ºC. 
B.  Procedures 
BnO Me
OH
 
 Homoallylic alcohol 8.  Into a flask equipped with a reflux condenser and an 
addition funnel was added freshly ground magnesium (10.55 g, 434.0 mmol).  The 
flask and its contents were flame dried.  125 mL of THF and iodine (one crystal) 
were added to the flask.  2-bromopropene (50.00 g, 413.3 mmol) was added in 125 
mL of THF to the addition funnel.  Several drops of the 2-bromopropene solution 
were added to the flask via addition funnel and the solution was stirred until 
colorless.  350 mL of THF was added to the addition funnel and the solution was 
added dropwise to the flask.  Following addition, 125 mL of THF was added to the 
flask, and the solution was stirred vigorously for 2 hours.   
Into a flask equipped with an addition funnel and a low-temperature 
thermometer was added cuprous iodide (3.58 g, 18.8 mmol) in 375 mL of THF.  The 
solution was cooled to –35 oC.  The solution of 2-propenylmagnesium bromide was 
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transferred via cannula to the addition funnel and added dropwise to yield a yellow 
solution.  (R)-benzylglycidyl ether (5) (28.66 mL, 187.4 mmol) was added to the 
addition funnel in 200 mL of THF.  The epoxide was added dropwise, and the 
solution was stirred at –35 oC for 1 hour.  The reaction was quenched by the addition 
of saturated aqueous NH4Cl, and then warmed to room temperature.  The resultant 
mixture was filtered through celite, yielding a blue solution.  The layers were 
separated and the organic layer was washed with brine.  The aqueous portions were 
extracted twice with a 1:1 solution of EtOAc/hexanes.  The organic layers were 
combined, dried over Na2SO4, and concentrated in vacuo.  Purification by flash 
column chromatography (25% EtOAc/Hexanes) provided 38.22 g (99%) of the 
alcohol as a colorless oil.  
Me
OBn
O CO2H
 
 Glycolic acid 9.  Into a flask equipped with an addition funnel was added 
sodium hydride (60% dispersion in mineral oil, 23.95 g, 598.6 mmol).  The sodium 
hydride was rinsed with pentane three times, diluted in 100 mL of THF, and cooled 
to 0 °C.  Bromoacetic acid (41.58 g, 299.3 mmol) was added to the addition funnel in 
100 mL of THF and added dropwise to the flask.  The solution was warmed to room 
temperature and stirred for 1 hour.  The flask was again cooled to 0 oC, and the 
previous secondary alcohol 8 (41.16 g, 199.5 mmol) was added to the addition 
funnel in 200 mL of DMF.  The solution of alcohol was added to the flask dropwise.  
Following addition, the reaction was warmed to room temperature and allowed to stir 
overnight.   The reaction was quenched by the addition of saturated aqueous NH4Cl 
and diluted with diethyl ether.  The solution was acidified to pH 3-4 by the addition of 
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10% H2SO4, then extracted.  The organic layer was washed with brine, dried over 
Na2SO4, and concentrated in vacuo.  Purification by flash column chromatography 
(10% then 25% EtOAc/Hexanes) provided 49.71 g (95%) of the acid as a colorless 
oil:  1H NMR (400 MHz, CDCl3) δ 1.75 (s, 3H), 2.13 (dd, J = 14.0, 6.0 Hz, 1H), 2.27 
(dd, J = 14.0, 7.1 Hz, 1H), 3.48 (dd, J = 10.0, 8.5 Hz, 1H), 3.54 (dd, J = 10.1, 2.9 Hz, 
1H), 3.71 (m, 1H), 4.10 (d, J = 17.3 Hz, 1H), 4.28 (d, J = 17.3 Hz, 1H), 4.59 (d, J = 
12.0 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.77 (d, J = 0.8 Hz, 1H), 4.85 (dd, J = 1.6, 
1.6 Hz, 1H), 7.29-7.39 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 22.6, 40.0, 68.2, 72.2, 
73.6, 79.6, 114.3, 127.9, 128.1, 128.6, 136.7, 140.8, 172.2; IR (film) 3483 (br), 3201 
(br), 2917, 1733 (str), 1454, 1454, 1364, 1205, 1129 cm-1; [α]25D = -25.0 (c = 1.30, 
CH2Cl2); MS (electrospray ionization) calculated for C15H21O4 [M + 1]+:  265.14, 
found: 265.2.   
NO
S
Bn
O Me
O
OBn
 
Oxazolidinethione glycolate 6.  A flask was charged with the glycolic acid 9 
(49.13 g, 185.9 mmol) and (4S)-4-benzyl-1,3-oxazolidine-2-thione (39.52 g, 204.5 
mmol) in 150 mL of CH2Cl2.  The solution was cooled to 0 oC.  
Dicyclohexylcarbodiimide (38.35 g, 185.9 mmol), 4-dimethylaminopyridine (1.14 g, 
9.33 mmol), and 35 mL of CH2Cl2 were added to the solution and the mixture was 
warmed to room temperature.  The yellow solution was stirred 4 hours, then cooled 
to 0 oC, and filtered.  The filtrate was washed with CH2Cl2.  The combined organic 
portions were washed with saturated aqueous NaHCO3, and the aqueous layer was 
extracted twice with CH2Cl2.  The combined organic extracts were washed with 
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brine, dried over Na2SO4, and concentrated in vacuo.  Purification by flash column 
chromatography (25% EtOAc/Hexanes) provided 70.13 g (86%) of the glycolate as a 
yellow oil:  1H NMR (400 MHz, CDCl3) δ 1.81 (s, 3H), 2.31 (dd, J = 14.1, 6.7 Hz, 1H), 
2.44 (dd, J = 14.3, 6.8 Hz, 1H), 2.64 (dd, J = 13.3, 10.2 Hz, 1H), 3.26 (dd, J = 13.3, 
3.2 Hz, 1H), 3.64 (m, 2H), 3.93 (m, 1H), 4.23 (dd, J = 7.7, 7.7 Hz, 1H), 4.31 (dd, J = 
9.3, 2.4 Hz, 1H), 4.54 (s, 2H), 4.79 (s, 1H), 4.83-4.90 (m, 1H), 4.83 (s, 1H), 5.23 (d, J 
= 18.3 Hz, 1H), 5.34 (d, J = 18.3 Hz, 1H), 7.17-7.36 (m, 10H); 13C NMR (100 MHz, 
CDCl3) δ 22.8, 37.3, 40.3, 59.8, 71.2, 71.9, 73.3, 73.5, 77.7, 113.1, 127.4, 127.5, 
127.6, 128.4, 129.0, 129.4, 135.1, 138.1, 142.1, 171.4, 184.7; IR (film) 2924, 1712 
(str), 1361, 1324, 1206, 1124 cm-1; [α]22D = +93 (c = 0.26, CH2Cl2); MS (electrospray 
ionization) calculated for C25H30NO4S [M + 1]+:  440.18, found: 440.3.   
 
OH
OH
 
 Hex-5-ene-1,2-diol.  Into a flask equipped with a mechanical stirrer, an 
addition funnel, and a low temperature thermometer was added allylmagnesium 
chloride (2.0 M in THF, 800.0 mL, 1.600 mol) and 800 mL of THF.  The solution was 
cooled to –20 oC.  Glycidol (35.40 mL, 533.3 mmol) in 800 mL of THF was added 
dropwise via addition funnel keeping the temperature at –20 oC.  The mixture was 
stirred 1 hour at –20 oC, then quenched by the addition of saturated aqueous NH4Cl.  
The organic layer was washed with brine, and the combined aqueous extracts were 
washed twice with 50% EtOAc/Hexanes.  The combined organic extracts were dried 
over Na2SO4 and concentrated in vacuo.  Purification by flash column 
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chromatography (10% then 50% EtOAc/Hexanes) provided 57.16 g (93%) of the diol 
as a colorless oil.  
H
O
 
Pent-4-enal.  Into a flask equipped with a mechanical stirrer was added hex-
5-ene-1,2-diol (65.31 g, 562.2 mmol), 800 mL of CH2Cl2, and 800 mL of water.  
Sodium periodate (240.52 g, 1.1245 mol) was added to the biphasic solution which 
was stirred for one hour.  The reaction was quenched by the addition of saturated 
aqueous NaHCO3.  The organic layer was washed twice with 10% Na2S2O3 in water, 
then dried over Na2SO4.  The volume was reduced to 100 mL in vacuo at 0 oC.  
Purification via distillation (bp:  96 oC, 760 mm Hg) gave 29.33 g (63%) of the 
aldehyde as a colorless liquid. 
NO
S
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Glycolate Aldol Adduct 11.  Into a flask equipped with an addition funnel 
was added glycolate 6 (28.63 g, 65.13 mmol) and 435 mL of CH2Cl2.  The solution 
was cooled to –78 oC and titanium tetrachloride (7.50 mL, 68.4 mmol) was added 
dropwise via addition funnel.  The solution was stirred 10 minutes at –78 oC and N, 
N-diisopropylethylamine (26.92 mL, 162.8 mmol) was added dropwise to give a 
purple solution that was stirred at –78 oC for 2.5 hours.  N-methylpyrrolidinone (6.57 
mL, 68.3 mmol) was added to the solution via addition funnel and stirred for 10 
minutes.  4- pentenal was added dropwise via addition funnel and stirred at –78 oC 
for 2 hours.  The solution was warmed to –40 oC for 1 hour, then quenched by the 
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addition of half saturated aqueous NH4Cl and warmed to room temperature.  The 
aqueous layer was extracted twice with CH2Cl2, then the combined organic extracts 
were dried over Na2SO4 and concentrated in vacuo.  Purification by flash column 
chromatography (20% then 50% EtOAc/Hexanes) provided 23.61 g (70%) of the 
alcohol as a yellow oil:  1H NMR (400 MHz, CDCl3) δ 1.67-1.78 (m, 2H), 1.80 (s, 3H), 
2.01 (dd, J = 13.2, 11.1 Hz, 1H), 2.15 (ddd, J = 14.9 , 7.1, 7.1 Hz, 1H), 2.20-2.36 (m, 
3H), 2.41 (dd, J = 14.0, 7.9 Hz, 1H), 3.20 (dd, J = 13.3, 2.8 Hz, 1H), 3.51 (dd, J = 
10.3, 2.7 Hz, 1H), 3.68 (dd, J = 10.3, 7.6 Hz, 1H), 3.92-4.01 (m, 2H), 4.14 (dd, J = 
9.4, 2.1 Hz, 1H), 4.19 (ddd, J = 9.3, 9.3, 9.3 Hz, 1H), 4.47 (d, J = 12.3 Hz, 1H), 4.53 
(d, J = 12.3 Hz, 1H), 4.77 (m, 1H), 4.84 (s, 1H), 4.86 (s, 1H), 4.98 (d, J = 10.2 Hz, 
1H), 5.05 (dd, J = 17.2, 1.5 Hz, 1H), 5.83 (dddd, J = 17.0, 10.3, 3.6, 3.6 Hz, 1H), 
6.34 (d, J = 2.0 Hz, 1H), 7.08-7.35 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 22.6, 
29.9, 33.2, 36.7, 40.7, 60.9, 70.6, 72.5, 73.1, 74.2, 78.7, 80.8, 114.0, 114.9, 127.22, 
127.24, 127.5, 128.4, 128.9, 129.3, 135.6, 138.0, 138.1, 141.6, 172.2, 185.2; IR 
(film) 3458 (br), 2924, 1712 (str), 1446, 1361, 1324, 1206, 1128 cm-1; [α]23D = +25 (c 
= 0.43, CH2Cl2); MS (electrospray ionization) calculated for C30H38NO5S [M + 1]+:  
524.24, found: 524.3.   
 
O
HO
Me
OBn
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Dien diol 14.  Into a flask equipped with an addtion funnel was added alcohol 
11 (19.89 g, 38.01 mmol) in 380 mL of Et2O.  Methanol (3.08 mL, 76.0 mmol) was 
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added, and the solution was cooled to 0 oC.  Lithium borohydride (2.0 M in Et2O, 
38.01 mL, 76.03 mmol) was added dropwise via addition funnel, and the solution 
was stirred 1.5 hours at 0 oC.  The reaction was quenched by the addition of 
aqueous NaOH (380 mL, 190 mmol) and stirred 15 minutes at room temperature.  
The layers were separated and the aqueous was washed three times with Et2O.  
The combined organic extracts were dried over Na2SO4 and concentrated in vacuo.  
Purification by flash column chromatography (20% EtOAc/Hexanes) gave 11.96 g 
(95%) of the diol as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 1.51-1.60 (m, 2H), 
1.75 (s, 3H), 2.08-2.19 (m, 2H), 2.26 (ddd, J = 14.4, 7.8, 7.8 Hz, 1H), 2.36 (dd, J = 
14.0, 6.5 Hz, 1H), 2.72 (br s, 1H), 3.32 (m, 1H), 3.47 (dd, J = 10.0, 7.9 Hz, 1H), 3.56-
3.61 (m, 3H), 3.75 (br s, 1H), 3.77 (br s, 1H), 3.90 (dddd, J = 7.0, 7.0, 7.0, 2.6 Hz, 
1H), 4.56 (s, 2H), 4.77 (s, 1H), 4.84 (s, 1H), 4.96 (ddd, J = 10.2, 1.9, 0.7 Hz, 1H), 
5.03 (ddd, J = 17.1, 3.5, 1.6, 1H), 5.82 (dddd, J = 16.9, 10.2, 6.7, 6.7 Hz, 1H), 7.29-
7.38 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 22.7, 29.8, 32.5, 41.2, 62.7, 71.2, 72.9, 
73.6, 76.7, 83.0, 114.0, 114.8, 127.9, 128.1, 128.6, 137.1, 138.3, 141.7; IR (film) 
3436 (br), 2921, 1641, 1454, 1092 cm-1; [α]24D = -11 (c = 0.32, CH2Cl2); MS 
(electrospray ionization) calculated for C20H30O4Na [M + Na]+: 357.20, found: 357.3. 
O
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 Diene 5.  A flask was charged with the 1,3-diol 14 (11.96 g, 35.76 
mmol) and 140 mL DMF.  Imidazole (18.26 g, 268.2 mmol) and 4-
dimethylaminopyridine (437 mg, 3.58 mmol) were added to the solution, followed by 
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tert-butyldimethylsilyl chloride (13.48 g, 89.40 mmol).  The solution was warmed to 
50 oC and stirred overnight.  The reaction was quenched by the addtion of saturated 
aqueous NH4Cl, cooled to room temperature, and diluted with Et2O.  The layers 
were separated, and the aqueous portion was washed twice with Et2O.  The 
combined organic extracts were washed with brine, dried over Na2SO4, and 
concentrated in vacuo.  Purification by flash column chromatography (1% 
EtOAc/Hexanes) provided 17.42 g (86%) of the diene as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 0.07 (s, 3H), 0.08 (s, 3H), 0.107 (s, 3H), 0.112 (s, 3H), 0.93 (s, 
9H), 0.95 (s, 9H), 1.29 (dddd, J = 14.7, 9.9, 9.9, 5.0 Hz, 1H), 1.74-1.82 (m, 1H), 1.82 
(s, 3H), 1.98 (m, 1H), 2.18-2.28 (m, 1H), 2.24 (dd, J = 13.8, 7.9 Hz, 1H), 2.39 (dd, J 
= 13.8, 4.6 Hz, 1H), 3.45 (dd, J = 9.7, 6.2 Hz, 1H), 3.45-3.50 (m, 1H), 3.61 (dd, J = 
10.6, 7.9 Hz, 1H), 3.69 (dd, J = 9.8, 4.6 Hz, 1H), 3.70-3.75 (m, 1H), 3.82-3.88 (m, 
1H), 3.89 (dd, J = 10.6, 2.2 Hz, 1H), 4.59 (s, 2H), 4.82 (s, 1H), 4.85 (m, 1H), 4.98 
(dd, J = 10.2, 1.9 Hz, 1H), 5.05 (ddd, J = 17.0, 3.3, 1.5 Hz, 1H), 5.85 (dddd, J = 16.9, 
10.2, 6.6, 6.6 Hz, 1H), 7.27-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ –5.5, -5.3, -
4.6, -4.3, 18.0, 18.2, 23.0, 25.8, 25.86, 25.92, 25.93, 30.6, 30.9, 41.4, 62.8, 71.9, 
72.7, 73.2, 77.2, 83.3, 113.0, 114.3, 127.4, 127.5, 128.2, 138.6, 138.8, 142.6; IR 
(film) 2929, 1463, 1255, 1095 cm-1; [α]24D = +35.7 (c = 1.24, CH2Cl2); MS 
(electrospray ionization) calculated for C32H58O4Si2Na [M + Na]+: 585.38, found: 
585.5. 
O
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 Oxonene 18.  Into a flask equipped with a reflux condenser was added diene 
5 (16.56 g, 29.24 mmol) and 2.9 L CH2Cl2.  The solution was brought to reflux for 30 
minutes, followed by the addtion of Grubbs’ catalyst (1.25 g, 1.47 mmol) and stirring 
three hours at reflux.  The solution was cooled to room temperature and 
concentrated in vacuo.  Purification by flash column chromatography (1% 
EtOAc/Hexanes) provided 15.53 g (99%) of the oxonene as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 0.02 (s, 3H), 0.03 (s, 9H), 0.88 (s, 9H), 0.89 (s, 9H), 1.42 (dddd, 
J = 3.9, 3.9, 13.5, 13.5 Hz, 1H), 1.73 (m, 1H), 1.79 (s, 3H), 1.86 (m, 1H), 1.98 (d, J = 
14.02 Hz, 1H), 2.44 (dd, J = 14.2, 7.9 Hz, 1H), 2.81 (dddd, J = 13.2, 13.2, 13.2, 4.4 
Hz , 1H), 3.29-3.35 (m, 2H), 3.38 (m, 1H), 3.54 (dd, J = 13.6, 8.9 Hz, 1H), 3.67 (dd, J 
= 11.0, 8.5 Hz, 1H), 3.92 (dd, J = 11.1, 2.4 Hz, 1H), 3.96 (m, 1H), 4.56 (s, 2H), 5.34 
(dd, J = 11.4, 5.3 Hz, 1H), 7.27-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ –5.2, -
5.1, -4.8, 18.1, 18.3, 25.3, 25.8, 25.9, 26.0, 26.1, 32.2, 36.1, 61.8, 67.7, 73.0, 73.4, 
77.9, 84.3, 126.1, 127.5, 127.6, 128.3, 134.7, 138.4; IR (film) 2928, 1471, 1254, 
1089 cm-1; [α]24D = +33.6 (c = 1.16, CH2Cl2); MS (electrosray ionization) calculated 
for C30H54O4Si2Na [M + Na]+: 557.35, found: 557.4. 
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 Primary alcohol 37.  Into a flask equipped with a cold finger condenser, 
cooled to –78 oC, and a stir bar was added oxonene 18 (4.03 g, 7.52 mmol) and 210 
mL of THF.  The solution was cooled to –78 oC, and 105 mL of ammonia was 
condensed into the flask.  Freshly cut sodium metal (3.46 g, 150 mmol) was added 
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to the solution yielding a blue color.  After 15 minutes at –78 oC, the reaction was 
quenched by the addition of saturated aqueous NH4Cl.  The ammonia was allowed 
to evaporate at room temperature, and the layers were separated.  The aqueous 
portion was washed three times with Et2O, dried over Na2SO4 and concentrated in 
vacuo.  Purification via flash column chromatography (5% EtOAc/Hexanes) gave 
2.86 g (86%) of the alcohol as a colorless oil.  1H NMR (400 MHz, CDCl3) δ 0.01 (s, 
3H), 0.02 (s, 3H), 0.09 (s, 3H), 0.10 (s, 3H), 0.86 (s, 9H), 0.91 (s, 9H), 1.44 (m, 1H), 
1.49 (d, J = 10.6 Hz, 1H), 1.70 (dddd, J = 13.8, 13.8, 5.3, 2.0 Hz, 1H), 1.78 (s, 3H), 
1.90 (m, 1H), 2.39 (dd, J = 14.1, 9.9 Hz, 1H), 2.77 (dddd, J = 13.0, 13.0, 13.0, 5.4 
Hz, 1H), 3.33 (m, 1H), 3.44-3.52 (m, 2H), 3.59 (m, 1H), 3.73 (dd, 10.0, 10.0 Hz, 1H), 
3.88 (ddd, J = 6.6, 3.5, 3.5 Hz, 1H), 3.97 (ddd, J = 8.8, 3.2, 3.2 Hz, 1H), 4.01 (dd, J = 
10.5, 2.1 Hz, 1H), 5.35 (dd, J = 11.8, 5.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ –
5.5, -5.3, -5.0, -4.9, 18.0, 18.5, 25.6, 25.78, 25.79, 26.0, 31.6, 35.0, 62.5, 67.7, 68.0, 
81.2, 85.8, 125.9, 133.9; IR (film) 3477 (br), 2929, 1463, 1255, 1089 cm-1; [α]24D = 
+26.9 (c = 2.44, CH2Cl2); MS (electrospray ionization) calculated for C23H48O4Si2Na 
[M + Na]+: 467.30, found: 467.4. 
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 Aldehyde.  A flask was charged with oxalyl chloride (2.0 M in CH2Cl2, 3.52 
mL, 7.04 mmol) and 40 mL of CH2Cl2 and cooled to –78 oC.  Dimethylsulfoxide (1.00 
mL, 14.1 mmol) in 8 mL of CH2Cl2 was added dropwise, and the solution was stirred 
2 minutes.  The primary alcohol 37 (2.85 g, 6.40 mmol) and 16 mL CH2Cl2 were 
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added dropwise to the mixture and allowed to stir 30 minutes at –78 oC.  
Triethylamine (4.46 mL, 32.0 mmol) was added dropwise and stirred 5 minutes at –
78 oC, followed by warming to 0 oC for 1 hour.  The reaction was quenched by the 
addition of cold water.  The organic portion was washed with cold saturated aqueous 
NaHCO3, then water.  The combined aqueous portions were washed with CH2Cl2.  
The combined organic extracts were then washed with brine, dried over Na2SO4, 
and concentrated in vacuo.  Purification by flash column chromatography (5% 
EtOAc/Hexanes) provided 2.64 g (94%) of the aldehyde as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 0.01 (s, 3H), 0.02 (s, 3H), 0.06 (m, 6H), 0.86 (s, 9H), 0.89 (s, 
9H), 1.46 (dddd, J = 13.6, 13.6, 4.2, 4.2 Hz , 1H), 1.74-1.85 (m, 1H), 1.79 (s, 3H), 
1.89 (m, 1H), 2.06 (d, J = 14.3 Hz, 1H), 2.50 (dd, J = 14.1, 10.2 Hz, 1H), 2.76 (dddd, 
J = 13.1, 13.1, 13.1, 4.1 Hz, 1H), 3.49 (d, J = 10.0 Hz, 1H), 3.49-3.53 (m, 1H), 3.78 
(dd, J = 10.9, 8.7 Hz, 1H), 3.89 (ddd, J = 10.3, 3.7, 3.7 Hz, 1H), 3.95 (dd, J = 16.5, 
1.6 Hz, 1H), 5.39 (dd, J = 11.3, 5.3 Hz, 1H), 9.80 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ –5.3, -5.1, -4.9, -4.7, 18.1, 18.3, 24.9, 25.8, 25.9, 32.5, 34.0, 62.3, 67.6, 
83.6, 85.6, 127.5, 132.8, 204.5; IR (film) 2929, 1737 (str), 1473, 1254, 1086 cm-1; 
[α]24D = +84 (c = 0.48, CH2Cl2); MS (electrospray ionization) calculated for 
C23H46O4Si2Na [M + Na]+: 443.28, found: 443.4. 
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 Enone.  Into a flask equipped with a reflux condenser was added the 
aldehyde  (2.70 g, 6.10 mmol), 60 mL of toluene, and 1-Methoxy-1-(triphenyl-l5-
phosphanylidene)-propan-2-one (21) (6.37 g, 18.3 mmol).  The solution was brought 
to reflux overnight, then cooled to room temperature.  The mixture was concentrated 
in vacuo, then purified by flash column chromatography (5% EtOAc/Hexanes) to 
provide 2.59 g (84%) of the enone as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 
0.01 (s, 6H), 0.02 (s, 6H), 0.85 (s, 18H), 1.42 (dddd, J = 13.4, 13.4, 3.8, 3.8 Hz, 1H), 
1.69 (d, J = 14.0 Hz, 1H), 1.70-1.78 (m, 1H), 1.79 (s, 3H), 1.85 (m, 1H), 2.42 (s, 3H), 
2.71 (dd, J = 13.8, 9.1 Hz, 1H), 2.77 (dddd, J = 13.1, 13.1, 13.1, 4.5 Hz , 1H), 3.34 
(dd, J = 5.9, 5.9 Hz, 1H), 3.62-3.68 (m, 1H), 3.64 (s, 3H), 3.91 (dd, J = 11.4, 2.2 Hz, 
1H), 3.96 (ddd, J = 11.4, 3.7, 3.7 Hz, 1H), 4.21 (dd, J = 8.7, 8.7 Hz, 1H), 5.34 (dd, J 
= 11.5, 5.4 Hz, 1H), 6.20 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ –5.2, -
5.04, -5.01, -4.97, 18.1, 18.2, 25.4, 25.79, 25.81, 25.86, 26.0, 32.2, 39.4, 59.7, 61.6, 
74.2, 84.0, 126.3, 131.7, 134.1, 151.5, 195.0; IR (film) 2929, 1687 (str), 1471, 1253, 
1086 cm-1; [α]24D = -48.6 (c = 1.46, CH2Cl2); MS (electrospray ionization) calculated 
for C27H52O5Si2Na [M + Na]+: 535.32, found: 535.5. 
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 Triene 38.  A flask was charged with methylenetriphenylphosphine bromide 
(6.59 g, 18.5 mmol) and 15 mL of THF and cooled to 0 oC.  Potassium tert-butoxide 
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(1.0 M in THF, 14.8 mL, 14.8 mmol) was added to the heterogeneous mixture to give 
a yellow homogeneous solution.  After stirring 30 minutes at 0 oC, the enone (1.89 g, 
3.69 mmol) in 20 mL of THF was added dropwise and stirred 30 minutes at 0 oC.  
The reaction was quenched by the addition of saturated aqueous NH4Cl, warmed to 
room temperature, and diluted with Et2O.  The layers were separated and the 
aqueous portion was washed twice with Et2O, dried over Na2SO4, and concentrated 
in vacuo.  Purification via flash column chromatography (5% EtOAc/Hexanes) gave 
1.63 g (87%) of the diene as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 0.03 (s, 
3H), 0.038 (s, 3H), 0.045 (s, 3H), 0.06 (s, 3H), 0.87 (s, 9H), 0.89 (s, 9H), 1.43 (m, 
1H), 1.72 (d, J = 14.1 Hz, 1H), 1.74 (m, 1H), 1.82 (s, 6H), 1.85 (m, 1H), 2.72 (dd, J = 
14.1, 9.7 Hz, 1H), 2.84 (dddd, J = 13.0, 13.0, 13.0, 4.6 Hz, 1H), 3.39 (dd, J = 6.5, 4.7 
Hz, 1H), 3.57 (s, 3H), 3.67 (dd, J = 11.2, 8.9 Hz, 1H), 3.95 (dd, J = 11.2, 2.1 Hz, 1H), 
4.02 (ddd, J = 11.5, 3.6, 3.6 Hz, 1H), 4.19 (dd, J = 8.9, 8.9 Hz, 1H), 5.00 (s, 1H), 
5.24 (d, J = 1.5 Hz, 1H), 5.30 (d, J = 8.6 Hz, 1H), 5.34 (dd, J = 11.4, 5.1 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ –5.1, -4.97, -4.96, -4.9, 18.2, 18.3, 19.6, 25.5, 25.9, 26.0, 
26.3, 32.3, 40.3, 59.9, 61.8, 67.8, 74.5, 83.6, 113.4, 118.7, 125.9, 134.8, 137.2, 
154.6; IR (film) 2928, 1463, 1253, 1086 cm-1; [α]24D = -31 (c = 0.38, CH2Cl2); MS 
(electrospray ionization) calculated for C28H54O4Si2Na [M + Na]+: 533.35, found: 
533.5. 
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 Primary alcohol 40.  A flask was charged with triene 38 (1.55 g, 3.03 mmol) 
and 30 mL of methanol.  Ammonium fluoride (2.25 g, 60.6 mmol) was added to the 
solution and stirred overnight.  The reaction was quenched by the addition of 
saturated aqueous NaHCO3 and diluted with Et2O.  The layers were separated and 
the aqueous portion was washed twice with Et2O.  The combined organic extracts 
were dried over Na2SO4 and concentrated in vacuo.  Purification by flash column 
chromatography (5% EtOAc/Hexanes) provided 940 mg (79%) of the alcohol as a 
colorless oil, as well as 240 mg (16%) of recovered starting diene:  1H NMR (400 
MHz, CDCl3) δ 0.06 (s, 3H), 0.07 (s, 3H), 0.88 (m, 9H), 1.49 (dddd, J = 14.5, 14.5, 
6.0, 6.0 Hz, 1H), 1.72 (d, J = 14.2 Hz, 1H), 1.82 (s, 3H), 1.83 (s, 3H), 1.85-1.94 (m, 
2H), 2.38 (dd, J = 7.8, 4.2 Hz, 1H), 2.65 (dd, J = 15.0, 10.5 Hz, 1H), 2.73 (m, 1H), 
3.52-3.59 (m, 1H), 3.58 (s, 3H), 3.65 (m, 1H), 3.83 (ddd, 11.1, 7.9, 4.6 Hz, 1H), 4.10 
(ddd, J = 11.5, 3.9, 3.9 Hz, 1H), 4.21 (dd, J = 9.1, 9.1 Hz, 1H), 5.04 (d, J = 0.5 Hz, 
1H), 5.17 (d, J = 8.6 Hz, 1H), 5.27 (m, 1H), 5.37 (dd, J = 11.5, 5.3 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ –5.1, -4.9, 18.1, 19.8, 25.4, 25.8, 26.2, 31.8, 40.2, 59.9, 61.2, 
68.7, 75.1, 81.4, 114.4, 117.2, 125.9, 134.6, 137.1, 155.7; IR (film) 3435 (br), 2928, 
1644, 1444, 1247, 1085 cm-1; [α]22D = -13 (c = 0.31, CH2Cl2); MS (electrospray 
ionization) calculated for C22H40O4SiNa [M + Na]+: 419.26, found: 419.3. 
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 Aldehyde.  A flask was charged with oxalyl chloride (2.0 M in CH2Cl2, 1.20 
mL, 2.40 mmol) and 15 mL of CH2Cl2 and cooled to –78 oC.  Dimethylsulfoxide (341 
µL, 4.80 mmol) in 3 mL of CH2Cl2 was added dropwise, and the solution was stirred 
2 minutes.  The primary alcohol 40 (865 mg, 2.18 mmol) and 6 mL of CH2Cl2 were 
added dropwise to the mixture and allowed to stir 30 minutes at –78 oC.  
Triethylamine (1.52 mL, 10.9 mmol) was added dropwise and stirred 5 minutes at –
78 oC followed by warming to 0 oC for 1 hour.  The reaction was quenched by the 
addition of cold water.  The organic portion was washed with cold saturated aqueous 
NaHCO3, then water.  The combined aqueous portions were washed with CH2Cl2.  
The combined organic extracts were washed with brine, dried over Na2SO4, and 
concentrated in vacuo.  Purification by flash column chromatography (5% 
EtOAc/Hexanes) provided 797 mg (93%) of the aldehyde as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 0.09 (m, 6H), 0.89 (m, 9H), 1.57-1.77 (m, 3H), 1.81 (s, 3H), 1.82 
(s, 3H), 1.87 (m, 1H), 2.69-2.81 (m, 2H), 3.54 (s, 3H), 4.09 (d, J = 4.8 Hz, 1H), 4.21-
4.27 (m, 1H), 4.23 (d, J = 9.0 Hz, 1H), 5.03 (d, J = 0.5 Hz, 1H), 5.24 (m, 1H), 5.30 (d, 
J = 8.6 Hz, 1H), 5.35 (dd, J = 11.3, 5.6 Hz, 1H), 9.81 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ –5.1, -4.8, 18.1, 19.7, 24.6, 25.7, 26.2, 33.9, 39.6, 59.8, 69.4, 74.8, 85.9, 
114.3, 117.1, 126.0, 134.3, 137.0, 155.5, 202.5; IR (film) 2925, 1735 (str), 1462, 
1255, 1083 cm-1; [α]22D = -11 (c = 0.33, CH2Cl2). 
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 Tricycle 41.  Into a flask equipped with a reflux condenser was added the 
previous aldehyde (664 mg, 1.68 mmol), 17 mL of toluene, and 1-(Triphenyl-l5-
phosphanylidene)-propan-2-one (28) (1.61 g, 5.05 mmol).  The solution was brought 
to reflux overnight, then cooled to room temperature.  The mixture was concentrated 
in vacuo, then purified by flash column chromatography (5% then 10% 
EtOAc/Hexanes) provided 583 g (80%) of the ketone as a colorless oil:  1H NMR 
(400 MHz, C6D6, 60 oC) δ 0.007 (s, 3H), 0.011 (s, 3H), 0.89 (s, 9H), 1.56-1.65 (m, 
1H), 1.62 (s, 3H), 1.84 (s, 3H), 1.86 (s, 3H), 1.87-2.02 (m, 3H), 2.12 (m, 1H), 2.29 
(dd, J = 17.2, 6.5 Hz, 1H), 2.67 (m, 1H), 2.70 (d, J = 14.4 Hz, 1H), 2.89 (ddd, J = 6.9, 
3.6, 3.6 Hz, 1H), 3.10 (m, 1H), 3.22 (m, 1H), 3.26 (s, 3H), 4.02 (dd, J = 8.4, 3.7 Hz, 
1H), 4.20 (ddd, J = 10.4, 4.5, 4.5 Hz, 1H), 4.45 (ddd, J = 4.9, 2.5, 2.5 Hz, 1H), 5.49 
(m, 1H); 13C NMR (100 MHz, C6D6, 60 oC ) δ –4.8, -4.7, 16.2, 18.2, 23.0, 26.1, 27.6, 
28.2, 28.5, 33.1, 39.0, 40.1, 41.2, 46.7, 56.7, 73.3, 80.4, 84.3, 113.3, 130.0, 131.2, 
149.1, 207.4; IR (film) 2927, 1712 (str), 1445, 1360, 1251, 1088 cm-1; [α]22D = +40.8 
(c = 1.10, CH2Cl2); MS (electrospray ionization) calculated for C25H43O4Si [M + 1]+: 
435.29, found: 435.3. 
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 Triene 42.  A flask was charged with methylenetriphenylphosphine bromide 
(2.30 g, 6.43 mmol) and 10 mL of THF.  Potassium tert-butoxide (1.0 M in THF, 5.14 
mL, 5.14 mmol) was added to the heterogeneous mixture to give a yellow 
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homogeneous solution.  After stirring 30 minutes, ketone 41 (559 mg, 1.29 mmol) in 
15 mL of THF was added dropwise and stirred 3 hours.  The reaction was quenched 
by the addition of saturated aqueous NH4Cl and diluted with Et2O.  The layers were 
separated and the aqueous portion was washed twice with Et2O, dried over Na2SO4,, 
and concentrated in vacuo.  Purification via flash column chromatography (5% 
EtOAc/Hexanes) gave 468 mg (85%) of the alkene as a colorless oil:  1H NMR (400 
MHz, C6D6, 60 oC) δ 0.016 (s, 3H), 0.022 (s, 3H), 0.93 (s, 9H), 1.58-1.68 (m, 1H), 
1.65 (s, 3H), 1.75 (s, 3H), 1.81 (s, 3H), 1.90 (m, 1H), 2.04 (dd, J = 17.2, 5.6 Hz, 1H), 
2.05-2.17 (m, 2H), 2.24 (dd, J = 7.1, 5.5 Hz, 1H), 2.60 (dd, J = 12.0, 6.1 Hz, 1H), 
2.60-2.71 (m, 1H), 2.72 (d, J = 14.2 Hz, 1H), 2.82 (dd, J = 13.5, 6.4 Hz, 1H), 2.97 
(m, 1H), 3.32 (s, 3H), 4.07-4.16 (m, 2H), 4.44 (m, 1H), 4.83 (m, 1H), 4.85 (m, 1H), 
5.56 (m, 1H); 13C NMR (100 MHz, C6D6, 60 oC ) δ –4.8, -4.6, 16.1, 18.3, 21.3, 23.2, 
26.2, 27.6, 33.0, 38.9, 40.7, 42.1, 43.0, 57.0, 73.7, 80.3, 84.6, 110.6, 114.8, 129.5, 
131.7, 148.6, 149.0; IR (film) 2928, 1706, 1644, 1452, 1254, 1086 cm-1; [α]25D = 
+22.3 (c = 1.32, CH2Cl2); MS (electrospray ionization) calculated for C26H45O3Si [M + 
1]+: 433.31, found: 433.4. 
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 Secondary alcohol.  A flask was charged with the previous alkene 42 (410 
mg, 0.948 mmol) and 10 mL of THF.  Tetrabutylammonium fluoride (1.0 M in THF, 
1.90 mL, 1.90 mmol) was added to the solution and stirred 4 hours.  Saturated 
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aqueous NH4Cl was added and the solution was diluted with Et2O.  The layers were 
separated and the aqueous portion was washed twice with Et2O.  The combined 
organic extracts were dried over Na2SO4 and concentrated in vacuo.  Purification via 
flash column chromatography (10% EtOAc/Hexanes) provided 283 mg (95%) of the 
alcohol as a colorless oil:  1H NMR (400 MHz, C6D6, 60 oC) δ 1.60 (s, 3H), 1.61 (s, 
3H), 1.71-1.85 (m, 2H), 1.79 (s, 3H), 1.90-2.08 (m, 4H), 2.11 (dd, J = 14.5, 3.9 Hz, 
1H), 2.40 (ddd, J = 9.5, 9.5, 5.7 Hz, 1H), 2.69 (ddd, J = 10.2, 7.2, 2.6 Hz, 1H), 2.85-
2.92 (m, 2H), 3.07 (m, 1H), 3.30 (s, 3H), 3.70 (m, 1H), 4.16 (dd, J = 4.4, 2.7 Hz, 1H), 
4.31 (ddd, J = 7.1, 3.5, 3.5 Hz, 1H), 4.78-4.82 (m, 2H), 5.67 (m, 1H); 13C NMR (100 
MHz, C6D6, 60 oC ) δ 16.1, 19.9, 25.7, 28.2, 32.5, 35.4, 37.8, 42.6, 42.8, 44.3, 57.9, 
73.4, 82.3, 85.9, 111.7, 115.7, 129.6, 134.3, 148.2, 150.0; IR (film) 3445 (br), 2918, 
1695, 1638, 1448, 1221, 1053 cm-1; [α]25D = +100 (c = 0.67, CH2Cl2); MS 
(electrospray ionization) calculated for C20H30O3Na [M + Na]+: 341.21, found: 341.4. 
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 Ketone 43.  A flask was charged with the secondary alcohol (300 mg, 0.866 
mmol) and 17 mL of CH2Cl2.  Pyridine (351 µL, 4.33 mmol) followed by Dess-Martin 
periodinane (735 mg, 1.73 mmol) were added to the solution and stirred 15 minutes.  
The reaction was quenched by the addition of Na2S2O3/NaHCO3 (5:1 v:v) and the 
layers were separated.  The aqueous portion was washed twice with CH2Cl2 and the 
combined organic extracts were dried over Na2SO4 and concentrated in vacuo.  
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Purification via flash column chromatography (10% EtOAc/Hexanes) gave 290 mg 
(98%) of the ketone as a white solid:  1H NMR (400 MHz, CDCl3) δ 1.64 (s, 6H), 1.78 
(s, 3H), 1.93 (dd, J = 16.3, 4.6 Hz, 1H), 2.02 (dd, J = 14.4, 5.4 Hz, 1H), 2.05-2.18 (m, 
2H), 2.24 (ddd, J = 11.2, 11.2, 4.7 Hz, 1H), 2.35 (ddd, J = 12.1, 12.1, 5.6 Hz, 1H), 
2.51 (dd, J = 7.3, 7.3 Hz, 1H), 2.73 (d, J = 14.1 Hz, 1H), 2.82 (ddd, J = 12.4, 4.6, 4.6 
Hz, 1H), 2.89 (dd, J = 11.8, 7.1 Hz, 1H), 3.10 (dddd, J = 12.2, 12.2, 12.2, 5.5 Hz, 
1H), 3.49 (s, 3H), 4.06 (s, 1H), 4.30 (ddd, J = 8.0, 5.4, 3.3 Hz, 1H), 4.77 (s, 2H), 5.53 
(dd, J = 10.8, 6.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 15.9, 19.0, 26.0, 26.4, 35.1, 
37.3, 41.3, 42.0, 42.1, 42.6, 58.6, 85.1, 87.7, 112.7, 117.2, 126.9, 134.3, 146.7, 
148.6, 214.0; IR (film) 3070, 1705 (str), 1448, 1202, 1119, 1032 cm-1; [α]25D = -10.3 
(c = 1.44, CH2Cl2); MS (electrospray ionization) calculated for C20H28O3Na [M + Na]+: 
339.19, found: 339.3. 
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Secondary alcohol 51.  A flask containing the ketone 43 (280 mg, 0.885 
mmol) in 20 mL of THF was cooled to -78 oC.  Potassium hexamethyldisilazide (0.5 
M in toluene) was added dropwise, and the solution was allowed to stir for one hour 
at -78 oC.  Davis oxaziridine (278 mg, 1.062 mmol) was added in 10 mL of THF to 
the enolate, and the solution was allowed to stir 45 minutes at -78 oC.  The reaction 
was quenched by the addition of saturated aqueous NH4Cl.  The mixture was diluted 
with Et2O and the layers were separated.  The aqueous portions were washed three 
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times with Et2O, dried over Na2SO4 and concentrated in vacuo.  Purification via flash 
column chromatography (10% EtOAc/Hexanes) gave 245 mg (84%) of the alcohol 
as a white solid:  1H NMR (400 MHz, C6D6, 60 oC) δ 1.54 (s, 3H), 1.56 (s, 3H), 1.67 
(s, 3H), 1.80 (dd, J = 16.5, 4.9 Hz, 1H), 1.95 (m, 1H), 2.03 (dd, J = 14.0, 8.3 Hz, 1H), 
2.20-2.31 (m , 2H), 2.44 (m, 1H), 2.61 (dd, J = 6.3, 6.3 Hz, 1H), 2.76 (m, 1H), 3.03 
(dd, J = 11.4, 7.6 Hz, 1H), 3.14 (br d, J = 9.6 Hz, 1H), 3.23 (s, 3H), 4.22 (ddd, J = 
10.1, 10.1, 3.7 Hz, 1H), 4.30 (m, 1H), 4.59 (s, 1H), 4.74 (s, 1H), 4.78 (s, 1H), 5.30 
(dd, J = 7.5, 7.5 Hz, 1H); 13C NMR (100 MHz, C6D6, 60 oC ) δ 16.0, 19.5, 24.8, 34.9, 
35.3, 39.9, 42.0, 42.8, 43.7, 57.8, 79.2, 83.6, 84.1, 112.7, 116.7, 121.8, 138.7, 
147.1, 149.0, 214.4; IR (film) 3419 (br), 2912, 1715 (str), 1447, 1051 cm-1; [α]24D = 
+55.3 (c = 6.50, CH2Cl2); MS (electrospray ionization) calculated for C20H28O4 [M + 
Na]+: 355.19, found: 355.3. 
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 Diol 52.  A flask was charged with methylmagnesium chloride (3.0 M in THF, 
6.42 mL, 19.3 mmol) and 24 mL of THF.  The solution was cooled to 0 oC and the 
ketone 51 (320 mg, 0.963 mmol) was added in 8 mL of THF dropwise.  The solution 
was stirred 30 minutes, then quenched with saturated aqueous NH4Cl, warmed to 
room temperature, and diluted with Et2O.  The layers were separated and the 
aqueous portion was washed twice with Et2O.  The combined organic extracts were 
dried over Na2SO4 and concentrated in vacuo.  Purification via flash column 
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chromatography (20% EtOAc/ Hexanes) provided 278 mg (83%) of the alcohol as a 
white solid:  1H NMR (400 MHz, C6D6, 60 oC) δ 1.28 (s, 3H), 1.59 (s, 3H), 1.65 (s, 
3H), 1.78 (s, 3H), 1.91 (dd, J = 16.8, 5.1 Hz, 1H), 1.99-2.09 (m, 2H), 2.13 (dd, J = 
14.6, 4.4 Hz, 1H), 2.20-2.31 (m, 2H), 2.40 (ddd, J = 9.7, 9.7, 5.2 Hz, 1H), 2.56 (ddd, 
J = 10.3, 7.4, 2.7 Hz, 1H), 2.76-2.85 (m, 2H), 3.12 (m, 1H), 3.29 (s, 3H), 3.51 (dd, J 
= 7.5, 4.3 Hz, 1H), 4.13 (d, J = 2.6 Hz, 1H), 4.27 (ddd, J = 7.4, 4.4, 2.9 Hz, 1H), 4.83 
(s, 2H), 5.68 (dd, J = 10.7, 6.7 Hz, 1H); 13C NMR (100 MHz, C6D6, 60 oC) δ 16.0, 
19.6, 24.3, 27.7, 35.1, 36.1, 38.0, 42.9, 43.4, 44.1, 58.0, 76.5, 77.4, 82.5, 87.5, 
112.5, 115.8, 126.0, 135.9, 147.8, 149.7; IR (film) 3437 (br), 2910, 1445, 1376, 
1118, 1092, 1050 cm-1; [α]24D = +82 (c = 0.34, CH2Cl2); MS (electrospray ionization) 
calculated for C21H32O4Na [M + Na]+: 371.22, found: 371.4. 
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 Ketone 53.  A flask was charged with diol 52 (220 mg, 0.631 mmol), 10 mL of 
CHCl3, and 450 µL of water.  Hydrochloric acid (12 M, 450 µL, 5.4 mmol) was added 
to the biphasic solution and stirred for 2 hours.  The reaction was quenched by the 
slow addition of saturated aqueous NaHCO3 and diluted with CH2Cl2.  The layers 
were separated and the aqueous portion was washed twice with CH2Cl2.  The 
combined organic extracts were dried over Na2SO4 and concentrated in vacuo.  
Purification by flash column chromatography (20% EtOAc/Hexanes) gave 192 mg 
(91%) of the ketone as a white solid and 16 mg (8%) of the (4S)-product (#) as a 
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colorless oil:  1H NMR (400 MHz, CDCl3, 60 oC) δ 1.06 (d, J = 6.6 Hz, 3H), 1.08 (s, 
3H), 1.58 (ddd, J = 13.0, 13.0, 13.0 Hz, 1H), 1.69 (s, 3H), 1.89 (s, 3H), 1.88-1.99 (m, 
2H), 2.08 (m, 1H), 2.33 (br s, 1H), 2.46 (ddd, J = 15.0, 12.3, 2.8 Hz, 1H), 2.48-2.60 
(m, 2H), 2.63 (dd, J = 11.7, 7.6 Hz, 1H), 2.83-3.06 (m, 3H), 3.53 (br dd, J = 6.9, 6.9 
Hz, 1H), 4.09 (s, 1H), 4.36 (ddd, J = 9.5, 3.2, 3.2 Hz, 1H), 4.86 (s, 2H), 5.76 (dd, J = 
10.6, 6.3 Hz, 1H); 13C NMR (100 MHz, CDCl3, 60 oC) δ 14.5, 18.6, 24.4, 27.9, 35.9, 
36.9, 39.3, 42.1, 46.8, 47.9, 54.4, 76.3, 77.0, 80.5, 89.2, 113.4, 125.0, 137.0, 146.3, 
210.9; IR (film) 3523 (br), 2925, 1705 (str), 1450, 1184, 1071 cm-1; [α]22D = +35 (c = 
0.37, CH2Cl2); MS (electrospray ionization) calculated for C20H30O4Na [M + Na]+: 
357.20, found: 357.3. 
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 Ketone 54.  Into a flask containing the previous ketone 53 (242 mg, 0.724 
mmol) and 24 mL of methanol was added catalytic sodium hydride.  After stirring 15 
minutes, the reaction was quenched by the slow addition of saturated aqueous 
NH4Cl and diluted with Et2O.  The layers were separated and the aqueous portion 
was washed twice with Et2O.  The combined organic extracts were dried over 
Na2SO4 and concentrated in vacuo.  Purification by flash column chromatography 
(20% EtOAc/Hexanes) gave 103 mg (42%) of the ketone as a colorless oil and 139 
mg (58%) of the (4R)-product as a white solid:  1H NMR (400 MHz, CDCl3, 60 oC) δ 
1.02 (d, J = 6.8 Hz, 3H), 1.21 (s, 3H), 1.62 (ddd, J = 14.2, 9.2, 5.5, Hz, 1H), 1.73 (s, 
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3H), 1.77 (s, 3H), 1.94-2.09 (m, 3H), 2.35-2.55 (m, 4H), 2.72-2.81 (m, 2H), 2.95 
(ddd, J = 13.3, 11.4, 7.5 Hz, 1H), 3.04 (ddd, J = 7.6, 7.6, 7.6 Hz, 1H), 3.53 (dd, J = 
7.4, 3.0 Hz, 1H), 3.77 (d, J = 5.7 Hz, 1H), 4.60 (m, 1H), 4.84 (s, 1H), 4.90 (s, 1H), 
5.65 (dd, J = 10.7, 6.4 Hz, 1H); 13C NMR (100 MHz, CDCl3, 60 oC) δ 15.0, 20.2, 
22.7, 27.9, 34.7, 34.8, 37.2, 40.2, 41.2, 45.0, 53.5, 76.1, 76.2, 77.2, 87.3, 112.1, 
125.8, 134.5, 147.0, 211.9; IR (film) 3459 (br), 2930, 1710 (str), 1448, 1377, 1048 
cm-1; [α]21D = +54 (c = 1.9, CH2Cl2); MS (electrospray ionization) calculated for 
C20H30O4Na [M + Na]+: 357.20, found: 357.3. 
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Triol.  Into a flask charged with the ketone 54 (158 mg, 0.472 mmol) was 
added 5 mL of THF.  The solution was cooled to –78 oC and L-Selectride® (1.0 M in 
THF, 567 µL, 0.567 mmol) dropwise.  The reaction was stirred 10 minutes, then 
quenched by the addition of sodium hydroxide (3 M, 288 µL, 0.864 mmol) and 
hydrogen peroxide (30%, 566 µL, 5.184 mmol).  The mixture was stirred three hours 
at room temperature, then diluted with CH2Cl2.  The layers were separated and the 
aqueous portions were washed twice with CH2Cl2.  The combined organic extracts 
were dried over Na2SO4 and concentrated in vacuo.  Purification by flash column 
chromatography (50% EtOAc/Hexanes) gave 148 mg (94%) of the alcohol as a 
white solid:  1H NMR (400 MHz, CDCl3, 60 oC) δ 0.99 (d, J = 6.1 Hz, 3H)1.29 (s, 3H), 
1.38 (m, 1H), 1.73 (s, 3H), 1.83 (s, 3H), 1.98 (dd, J = 14.6, 3.9 Hz, 1H), 2.06 (m, 1H), 
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2.13-2.28 (m, 3H), 2.61 (s, 2H), 2.78 (d, J = 14.4 Hz, 1H), 3.00 (ddd, J = 11.6, 8.2, 
8.2, Hz, 1H), 3.65 (m, 1H), 3.78 (s, 1H), 3.92 (d, J = 7.0 Hz, 1H), 4.37 (d, J = 2.5 Hz, 
1H), 4.75 (s, 1H), 4.84 (s, 1H), 5.64 (dd, J = 9.8, 7.0 Hz, 1H); 13C NMR (100 MHz, 
CDCl3, 60 oC ) δ 16.9, 21.6, 22.9, 28.2, 28.4, 31.4, 34.4, 38.3, 39.5, 41.3, 45.5, 72.2, 
75.9, 76.9, 79.8, 88.0, 110.7, 125.8, 134.2, 149.1; IR (film) 3382 (br), 2912, 1440, 
1366, 1052 cm-1; [α]21D = +2.8 (c = 3.2, CH2Cl2); MS (electrospray ionization) 
calculated for C20H32O4Na [M + K]+: 375.33, found: 375.2. 
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Diester 55.  Into a flask containing the triol (122 mg, 0.363 mmol) in 10 mL of 
CH2Cl2 was added triethylamine (253 µL, 1.81 mmol) and 4-dimethylaminopyridine 
(4.4 mg, 0.036 mmol).  Acetic anhydride (103 µL, 1.09 mmol) was added to the 
solution and stirred for firve hours.  The reaction was quenched using saturated 
aqueous NH4Cl and the layers were separated.  The aqueous portions were washed 
twice with CH2Cl2, dried over Na2SO4 and concentrated in vacuo.  Purification via 
flash column chromatography (20% EtOAc/Hexanes) gave 130 mg (85%) of the 
ester as a white solid:  1H NMR (400 MHz, CDCl3, 60 oC) δ 0.90 (d, J = 7.0 Hz, 3H), 
1.24 (s, 3H), 1.47 (m, 1H), 1.63 (ddd, J = 13.5, 8.8, 4.1 Hz, 1H), 1.71 (s, 3H), 1.79 (s, 
3H), 1.90 (dd, J = 14.8, 3.6 Hz, 1H), 1.91-2.08 (m, 2H), 2.04 (s, 3H), 2.07 (s, 3H), 
2.25-2.34 (m, 2H), 2.61-2.68 (m, 2H), 2.77 (d, J = 14.9 Hz, 1H), 3.12 (ddd, J = 12.9, 
11.5, 8.2 Hz, 1H), 3.90 (d, J = 6.4 Hz, 1H), 4.19 (d, J = 2.6 Hz, 1H), 4.75 (m 1H), 
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4.76 (s, 1H), 4.84 (s, 1H), 5.16 (dd, J = 4.1, 4.1 Hz, 1H), 5.70 (dd, J = 11.2, 6.0 Hz, 
1H); 13C NMR (100 MHz, CDCl3, 60 oC ) δ 16.5, 20.9, 21.1, 21.3, 23.5, 28.3, 29.6, 
29.8, 32.9, 37.9, 39.2, 42.1, 43.8, 73.7, 75.5, 78.7, 79.6, 87.6, 111.1, 125.2, 134.9, 
148.3, 170.51, 170.54; IR (film) 3362 (br), 2933, 1734 (str), 1448, 1374, 1238 (str), 
1038 cm-1; [α]22D = +18 (c = 3.1, CHCl3); MS (electrospray ionization) calculated for 
C24H36O6Na [M + Na]+: 443.24, found: 443.3. 
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Diol 56.  A flask was charged with alkene 55 (16.1 mg, 38.3 µmol) in 1 mL of 
THF.  (+)-Diisopinocampheylborane (33.1 mg, 115 µmol) was added to the solution 
and allowed to stir 30 minutes.  The reaction was quenched by the addition of 1 mL 
of water and sodium perborate tetrahydrate (53.0 mg, 345 µmol) and allowed to stir 
for three hours, then diluted with brine and Et2O.  The layers were separated and the 
aqueous portion was washed twice with Et2O, dried over Na2SO4, and concentrated 
in vacuo.  Purification via flash column chromatography (10% then 30% 
EtOAc/Hexanes) gave 12.3 mg (74%) of the diol as a colorless oil:  1H NMR (500 
MHz, CDCl3) δ 0.82 (d, J = 6.0 Hz, 3H), 8.87 (d, J = 6.9 Hz, 3H), 1.02 (m, 1H), 1.17 
(m, 1H), 1.38 (s, 3H), 1.70-1.92 (m, 5H), 1.81 (s, 3H), 2.06 (m, 1H), 2.10 (s, 3H), 
2.11 (s, 3H), 2.90 (br s, 1H), 2.46 (dd, J =10.3, 8.1 Hz, 1H), 2.69 (d, J = 14.8 Hz, 
1H), 3.15 (ddd, J = 13.5, 11.5, 7.7 Hz, 1H), 3.53-3.62 (m, 3H), 3.87 (d, J = 10.7 Hz, 
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1H), 4.04 (s, 1H), 4.89 (d, J = 7.6 Hz, 1H), 5.18 (d, J = 3.3 Hz, 1H), 5.65 (dd, J = 
10.3, 4.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 14.2, 18.4, 21.2, 21.5, 21.8, 23.3, 
24.7, 28.3, 29.4, 30.9, 32.5, 36.6, 38.0, 41.0, 45.7, 65.0, 73.8, 75.7, 77.8, 79.9, 88.7, 
125.2, 133.9, 171.4, 171.6; IR (film) 3392 (br), 2926, 1735 (str), 1375, 1244 (str), 
1024 cm-1; [α]21D = -11 (c = 0.40, CH2Cl2); MS (electrospray ionization) calculated for 
C24H38O7Na [M + Na]+: 461.25, found 461.4. 
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Asbestinin-12 (2).  A flask charged with diol 56 (13.7 mg, 31.2 µmol) in 1.6 
mL of CHCl3 was cooled to 0 oC.  2,6 lutidine (18.2 µL, 0.156 mmol) followed by 
trifluoromethanesulfonic anhydride (5.80 µL, 34.4 µmol) were added to the solution 
and allowed to stir 30 minutes at 0 oC.  The solution was warmed to room 
temperature for 4 hours, then quenched via the addition of saturated aqueous 
NH4Cl.  The mixture was diluted with CHCl2 and the layers were separated.  The 
aqueous portion was washed three times with CH2Cl2, dried over Na2SO4, and 
concentrated in vacuo.  Purification via flash column chromatography (15% 
EtOAc/Hexanes) gave 9.0 mg (69%) of asbestinin-12 as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 0.88 (d, J = 7.1 Hz, 3H), 0.92 (d, J = 7.2 Hz, 3H), 1.00 (ddd, J = 
13.4, 3.3, 1.7 Hz, 1H), 1.42 (s, 3H), 1.51 (ddd, J = 3.8, 3.8, 3.8 Hz, 1H), 1.62 (m, 
2H), 1.79 (s, 3H), 1.85 (dd, J = 14.6, 4.5 Hz, 1H), 1.98 (ddd, J = 10.8, 3.1, 3.1 Hz, 
1H), 2.02 (m, 1H), 2.10 (s, 3H), 2.12 (s, 3H), 2.26 (ddd, J = 11.0, 11.0, 11.0 Hz, 1H), 
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2.68 (d, J = 15.1 Hz, 1H), 3.19 (ddd, J = 13.8, 11.1, 7.4 Hz, 1H), 3.49 (dd, J = 13.3, 
3.8 Hz, 1H), 3.85 (d, J = 13.1 Hz, 1H), 3.93 (d, J = 9.1 Hz, 1H), 4.10 (ddd, J = 3.4, 
3.4, 3.4 Hz, 1H), 4.87 (d, J = 7.4 Hz, 1H), 5.28 (dd, J = 4.9, 2.9 Hz, 1H), 5.74 (dd, J = 
10.8, 6.8 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 10.8, 18.2, 19.3, 21.3, 21.6, 29.6, 
31.3, 31.4, 33.4, 36.9, 37.6, 38.3, 40.8, 44.9, 67.8, 73.6, 76.7, 79.2, 81.7, 91.3, 
126.7, 131.6, 170.8, 171.3; IR (film) 2926, 1737 (str), 1459, 1377, 1231, 1088 cm-1; 
[α]21D = -22 (c = 0.29, CHCl3); MS (electrospray ionization) calculated for C24H36O6 
[M + Na]+: 443.24, found: 443.3. 
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 Tertiary alcohol 44.  A flask was charged with methylmag-nesium chloride 
(3.0 M in THF, 3.47 mL, 10.4 mmol) and 70 mL of THF.  The solution was cooled to 
0 oC and the ketone 43 (659 mg, 2.08 mmol) was added in 35 mL of THF dropwise.  
The solution was stirred 30 minutes, then quenched with saturated aqueous NH4Cl, 
warmed to room temperature, and diluted with Et2O.  The layers were separated and 
the aqueous portion was washed twice with Et2O.  The combined organic extracts 
were dried over Na2SO4 and concentrated in vacuo.  Purification via flash column 
chromatography (10% EtOAc/ Hexanes) provided 678 mg (98%) of the alcohol as a 
colorless oil:  1H NMR (400 MHz, CDCl3) δ 0.95 (s, 3H), 1.66 (s, 3H), 1.69 (s, 3H), 
1.69-1.79 (m, 1H), 1.85-1.96 (m, 2H), 1.90 (s, 3H), 2.00 (m, 1H), 2.17 (m, 2H), 2.28 
(ddd, J = 11.2, 11.2, 4.5 Hz, 1H), 2.43 (dd, J = 11.7, 6.9 Hz, 1H), 2.75 (dd, J = 7.1, 
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7.1 Hz, 1H), 2.95 (d, J = 14.7 Hz, 1H), 3.07-3.24 (m, 2H), 3.52 (s, 3H), 3.87 (s, 1H), 
4.18 (ddd, J = 8.6, 3.3, 3.3 Hz, 1H), 4.82 (s, 1H), 4.83 (m, 1H), 5.84 (dd, J = 10.9, 
6.0 Hz, 1H) ; 13C NMR (100 MHz, CDCl3) δ 15.8, 19.0, 27.1, 28.3, 28.9, 35.2, 36.7, 
38.8, 41.8, 42.9, 45.0, 58.6, 75.3, 83.4, 89.4, 113.0, 116.7, 128.7, 136.5, 147.0, 
149.1; IR (film) 3511 (br), 2914, 1447, 1119, 1058 cm-1; [α]24D = +74 (c = 0.42, 
CH2Cl2); MS (electrospray ionization) calculated for C21H32O3Na [M + Na]+: 355.23, 
found: 355.3. 
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 Ketone 45.  A flask was charged with alcohol 44 (678 mg, 0.255 mmol), 20 
mL of CHCl3, and 2.5 mL of water.  Hydrochloric acid (12 M, 2.50 mL, 30.0 mmol) 
was added to the biphasic solution and stirred for 2 hours.  The reaction was 
quenched by the slow addition of saturated aqueous NaHCO3.  The layers were 
separated and the aqueous portion was washed twice with CH2Cl2.  The combined 
organic extracts were dried over Na2SO4 and concentrated in vacuo.  Purification by 
flash column chromatography (10% then 25% EtOAc/Hexanes) gave 562 mg (87%) 
of the ketone as a white solid and 58 mg (9%) of the (4S)-product (#) as a colorless 
oil:  1H NMR (400 MHz, CDCl3) δ 0.90 (s, 3H), 1.07 (d, J = 6.6 Hz, 3H), 1.59 (dd, J = 
25.8, 13.0 Hz, 1H), 1.69 (s, 3H), 1.71-1.78 (m, 1H), 1.85-2.03 (m, 4H), 1.93 (s, 3H), 
2.48 (ddd, J = 12.3, 12.3, 2.8 Hz, 1H), 2.59 (dddd, J = 11.7, 11.7, 6.5, 6.5 Hz, 1H), 
2.69 (dd, J = 12.0, 7.0 Hz, 1H), 2.91-2.97 (m, 2H), 3.07 (m, 1H), 3.13 (ddd, J = 11.9, 
11.9, 6.4 Hz, 1H), 3.94 (s, 1H), 4.36 (ddd, J = 9.9, 3.1, 3.1 Hz, 1H), 4.86 (m, 2H), 
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5.83 (dd, J = 11.5, 5.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.5, 18.5, 27.2, 28.4, 
28.7, 35.2, 38.5, 39.0, 41.8, 46.0, 48.7, 54.1, 74.8, 80.5, 91.3, 113.4, 128.3, 136.6, 
146.2, 211.7; IR (film) 3514 (br), 2928, 1702 (str), 1453, 1377, 1184, 1076 cm-1; 
[α]24D = +40 (c = 0.18, CH2Cl2); MS (electrospray ionization) calculated for 
C20H30O3Na [M + Na]+: 341.21, found: 341.3. 
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 Ketone 46.  Into a flask containing the previous ketone 45 (551 mg, 1.73 
mmol) and 17 mL of methanol was added catalytic sodium hydride.  After stirring 15 
minutes, the reaction was quenched by the slow addition of saturated aqueous 
NH4Cl and diluted with Et2O.  The layers were separated and the aqueous portion 
was washed twice with Et2O.  The combined organic extracts were dried over 
Na2SO4 and concentrated in vacuo.  Purification by flash column chromatography 
(10% then 25% EtOAc/Hexanes) gave 246 mg (45%) of the ketone as a colorless oil 
and 303 mg (55%) of the (4R)-product (#) as a white solid:  1H NMR (400 MHz, 
CDCl3) δ 1.09 (d, J = 6.8Hz, 3H), 1.14 (s, 3H), 1.59-1.71 (m, 2H), 1.77 (s, 3H), 1.80-
1.87 (m, 1H), 1.88 (s, 3H), 1.92-1.99 (m, 1H), 2.01 (dd, J = 14.8, 3.7 Hz, 1H), 2.11 
(ddd, J = 13.9, 8.6, 7.1 Hz, 1H), 2.34 (s, 1H), 2.47 (ddd, J = 8.6, 8.6, 5.5 Hz, 1H), 
2.58 (ddq, J = 21.7, 7.0, 7.0 Hz, 1H), 2.83 (ddd, J = 7.8, 7.8, 7.8 Hz, 1H), 2.84-2.93 
(m, 2H), 3.02 (ddd, J = 8.1, 8.1, 4.6 Hz, 1H), 3.72 (d, J = 4.6 Hz, 1H), 4.58 (ddd, J = 
6.3, 3.3, 3.3 Hz, 1H), 4.89 (d, J = 0.7 Hz, 1H), 4.92 (d, J = 1.3 Hz, 1H), 5.71 (dd, J = 
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11.3, 5.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 15.5, 20.0, 25.3, 28.5, 28.9, 34.7, 
36.5, 38.4, 40.7, 40.9, 45.9, 53.3, 74.7, 77.7, 89.1, 112.7, 129.2, 134.2, 146.9, 
212.9; IR (film) 3443 (br), 2928, 1710 (str), 1642, 1446, 1376, 1081 cm-1; [α]24D = 
+92 (c = 0.19, CH2Cl2); MS (electrospray ionization) calculated for C20H30O3Na [M + 
Na]+: 341.21, found: 341.4. 
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 Diol.  Into a flask charged with the ketone 46 (523 mg, 1.64 mmol) was added 
16 mL of THF.  The solution was cooled to –78 oC and L-Selectride® (1.0 M in THF, 
1.97 mL, 1.97 mmol) dropwise.  The reaction was stirred 10 minutes, then quenched 
by the addition of sodium hydroxide (3 M, 1.0 mL, 3.0 mmol) and hydrogen peroxide 
(30%, 2.0 mL, 18 mmol).  The mixture was stirred three hours at room temperature, 
then diluted with Et2O.  The layers were separated and the aqueous portions were 
washed twice with Et2O.  The combined organic extracts were dried over Na2SO4 
and concentrated in vacuo.  Purification by flash column chromatography (25% 
EtOAc/Hexanes) gave 493 mg (94%) of the alcohol as a white solid:  1H NMR (400 
MHz, C6D6, 60 oC) δ 0.95 (d, J = 7.0 Hz, 3H), 1.19 (m, 1H), 1.28 (s, 3H), 1.33 (m, 
2H), 1.56 (m, 1H), 1.64-1.73 (m, 2H), 1.70 (s, 3H), 1.75 (s, 3H), 1.77-1.94 (m, 2H), 
1.89 (m, 1H), 2.19 (ddd, J = 7.8, 4.2, 4.2 Hz, 1H), 2.69-2.92 (m, 4H), 3.42 (s, 1H), 
3.91 (d, J = 7.5 Hz, 1H), 4.24 (dd, J = 6.7, 3.8 Hz, 1H), 4.86 (s, 1H), 4.88 (d, J = 1.3 
Hz, 1H), 5.52 (dd, J = 11.0, 6.1 Hz, 1H); 13C NMR (100 MHz, C6D6, 60 oC ) δ 17.2, 
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22.0, 24.6, 28.4, 28.8, 29.7, 31.8, 38.5, 38.6, 39.8, 42.6, 45.9, 72.2, 74.7, 80.0, 89.5, 
110.6, 130.0, 132.3, 149.8; IR (film) 3329 (br), 2921, 1439, 1373, 1088 cm-1; [α]25D = 
+5.7 (c = 0.46, CH2Cl2); MS (electrospray ionization) calculated for C20H32O3Na [M + 
Na]+: 343.23, found: 343.3. 
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Ester 47.  Into a flask containing the secondary alcohol (406 mg, 1.27 mmol) 
in 26 mL of CH2Cl2 was added triethylamine (707 µL, 5.07 mmol) and 4-
dimethylaminopyridine (16.0 mg, 0.127 mmol).  Acetic anhydride (240 µL, 2.53 
mmol) was added to the solution and stirred overnight.  The reaction was quenched 
using saturated aqueous NH4Cl and the layers were separated.  The aqueous 
portions were washed twice with CH2Cl2, dried over Na2SO4 and concentrated in 
vacuo.  Purification via flash column chromatography (25% EtOAc/Hexanes) gave 
453 mg (99%) of the ester as a colorless oil:  1H NMR (400 MHz, C6D6, 60 oC) δ 0.87 
(d, J = 7.0 Hz, 3H), 1.25 (s, 3H), 1.37 (ddd, J = 13.7, 6.2, 4.1 Hz, 1H), 1.50-1.69 (m, 
4H), 1.66 (s, 3H), 1.67 (s, 3H), 1.74 (dd, J = 14.6, 3.9 Hz, 1H), 1.77-1.92 (m, 2H), 
1.81 (s, 3H), 2.32 (ddd, J = 4.9, 4.9, 4.9 Hz, 1H), 2.66-2.78 (m, 3H), 2.89 (m, 1H), 
3.88 (d, J = 6.6 Hz, 1H), 4.25 (dd, J = 7.0, 3.8 Hz, 1H), 4.83 (s, 1H), 4.85 (d, J = 1.3 
Hz, 1H), 5.22 (dd, J = 5.1, 3.7 Hz, 1H), 5.51 (dd, J = 11.1, 6.0 Hz, 1H); 13C NMR 
(100 MHz, C6D6, 60 oC ) δ 16.8, 20.7, 21.5, 24.9, 28.4, 29.7, 30.1, 30.2, 38.1, 38.8, 
39.7, 43.0, 44.2, 73.8, 74.7, 79.7, 89.3, 111.1, 130.0, 132.6, 149.2, 170.0; IR (film) 
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3465(br), 2924, 1737 (str), 1450, 1374, 1237, 1039 cm-1; [α]25D = +42.2 (c = 1.32, 
CH2Cl2); MS (electrospray ionization) calculated for C22H35O4 [M + 1]+: 363.25, 
found: 363.4. 
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 Diene 48.  A flask was charged with ester 13 (64.0 mg, 0.176 mmol) in 2 mL 
of CH2Cl2 and cooled to 0 oC.  2,6-lutidine (62 µL, 0.53 mmol) and triethylsilyl 
trifluoromethanesulfonate (60 µL, 0.27 mmol) were added sequentially and stirred for 
1 hour at 0 oC.  The reaction was quenched by the addition of saturated aqueous 
NH4Cl, warmed to room temperature and the layers were separated.  The aqueous 
portions were washed twice with CH2Cl2, dried over Na2SO4 and concentrated in 
vacuo.  Purification via flash column chromatography (5% EtOAc/Hexanes) gave 67 
mg (80%) of the alkene as a colorless oil:  1H NMR (400 MHz, C6D6, 60 oC) δ 0.62 
(q, J = 7.8 Hz, 6H), 0.83 (d, J = 5.8 Hz, 3H), 1.00 (t, J = 7.9 Hz, 9H), 1.38 (ddd, J = 
13.9, 3.1, 3.1 Hz, 1H), 1.55-1.65 (m, 2H), 1.57 (s, 3H), 1.71 (s, 3H), 1.73-1.89 (m, 
4H), 1.79 (s, 3H), 1.86 (s, 3H), 2.20 (dd, J = 7.1, 4.6 Hz, 1H), 2.63 (d, J = 13.9 Hz, 
1H), 2.68 (m, 1H), 2.96 (dd, J = 8.8, 8.8 Hz, 1H), 3.03 (d, J = 5.3 Hz, 1H), 3.97 (d, J 
= 10.4 Hz, 1H), 4.08 (d, J = 1.63 Hz, 1H), 4.88 (s, 1H), 4.94 (m, 1H), 5.19 (m, 1H), 
5.44 (dd, J = 10.6, 5.6 Hz, 1H); 13C NMR (100 MHz, C6D6, 60 oC ) δ 7.3, 7.5, 18.2, 
20.7, 23.1, 23.5, 26.7, 28.5, 28.9, 29.5, 38.5, 39.2, 39.5, 41.4, 44.8, 74.1, 78.4, 79.4, 
88.3, 110.1, 130.5, 130.9, 149.4, 170.5; IR (film) 2957, 1739 (str), 1462, 1373, 1235, 
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1116, 1048 cm-1; [α]23D = -33 (c = 0.43, CH2Cl2); MS (electrospray ionization) 
calculated for C28H48O4SiNa [M + Na]+: 499.32, found: 499.4. 
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 Diol 50.  A flask was charged with diene 48 (10.4 mg, 21.8 µmol) in 500 µL of 
THF.  (+)-Diisopinocampheylborane (24.0 mg, 83.2 µmol) was added to the solution 
and allowed to stir 30 minutes.  The reaction was quenched by the addition of 
sodium hydroxide (3 M, 130 µL, 0.390 mmol), then hydrogen peroxide (30%, 260 µL, 
2.29 mmol).  The biphasic solution was stirred three hours, then diluted with brine 
and Et2O.  The layers were separated and the aqueous portion was washed twice 
with Et2O, dried over Na2SO4, and concentrated in vacuo.  For purification purposes, 
the product and isopinocampheol were carried on to the next reaction as a mixture.  
In a separate experiment, purification via flash column chromatography (10% 
EtOAc/Hexanes) gave the alcohol as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 
0.59 (q, J = 7.8 Hz, 6H), 0.81 (d, J = 6.5 Hz, 3H), 0.94 (t, J = 7.9 Hz, 9 H), 1.01 (d, J 
= 6.7 Hz, 3H), 1.22 (d, J = 15.3 Hz, 1H), 1.47 (s, 3H), 1.59-1.94 (m, 9H), 1.77 (s, 
3H), 2.08-2.18 (m, 2H), 2.10 (s, 3H), 2.52 (ddd, J = 12.2, 12.2, 8.3 Hz, 1H), 2.66 (m, 
2H), 3.41 (dd, J = 10.9, 5.3 Hz, 1H), 3.63 (m, 1H), 3.78 (d, J = 10.7 Hz, 1H), 3.93 (s, 
1H), 5.14 (m, 1H), 5.48 (dd, J = 11.2, 5.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 6.8, 
6.9, 7.0, 15.8, 18.3, 21.2, 22.9, 26.7, 28.3, 28.5, 29.8, 32.9, 38.1, 38.7, 38.9, 44.4, 
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66.5, 73.9, 78.2, 78.8, 87.3, 130.0, 130.7, 171.4; IR (film) 3446 (br), 2957, 1737 (str), 
1457, 1374, 1237, 1137, 1117, 1043 cm-1; [α]26D = +2.3 (c = 0.68, CH2Cl2); MS 
(electrospray ionization) calculated for C28H50O5SiNa [M + Na]+: 517.33, found: 
517.5. 
Into a flask containing the alcohol 15 in 500 µL of THF was added 
tetrabutylammonium fluoride (1.0 M in THF, 63 µL, 63 µmol).  The solution was 
stirred 1 hour, then quenched by the addition of saturated aqueous NH4Cl and 
diluted with Et2O.  The layers were separated and the aqueous portion was washed 
three times with Et2O, dried over Na2SO4, and concentrated in vacuo.  Purification 
via flash column chromatography (30% EtOAc/Hexanes) gave 5.1 mg (64% over two 
steps) of the diol as a colorless oil:  1H NMR (500 MHz, CDCl3) δ 0.82 (d, J = 6.0 Hz, 
3H), 0.86-0.99 (m, 1H), 0.88 (d, J = 6.9 Hz, 3H), 1.17 (d, J = 9.8 Hz, 1H), 1.42 (s, 
3H), 1.64 (dd, J = 13.9, 8.4 Hz, 1H), 1.75-1.85 (m, 6H), 1.79 (s, 3H), 1.93 (m, 1H), 
2.09-2.13 (m, 1H), 2.10 (s, 3H), 2.34 (br s, 1H), 2.49 (dd, J = 8.7, 8.7 Hz, 1H), 2.60 
(dd, J = 21.1, 11.0 Hz, 1H), 2.69 (d, J = 14.4 Hz, 1H), 3.46 (dd, J = 11.6, 5.5 Hz, 1H), 
3.53 (dd, J = 11.5, 11.5 Hz, 1H), 3.78 (d, J = 10.2 Hz, 1H), 4.04 (s, 1H), 5.18 (d, J = 
3.7 Hz, 1H), 5.52 (dd, J = 10.7, 5.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 1.0, 14.1, 
18.4, 21.2, 23.0, 28.4, 29.4, 29.7, 29.8, 30.9, 37.9, 38.1, 42.2, 45.7, 65.4, 74.0, 75.1, 
79.9, 89.1, 130.1, 171.4; IR (film) 3355 (br), 2925, 1736 (str), 1455, 1381, 1237, 
1017 cm-1; [α]26D = +33 (c = 0.39, CH2Cl2); MS (electrospray ionization) calculated 
for C22H36O5K [M + K]+: 419.36, found: 419.4. 
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 11-acetoxy-4-deoxyasbestinin D (1).  A flask charged with diol 50 (8.9 mg, 
24 µmol) in 1.1 mL of THF was cooled to 0 oC.  2,6 lutidine (13.6 µL, 0.117 mmol) 
followed by trifluoromethanesulfonic anhydride (5.8 µL, 34 µmol) were added to the 
solution and allowed to stir 45 minutes at 0 oC.  The solution was warmed to room 
temperature for 4 hours, then quenched via the addition of saturated aqueous 
NH4Cl.  The mixture was diluted with Et2O and the layers were separated.  The 
aqueous portion was washed three times with Et2O, dried over Na2SO4, and 
concentrated in vacuo.  Purification via flash column chromatography (10% 
EtOAc/Hexanes) gave 5.5 mg (66%) of 11-acetoxy-4-deoxyasbestinin D as a 
colorless oil:  1H NMR (500 MHz, CDCl3) δ 0.91 (d, J = 7.1 Hz, 3H), 0.92 (d, J = 7.2 
Hz, 3H), 1.01 (m, 1H), 1.35 (s, 3H), 1.52 (ddd, J = 13.5, 13.5, 9.7 Hz, 1H), 1.61 (m, 
1H), 1.75 (s, 3H), 1.75 (m, 2H), 1.84-2.08 (m, 5H), 2.10 (s, 3H), 2.34 (ddd, J = 10.4, 
10.4, 10.4 Hz, 1H), 2.50 (br d, J = 14.8 Hz, 1H), 2.55 (ddd, J = 14.5, 10.3, 4.8 Hz, 
1H), 3.48 (dd, J = 13.2, 3.2 Hz, 1H), 3.86 (d, J = 15.2 Hz, 1H), 3.87 (d, J = 8.7 Hz, 
1H), 4.10 (ddd, J = 5.5, 2.9, 2.9 Hz, 1H), 5.31 (dd, J = 5.1, 2.8 Hz, 1H), 5.47 (dd, J = 
8.1, 8.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 11.0, 17.9, 21.3, 23.4, 26.1, 28.9, 
31.3, 31.5, 37.3, 37.5, 38.0, 38.5, 40.5, 45.8, 67.9, 73.5, 76.4, 81.0, 92.2, 128.7, 
130.8, 171.3; IR (film) 2926, 1737 (str), 1459, 1377, 1231, 1088 cm-1; [α]26D = -15 (c 
= 0.17, CHCl3); MS (electrospray ionization) calculated for C22H35O4 [M + 1]+: 
363.25, found: 363.2. 
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An authentic sample of 11-acetoxy-4-deoxyasbestinin D was provided by Dr. 
Abimael D. Rodríguez (University of Puerto Rico, Río Piedras),3 purified in the same 
manner as described above, and an optical rotation was obtained under identical 
conditions:  [α]25D = -15 (c = 0.10, CHCl3).  The 1H NMR (500 MHz, CDCl3) spectrum 
of the authentic sample also mirrored the synthetic material. 
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Alkylation Adduct.  Into a flask equipped with an addition funnel and a low-
temperature thermometer was added sodum bis(trimethylsilyl)amide (0.78 M in 
toluene/THF, 321.86 mL, 251.05 mmol) and 400 mL of THF.  The solution was 
cooled to –78 oC and glycolate 2 in 200 mL of THF was added dropwise via addition 
funnel keeping the temperature below –65 oC.  The resultant solution was stirred 30 
minutes at –78 oC, then methallyl iodide (90.66 mL, 836.8 mmol) was added 
dropwise via addition funnel.  The soludtion was stirred 5 minutes at –78 oC, then 
warmed to –45 oC for 1 hour.  The reaction was quenched by the addition of 
saturated aqueous NH4Cl, and then warmed to room temperature.  The layers were 
separated and the aqueous was extracted twice with  EtOAc.  The organic layers 
were combined, dried over Na2SO4, and concentrated in vacuo.  Purification by flash 
column chromatography (10% then 20% EtOAc/Hexanes) provided 47.07 g (78%) of 
the alkene as a yellow oil:  1H NMR (400 MHz, CDCl3) δ 0.82 (d, J = 6.9 Hz, 3H), 
0.87 (d, J = 7.0 Hz, 3H), 1.78 (s, 3H), 2.27 (m, 1H), 2.40 (dd, J = 13.9, 8.8 Hz, 1H), 
2.51 (dd, J = 13.9, 4.0 Hz, 1H), 3.78 (s, 3H), 4.18 (m, 2H), 4.34 (m, 1H), 4.45 (AB, 
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JAB = 11.3 Hz, ∆νAB = 27.3 Hz, 2H), 4.82 (s, 2H), 5.26 (dd, J = 4.0, 8.8 Hz, 1H), 6.82 
(d, J = 6.6 Hz, 2H), 7.24 (d, J = 6.7 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 14.6, 
17.7, 22.2, 28.3, 41.0, 55.1, 58.1, 63.8, 72.2, 75.4, 113.46, 113.52, 129.5, 129.8, 
140.9, 153.4, 159.2, 172.7; IR (film) 2964, 2360, 1779 (str), 1709 (str), 1514 (str), 
1248 cm-1; [α]21D = -75.0 (c = 2.75, CH2Cl2); MS (electrospray ionization) calculated 
for C20H27NO5Na [M + Na]+:  384.18, found: 384.2.   
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β-Keto Ester.  Into a flask equipped with an addition funnel and a low 
temperature thermometer was added diisopropylamine (50.52 mL, 360.5 mmol) and 
285 mL of THF.  The solution was cooled to 0 oC and n-butyl lithium (2.5 M in 
hexanes, 143.04 mL, 357.60 mmol) was added dropwise via addition funnel.  After 
10 minutes at 0 oC, the solution was cooled to –78 oC and ethyl acetate (35.21 mL, 
360.5 mmol) was added dropwise via addition funnel and stirred for 1 hour.  The 
alkene dissolved in 145 mL of THF was added dropwise and the reaction mixture 
was stirred 1 hour at –78 oC.  The reaction was quenched by the addition of 
saturated aqueous NH4Cl, and then warmed to room temperature.  The layers were 
separated and the aqueous was extracted twice with ethyl acetate.  The organic 
layers were combined, dried over Na2SO4, and concentrated in vacuo.  Purification 
by flash column chromatography (5% then 10% EtOAc/Hexanes) provided 38.31 g 
(84%) of the ester as a colorless oil:  1H NMR (400 MHz, CDCl3) δ β-keto ester 1.24 
(t, J = 7.1 Hz, 3H), 1.72 (s, 3H), 2.34-2.47 (m, 2H), 3.55 (AB, JAB = 16.1 Hz, ∆νAB = 
35.0 Hz, 2H), 3.78 (s, 3H), 4.03 (dd, J = 7.5, 5.5 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 
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4.47 (AB, JAB = 11.1 Hz, ∆νAB = 26.6 Hz, 2H), 4.78 (s, 1H), 4.84 (s, 1H), 6.86 (d, J = 
8.6 Hz, 2H), 7.24 (d, J = 8.6 Hz, 2H); β-enol ester 1.30 (t, J = 7.1 Hz, 3H), 1.68 (s, 
3H), 2.34-2.47 (m, 2H), 3.78 (s, 3H), 3.93 (dd, J = 8.1, 4.8 Hz, 1H), 4.21 (q, J = 7.1 
Hz, 2H), 4.45 (AB, JAB = 11.4 Hz, ∆νAB = 100.3 Hz, 2H), 4.76 (s, 1H), 4.80 (s, 1H), 
5.30 (s, 1H), 6.86 (d, J = 8.6 Hz, 2H), 7.24 (d, J = 8.6 Hz, 2H), 12.04 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 14.0, 14.1, 22.4, 39.9, 42.2, 44.7, 55.1, 60.1, 61.1, 71.2, 
72.3, 82.8, 88.7, 113.2, 113.6, 113.7, 114.0, 129.1, 129.4, 129.5, 129.6, 140.5, 
141.3, 159.2, 159.4, 167.2, 172.7, 176.8, 205.0; IR (film) 2980, 2938, 1747 (str), 
1719 (str), 1651, 1613 (str), 1515 (str), 1465, 1250 (str) cm-1; [α]22D = -45.3 (c = 5.50, 
CH2Cl2); MS (electrospray ionization) calculated for C18H24O5Na [M + Na]+:  343.15, 
found: 343.2.   
MePMBO
OH
HO
 
Diol.  A flask equipped with an addition funnel was charged with lithium 
aluminum hydride (9.08 g, 239 mmol) and 1.00 L of Et2O.  The suspension was 
cooled to 0 oC and ester 3 (38.31 g, 119.6 mmol) in 200 mL of Et2O was added 
dropwise.  The solution was allowed to stir for 1 hour at 0 oC, then the reaction was 
quenched by the slow addition of 9.08 mL of H2O, 9.08 mL of 15% sodium 
hydroxide, and 18.16 mL of H2O.  After warming to room temperature, the 
suspension was filtered through celite and the salts were washed with ethyl acetate.  
The organic layers were dried over Na2SO4 and concentrated in vacuo.  Purification 
by flash column chromatography (40% EtOAc/Hexanes) provided 26.7 g (80%) of 
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the diol as a colorless oil:  IR (film) 3390 (br), 2937, 1613, 1514 (str) cm-1; MS 
(electrospray ionization) calculated for C16H24O4Na [M + Na]+:  303.16, found: 303.2.   
MePMBO
OH
TIPSO
 
Silyl Ether.  A flask was charged with the diol  (22.21 g, 79.22 mmol) and 320 
mL of CH2Cl2.  Imidazole (16.18 g, 237.7 mmol) and triisopropylsilyl chloride (18.63 
mL, 87.14 mmol) were added sequentially.  The solution was allowed to stir 
overnight, then quenched by the addition of saturated aqueous NH4Cl.  The layers 
were separated, and the aqueous was washed twice with CH2Cl2.  The organic 
layers were combined, dried over Na2SO4, and concentrated in vacuo.  Purification 
by flash column chromatography (10% EtOAc/Hexanes) provided 34.59 g (100%) of 
the alcohol as a colorless oil:  IR (film) 3492 (br), 2943 (str), 2866 (str), 1514, 1249 
(str) cm-1; MS (electrospray ionization) calculated for C25H44O4SiNa [M + Na]+:  
459.29, found: 459.4. 
MePMBO
O
TIPSO
 
Ketone.  A flask was charged with oxalyl chloride (2.0 M in CH2Cl2, 59.41 mL, 
118.8 mmol) and 300 mL of CH2Cl2 and cooled to –78 oC.  Dimethylsulfoxide (14.06 
mL, 198.02 mmol) in 75 mL of CH2Cl2 was added dropwise, and the solution was 
stirred 2 minutes.  The alcohol (34.59 g, 79.21 mmol) and 125 mL CH2Cl2 were 
added dropwise to the mixture and allowed to stir 30 minutes at –78 oC.  
Triethylamine (55.20 mL, 396.04 mmol) was added dropwise and stirred 5 minutes 
at –78 oC, followed by warming to room temperature for 1 hour.  The reaction was 
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quenched by the addition of water.  The organic portion was washed with saturated 
aqueous NaHCO3, then water.  The combined aqueous portions were washed with 
CH2Cl2.  The combined organic extracts were then washed with brine, dried over 
Na2SO4, and concentrated in vacuo.  Purification by flash column chromatography 
(5% EtOAc/Hexanes) provided 34.43 g (100%) of the ketone as a colorless oil:  1H 
NMR (400 MHz, CDCl3) δ 1.05 (s, 21H), 1.71 (s, 3H), 2.3-2.43 (m, 2H), 2.67-2.82 
(m, 2H), 3.77 (s, 3H), 3.93-4.02 (m, 3H), 4.45 (AB, JAB = 11.3 Hz, ∆νAB = 65.8 Hz, 
2H), 4.77 (s, 1H), 4.81 (s, 1H), 6.85 (d, J = 8.6 Hz, 2H), 7.24 (d, J = 8.6 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 11.7, 17.8, 22.3, 39.8, 40.6, 55.0, 58.5, 71.9, 83.2, 113.3, 
113.6, 129.38, 129.42, 140.9, 159.2, 210.9; IR (film) 2043 (str), 2866 (str), 1719 (str), 
1613, 1514 (str), 1464, 1250 (str), 1099 (str) cm-1; [α]22D = -24.1 (c = 5.45, CH2Cl2); 
MS (electrospray ionization) calculated for C25H42O4SiNa [M + Na]+:  457.28, found: 
457.3.   
MePMBO
OH
TIPSO
 
Alcohol.  Into a flask equipped with an addition funnel and a low temperature 
thermometer was added ketone 4 (35.96 g, 82.73 mmol) in 800 mL of Et2O.  The 
solution was cooled to –40 oC and Zn(BH4)2 (~0.14 M in Et2O, 335 mL, 47 mmol) 
was added dropwise via addition funnel.  The mixture was warmed to –25 oC and 
stirred for 15 minutes.  The reaction was quenched by the addition of 33.5 mL of 
saturated aqueous NaCl.  The mixture was warmed to room temperature, dried over 
Na2SO4, and concentrated in vacuo.  Purification by flash column chromatography 
(5% EtOAc/Hexanes) provided 28.52 g (79%) of the alcohol as a colorless oil:  1H 
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NMR (400 MHz, CDCl3) δ 1.08 (s, 21H), 1.71-1.84 (m, 2H), 1.77 (s, 3H), 2.25-2.37 
(m, 2H), 3.36 (br s, 1H), 3.54-3.60 (m, 1H), 3.77 (s, 3H), 3.84-4.01 (m, 3H), 4.55 (s, 
2H), 4.82 (s, 2H), 6.85 (d, J = 8.6 Hz, 2H), 7.26 (d, J = 8.6 Hz, 2H); 13C NMR (100 
MHz, CDCl3) δ 11.7, 17.9, 22.9, 33.8, 38.9, 55.1, 62.7, 72.0, 72.8, 80.2, 112.8, 
113.6, 129.4, 130.8, 142.8, 159.1; IR (film) 3493 (br), 2943 (str), 2866 (str), 1613, 
1514 (str), 1464, 1249 (str) cm-1; [α]22D = +12 (c = 3.4, CH2Cl2); MS (electrospray 
ionization) calculated for C25H44O4SiNa [M + Na]+:  459.29, found: 459.4.  
MePMBO
O
TIPSO
OHO
 
Glycolic Acid.  A flask equipped with an addition funnel was charged with 
sodium hydride (60% dispersion in mineral oil, 6.59 g, 165 mmol).  The solid was 
rinsed with pentane three times, diluted in 55 mL of DMF, and cooled to 0 oC.  
Bromoacetic acid (9.16 g, 65.9 mmol) in 25 mL of THF was added dropwise, then 
allowed to stir 10 minutes.  The alcohol 5 (23.97 g, 54.89 mmol) was added via 
addition funnel in 30 mL of THF, and the solution was warmed to room temperature 
and stirred overnight.  The mixture was then cooled to 0 oC and quenched by the 
addition of saturated aqueous NH4Cl and diluted with Et2O.  The layers were 
separated, and the aqueous portion was extracted twice more using Et2O.  The 
combine organic layers were washed with brine, dried over Na2SO4, and 
concentrated in vacuo.  Purification by flash column chromatography (10% then 50% 
EtOAc/Hexanes) provided 24.4 g (90%) of the acid as a yellow oil:  1H NMR (400 
MHz, CDCl3) δ 1.06 (s, 21H), 1.67 (m, 1H), 1.71 (s, 3H), 1.78 (m, 1H), 2.19 (dd, J = 
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14.4, 4.4 Hz, 1H), 2.36 (dd, J = 14.5, 8.3 Hz, 1H), 3.48 (ddd, J = 4.3, 4.3, 2.1 Hz, 
1H), 3.77 (s, 3H), 3.77-3.88 (m, 3H), 4.22 (AB, JAB = 17.1 Hz, ∆νAB = 22.6 Hz, 2H), 
4.55 (AB, JAB = 11.5 Hz, ∆νAB = 8.3 Hz, 2H), 4.79 (s, 1H), 4.81 (s, 1H), 6.84 (d, J = 
8.5 Hz, 2H), 7.23 (d, J = 8.5 Hz, 2H), 10.80 (br s, 1H); 13C NMR (100 MHz, CDCl3) δ 
11.7, 17.8, 22.5, 33.6, 38.0, 54.9, 59.6, 68.1, 71.8, 78.3, 80.1, 113.0, 113.6, 129.5, 
129.6, 142.0, 159.2, 173.4; IR (film) 3074 (br), 2943 (str), 2866 (str), 1763, 1732 
(str), 1613, 1514 (str), 1464, 1249 (str) cm-1; [α]21D = +14 (c = 1.8, CH2Cl2); MS 
(electrospray ionization) calculated for C27H46O6SiK [M + K]+:  533.41, found: 533.3.   
ii.) Acylation of the acid to yield glycolate 6 
MePMBO
O
TIPSO
NO
O
O
Me Me
 
Complex Glycolate.  Into a flask fitted with an addition funnel was added the 
glycolic acid (24.36 g, 49.24 mmol) in 350 mL of THF.  The solution was cooled to –
78 oC and triethylamine (7.55 mL, 54.2 mmol) was added to the solution, followed by 
dropwise addition of pivaloyl chloride (6.68 mL, 54.16 mL).  The mixture was 
warmed to 0 oC and stirred for 1 hour, then cooled to –78 oC. 
In a separate flask equipped with an addition funnel was added (4S)-4-Isopropyl-
oxazolidin-2-one (8.27 g, 64.0 mmol) and 175 mL of THF.  The solution was cooled 
to –78 oC, and n-butyl lithium (2.3 M in hexanes, 25.69 mL, 59.09 mmol) was added 
dropwise, and stirred for 30 minutes. 
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The lithiated oxazolidinone was then transferred via cannula into the mixed 
anhydride and the mixture was stirred for 1 hour at –78 oC followed by warming to 0 
oC for 45 minutes.  The reaction was quenched using saturated aqueous NH4Cl, 
then warmed to room temperature.  The layers were separated and the aqueous 
was washed twice with EtOAc.  The combined organic layers were washed with 
brine, dried over Na2SO4, and concentrated in vacuo.  Purification by flash column 
chromatography (10% then 20% EtOAc/Hexanes) provided 27.6 g (90%) of the 
glycolate as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 0.83 (d, J = 6.9 Hz, 3H), 
0.89 (d, J = 7.0 Hz, 3H), 1.05 (s, 21H), 1.68-1.78 (m, 1H), 1.73 (s, 3H), 1.85 (dddd, J 
= 9.5, 9.5, 4.6, 4.6 Hz, 1H), 2.18 (dd, J = 14.5, 4.7 Hz, 1H), 2.34-2.43 (m, 2H), 3.72-
3.78 (m, 1H), 3.77 (s, 3H), 3.79-3.86 (m, 2H), 3.90 (ddd, J = 9.7, 9.7, 4.7 Hz, 1H), 
4.17-4.23 (m, 2H), 4.36 (ddd, J = 7.9, 4.0, 4.0 Hz, 1H), 4.54 (AB, JAB = 11.2 Hz, ∆νAB 
= 53.4 Hz, 2H), 4.77 (s, 2H), 4.78 (AB, JAB = 18.0 Hz, ∆νAB = 28.1 Hz, 2H), 6.83 (d, J 
= 8.6 Hz, 2H), 7.26 (d, J = 8.5 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 11.8, 14.5, 
17.9, 22.8, 26.9, 28.1, 33.8, 38.9, 55.1, 58.0, 59.7, 64.1, 70.5, 71.7, 78.8, 79.2, 
112.5, 113.5, 129.3, 130.8, 142.8, 153.8, 158.9, 170.0; IR (film) 2942, 2867, 1785 
(str), 1719 (str), 1613, 1514 (str), 1464, 1389, 1302, 1251 cm-1; [α]25D = -18.7 (c = 
14.4, CH2Cl2); MS (electrospray ionization) calculated for C33H55NO7SiNa [M + Na]+:  
628.36, found: 628.3.   
e.) B fragment alcohol 7 
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Alkylation Adduct.  A flask equipped with an addition funnel was charged 
with sodum bis(trimethylsilyl)amide (0.78 M in toluene/THF, 77.45 mL, 60.41 mmol) 
and 200 mL of THF.  The solution was cooled to –78 oC and glycolate 6 (24.40 g, 
40.27 mmol) in 200 mL of THF was added dropwise via addition funnel keeping the 
temperature below –65 oC.  The resultant solution was stirred 1 hour at –78 oC. 
In a separate flask, formaldehyde dibenzyl acetal (25.85 mL, 120.8 mmol) was 
cooled to 0 oC, and iodotrimethylsilane(16.62 mL, 116.8 mmol) was added and 
allowed to stir 30 minutes. 
The benzyl iodomethyl ether was then added to the enolate, and the solution was 
allowed to stir for 1 hour at –78 oC.  The reaction was quenched by the addition of 
saturated aqueous NH4Cl, and then warmed to room temperature.  The layers were 
separated, and the aqueous was extracted twice with Et2O.  The organic layers were 
combined, dried over Na2SO4, and concentrated in vacuo.  Purification by flash 
column chromatography (5% then 10% EtOAc/Hexanes) provided 23.98 g (83%) of 
the benzyl ether as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 0.66 (d, J = 6.9 Hz, 
3H), 0.77 (d, J = 7.0 Hz, 3H), 1.04 (s, 21H), 1.60 (m, 1H), 1.73 (s, 3H), 1.82 (m, 1H), 
2.17 (dd, J = 15.0, 3.8 Hz, 1H), 2.22 (m, 1H), 2.57 (dd, J = 14.7, 9.1 Hz, 1H), 3.52 
(dd, J = 8.8, 8.8 Hz, 1H), 3.60 (ddd, J = 9.0, 3.7, 4.1 Hz, 1H), 3.70 (dd, J = 10.4, 4.0 
Hz, 1H), 3.72 (s, 3H), 3.79 (dd, J = 4.4, 4.4 Hz, 1H), 3.83 (m, 2H), 3.88 (dd, J = 9.1, 
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3.0 Hz, 1H), 3.94 (m, 1H), 4.18 (ddd, J = 8.4, 3.2, 3.2 Hz, 1H), 4.47 (AB, JAB = 11.9 
Hz, ∆νAB = 89.5 Hz, 2H), 4.55 (AB, JAB = 11.9 Hz, ∆νAB = 21.5 Hz, 2H), 4.80 (s, 2H), 
5.58 (dd, J = 5.7, 4.1 Hz, 1H), 6.81 (d, J = 8.6 Hz, 2H), 7.17-7.30 (m, 7H); 13C NMR 
(100 MHz, CDCl3) δ 11.6, 14.1, 17.3, 17.7, 22.6, 27.7, 34.6, 37.4, 54.7, 57.7, 59.8, 
63.1, 71.0, 71.6, 72.9, 78.8, 79.4, 81.1, 111.9, 113.2, 127.0, 127.2, 127.8, 128.7, 
130.5, 137.7, 142.9, 153.3, 158.7, 170.4; IR (film) 2942, 2866, 1780 (str), 1715, 
1514, 1388, 1248 (str) cm-1; [α]25D = -34 (c = 1.9, CH2Cl2); MS (electrospray 
ionization) calculated for C41H63NO8SiNa [M + Na]+:  748.42, found: 748.4.   
MePMBO
O
TIPSO
BnO
OH
 
Primary Alcohol.  To a solution of the benzyl ether (21.55 g, 29.68 mmol) 
and methanol (1.81 mL, 44.52 mmol) in 300 mL of Et2O at 0 oC was added lithium 
borohydride (2.0M in THF, 22.26 mL, 44.52 mmol) dropwise via addition funnel.  
After stirring for 1 hour at 0 oC, MeOH (1.81 mL, 44.52 mmol) was added.  The 
solution was quenched by the addition of saturated sodium potassium tartrate, 
warmed to ambient temperature, and stirred for 2 hours.  The layers were separated, 
and the aqueous was extracted twice with Et2O.  The organic layers were combined, 
dried over Na2SO4, and concentrated in vacuo.  Purification by flash column 
chromatography (10% EtOAc/Hexanes) provided 15.28 g (86%) of the alcohol as a 
colorless oil:  1H NMR (400 MHz, CDCl3) δ 1.11 (s, 21H), 1.68 (m, 1H), 1.77 (s, 3H), 
1.83 (m, 1H), 2.24 (dd, J = 14.6, 5.2 Hz, 1H), 2.46 (dd, J = 14.6, 8.5 Hz, 1H), 3.32 
(br s, 1H), 3.54 (dd, J = 9.6, 6.0 Hz, 1H), 3.59-3.67 (m, 2H), 3.69 (ddd, J = 8.3, 4.3, 
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1.5 Hz, 1H), 3.75-3.88 (m, 4H), 3.78 (s, 3H), 4.02 (m, 1H), 4.55 (s, 2H), 4.58 (AB, 
JAB = 11.5 Hz, ∆νAB = 25.5 Hz, 2H), 4.85 (s, 2H), 6.88 (d, J = 8.6 Hz, 2H), 7.27-7.39 
(m, 7H) ); 13C NMR (100 MHz, CDCl3) δ 11.8, 17.9, 22.7, 34.8, 38.0, 54.9, 59.6, 
63.0, 70.2, 71.5, 73.1, 76.7, 79.1, 79.5, 112.6, 113.5, 127.2, 127.3, 128.1, 129.3, 
130.0, 138.1, 142.5, 159.0; IR (film) 3450 (br), 2942 (str), 2865 (str), 1514, 1249, 
1093 (str) cm-1; [α]23D = +17 (c = 4.7, CH2Cl2); MS (electrospray ionization) 
calculated for C35H56O6SiNa [M + Na]+:  623.37, found: 623.3. 
MePMBO
O
TIPSO
BnO
O
 
Aldehyde.  A flask was charged with oxalyl chloride (2.0 M in CH2Cl2, 18.45 
mL, 36.89 mmol) and 150 mL of CH2Cl2 and cooled to –78 oC.  Dimethylsulfoxide 
(4.37 mL, 61.49 mmol) in 30 mL of CH2Cl2 was added dropwise, and the solution 
was stirred 2 minutes.  The alcohol 7 (14.78 g, 24.60 mmol) and 60 mL CH2Cl2 were 
added dropwise to the mixture and allowed to stir 30 minutes at –78 oC.  
Triethylamine (17.14 mL, 123.0 mmol) was added dropwise and stirred 5 minutes at 
–78 oC, followed by warming to room temperature for 1 hour.  The reaction was 
quenched by the addition of water.  The organic portion was washed with saturated 
aqueous NaHCO3, then water.  The combined aqueous portions were washed with 
CH2Cl2.  The combined organic extracts were then washed with brine, dried over 
Na2SO4, and concentrated in vacuo.  Purification by passing through a short plug of 
silica (10% EtOAc/Hexanes) provided 14.44 g (99%) of the aldehyde as a colorless 
oil:  1H NMR (400 MHz, CDCl3) δ 1.09 (s, 21H), 1.66-1.78 (m, 1H), 1.73 (s, 3H), 1.88 
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(m, 1H), 2.25 (dd, J = 14.4, 4.5 Hz, 1H), 2.44 (dd, J = 14.4, 8.3 Hz, 1H), 3.69 (ddd, J 
= 8.2, 4.6, 1.7 Hz, 1H), 3.72-3.88 (m, 2H), 3.79 (s, 3H), 3.84-3.91 (m, 2H), 3.98 (m, 
1H), 4.13 (ddd, J = 4.4, 4.4, 1.3 Hz, 1H), 4.53 (AB, JAB = 11.4 Hz, ∆νAB = 31.1 Hz, 
2H), 4.55 (AB, JAB = 12.2 Hz, ∆νAB = 14.6 Hz, 2H), 4.80 (s,1H), 4.82 (s, 1H), 6.87 (d, 
J = 6.8 Hz, 2H), 7.21-7.48 (m, 7H), 9.77 (d, J = 1.3 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 11.9, 17.9, 22.7, 34.4, 38.7, 55.1, 59.7, 69.7, 71.4, 73.4, 78.7, 79.7, 84.6, 
112.7, 113.6, 127.5, 127.6, 128.2, 129.3, 130.4, 137.7, 142.6, 159.0, 202.6; IR (film) 
2942 (str), 2865 (str), 1734 (str), 1613, 1514, 1463, 1249 (str), 1096 (str) cm-1; [α]23D 
= +4.0 (c = 1.9, CH2Cl2); MS (electrospray ionization) calculated for C35H54O6SiNa 
[M + Na]+:  621.36, found: 621.4. 
O
H H
H
PMBO
OBn
TIPSO
OH
Me
 
Diene.  A flask fitted with an addition funnel and dry ice/acetone filled 
condenser was charged with freshly ground magnesium (3.65 g, 150 mmol) and the 
system was flame dried.  The solid was suspended in 12 mL of THF, and one crystal 
of iodine was added to the suspension.  Vinyl bromide (11.64 mL, 165 mmol) in 12 
mL of THF was added dropwise via addition funnel until the mixture began to reflux.  
The halide was added at a rate to maintain reflux until addition was complete.  The 
solution was stirred for 30 minutes upon completion of addition, then diluted with 83 
mL of THF. 
In a separate flask equipped with an addition funnel, the previously prepared vinyl 
magnesium bromide (1.4 M in THF, 52.71 mL, 73.79 mmol) was added to 160 mL of 
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THF.  The solution was cooled to 0 oC and the aldehyde (14.73 g, 24.60 mmol) was 
added dropwise via addition funnel.  The solution was stirred for 5 minutes, then the 
reaction was quenched by the slow addition of saturated aqueous ammonium 
chloride.  After dilution with Et2O, the layers were separated, and the aqueous 
portion was extracted twice more with Et2O.  The organic layers were combined, 
dried over Na2SO4, and concentrated in vacuo.  Purification by flash column 
chromatography (10% EtOAc/Hexanes) provided 12.99 g (86%) of a colorless oil 
consisting of a 3:1 inseparable mixture of alcohol epimers, favoring the configuration 
shown:  IR (film) 3437 (br), 2942 (str), 2866 (str), 1613, 1514 (str), 1463 (str), 1365, 
1303, 1249 (str), 1093 cm-1; MS (electrospray ionization) calculated for 
C37H58O6SiNa [M + Na]+:  649.39, found: 649.4. 
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Oxocenes.  A flask equipped with a reflux condenser was charged with the 
diene (11.31 g, 18.06 mmol) in 1.800 L of CH2Cl2.  The solution was refluxed for 30 
minutes while purging the system with argon.  The vessel was cooled to room 
temperature and (Cl2(PCy3)(Imes)Ru=CHPh (765 mg, 0.903 mmol) was added.  The 
solution was stirred at reflux overnight, then cooled to room temperature.  
Evaporation of the solvents and purification via flash column chromatography (10% 
then 25% EtOAc/Hexanes) provided a separable mixture 5.58 g (52%) and 1.95 g 
(19%%) of the oxocenes as a colorless oil:  Major epimer:  1H NMR (400 MHz, 
CDCl3) δ 1.07 (s, 21H), 1.52 (dddd, J = 14.4, 9.8, 4.9, 4.9 Hz, 1H), 1.86 (s, 3H), 2.10 
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(m, 1H), 2.32 (d, J = 12.1 Hz, 1H), 2.67 (dd, J = 13.5, 2.9 Hz, 1H), 3.10 (br s, 1H), 
3.43 (ddd, J = 8.8, 4.3, 4.3 Hz, 1H), 3.50 (m, 1H), 3.64 (m, 1H), 3.69-3.87 (m, 4H), 
3.77 (s, 3H), 4.38 (m, 1H), 4.48 (AB, JAB = 11.1 Hz, ∆νAB = 122.3 Hz, 2H), 4.57 (AB, 
JAB = 12.1 Hz, ∆νAB = 46.9 Hz, 2H), 5.46 (d, J = 4.4 Hz, 1H), 6.87 (d, J = 8.3 Hz, 2H), 
7.25 (d, J = 8.5 Hz, 2H), 7.27-7.36 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 11.8, 17.8, 
26.0, 31.8, 36.8, 54.87, 54.89, 70.7, 71.2, 71.9, 73.3, 77.5, 82.2, 82.6, 113.4, 
127.46, 127.53, 128.2, 129.0, 129.7, 130.2, 134.7, 137.6, 158.9; IR (film) 3465 (br), 
2942, 2865, 1613, 1514 (str), 1464, 1302, 1249 cm-1; [α]21D = +95.5 (c = 8.94 
CH2Cl2); MS (electrospray ionization) calculated for C35H54O6SiNa [M + Na]+:  
621.36, found: 621.3.   
Minor epimer:  1H NMR (400 MHz, CDCl3) δ 1.05 (s, 21H), 1.50 (m, 1H), 1.83 (s, 
3H), 2.13 (m, 1H), 2.36 (dd, J = 13.5, 5.7 Hz, 1H), 2.73 (br s, 1H), 3.08 (d, J = 12.5 
Hz, 1H), 3.40 (m, 1H), 3.54-3.72 (m, 4H), 3.76-3.86 (m, 2H), 3.81 (s, 3H), 4.38 (d, J 
= 6.6 Hz, 1H), 4.48 (AB, JAB = 11.3 Hz, ∆νAB = 101.7 Hz, 2H), 4.54 (AB, JAB = 12.1 
Hz, ∆νAB = 23.8 Hz, 2H), 5.56 (dd, J = 7.5, 1.1 Hz, 1H), 6.86 (d, J = 6.7 Hz, 2H), 
7.21-7.38 (m, 7H); 13C NMR (100 MHz, CDCl3) δ 12.0, 18.0, 26.8, 33.9, 37.1, 55.2, 
59.9, 69.9, 71.0, 71.5, 73.7, 79.5, 80.3, 82.0, 113.7, 125.5, 127.72, 127.75, 128.4, 
129.4, 130.4, 137.7, 139.3, 159.1; IR (film) 3445 (br), 2941, 2865, 1612, 1514, 1463, 
1248 cm-1; [α]23D = +84 (c = 0.47 CH2Cl2); MS (electrospray ionization) calculated for 
C35H54O6SiNa [M + Na]+:  621.36, found: 621.4.   
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Enone.  A flask was charged with oxalyl chloride (2.0 M in CH2Cl2, 2.91 mL, 
5.81 mmol) and 25 mL of CH2Cl2 and cooled to –78 oC.  Dimethylsulfoxide (688 µL, 
9.69 mmol) in 5 mL of CH2Cl2 was added dropwise, and the solution was stirred 2 
minutes.  The alcohol (2.32 g, 3.87 mmol) and 10 mL CH2Cl2 were added dropwise 
to the mixture and allowed to stir 30 minutes at –78 oC.  Triethylamine (2.70 mL, 
19.4 mmol) was added dropwise and stirred 5 minutes at –78 oC, followed by 
warming to room temperature for 1 hour.  The reaction was quenched by the 
addition of water.  The organic portion was washed with saturated aqueous 
NaHCO3, then water.  The combined aqueous portions were washed with CH2Cl2.  
The combined organic extracts were then washed with brine, dried over Na2SO4, 
and concentrated in vacuo.  Purification by flash column chromatography (10% 
EtOAc/Hexanes) provided 1.47 g (64%) of the enone as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 1.04 (s, 21H), 1.75 (m, 1H), 1.86 (m, 1H), 1.94 (s, 3H), 2.54 (d, 
J = 16.7 Hz, 1H), 2.65 (dd, J = 16.8, 7.6, Hz, 1H), 3.50 (m, 1H), 3.67-3.76 (m, 2H), 
3.79 (s, 3H), 3.82-3.92 (m, 3H), 4.24-4.31 (m, 2H), 4.47-4.58 (m, 3H), 5.80 (s, 1H), 
6.88 (d, J = 8.7 Hz, 2H), 7.22 (d, J = 8.7 Hz, 2H), 7.24-7.35 (m, 5H); ); 13C NMR (100 
MHz, CDCl3) δ 11.9, 18.0, 27.5, 35.8, 36.8, 55.17, 55.18, 59.9, 70.2, 72.3, 73.4, 
78.5, 82.5, 87.2, 113.7, 126.0, 127.38, 127.42, 128.2, 129.4, 129.5, 138.1, 146.5, 
159.2, 203.4; IR (film) 2942, 2865, 1668, 1514, 1250 cm-1; [α]24D = -7.5 (c = 2.4 
CH2Cl2); MS (electrospray ionization) calculated for C35H52O6SiNa [M + Na]+:  
619.34, found: 619.2. 
The resultant enone 1.17 g (1.96 mmol) was dissolved in 10 mL of methanol and 
cooled to 0 oC.  Cerium chloride heptahydrate (740 mg, 1.96 mmol) was added, 
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followed by sodium borohydride (74 mg, 2.0 mmol).  The solution was stirred for five 
minutes, then quenched by the addition of 1M HCl and diluted with Et2O.  After 
warming to room temperature, the layers were separated, and the aqueous fraction 
was extracted twice with Et2O.  The combined organic extracts were then washed 
with brine, dried over Na2SO4, and concentrated in vacuo.  Purification by flash 
column chromatography (10% EtOAc/Hexanes) provided 950 mg (82%) of oxocene 
8 as a colorless oil. 
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Oxocane.  To a solution of oxocene 8 (5.58 g, 9.32 mmol) in 93 mL of CH2Cl2 
was added Crabtree’s catalyst ([PCy3][COD][Pyr]Ir+PF6-; 188 mg, 0.233 mmol).  The 
mixture was cooled to –50 oC and fitted with a hydrogen balloon.  The flask was 
purged under vacuum and filled with hydrogen five times.  The solution was allowed 
to stir overnight under an atmosphere of hydrogen.  The balloon was removed and 
the solution was warmed to room temperature.  Evaporation of the solvents and 
purification via flash column chromatography (10% EtOAc/Hexanes) provided 5.24 g 
(94%) of the oxocane as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 1.03-1.14 (m, 
24H), 1.55 (dddd, J = 13.8, 9.5, 4.6, 4.6 Hz, 1H), 1.67-1.81 (m, 2H), 1.83-2.02 (m, 
3H), 2.08 (m, 1H), 2.96 (br s, 1H), 3.26 (ddd, J = 8.8, 8.8, 2.7 Hz, 1H), 3.63-3.72 (m, 
2H), 3.72-3.80 (m, 3H), 3.78 (s, 3H), 3.82-3.87 (m, 2H), 4.44 (AB, JAB = 11.1 Hz, 
∆νAB = 84.2 Hz, 2H), 4.56 (AB, JAB = 12.0 Hz, ∆νAB = 32.8 Hz, 2H), 6.87 (d, J = 8.7 
Hz, 2H), 7.26 (d, J = 8.6 Hz, 2H), 7.27-7.46 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 
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11.8, 17.9, 26.8, 27.7, 37.3, 40.1, 45.3, 55.0, 59.6, 70.6, 72.4, 73.0, 73.4, 81.5, 82.3, 
83.0, 113.5, 127.5, 127.6, 128.3, 129.1, 130.4, 137.6, 158.9; IR (film) 3461 (br), 
2943, 2865, 1613, 1514, 1463, 1249 cm-1; [α]21D = +38.0 (c = 8.10 CH2Cl2); MS 
(electrospray ionization) calculated for C35H56O6SiNa [M + Na]+:  623.37, found: 
623.3.   
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Ketone.  A flask was charged with oxalyl chloride (2.0 M in CH2Cl2, 6.54 mL, 
13.1 mmol) and 50 mL of CH2Cl2 and cooled to –78 oC.  Dimethylsulfoxide (1.55 mL, 
21.8 mmol) in 10 mL of CH2Cl2 was added dropwise, and the solution was stirred 2 
minutes.  The oxocane (5.24 g, 8.72 mmol) and 20 mL CH2Cl2 were added dropwise 
to the mixture and allowed to stir 30 minutes at –78 oC.  Triethylamine (6.08 mL, 
43.6 mmol) was added dropwise and stirred 5 minutes at –78 oC, followed by 
warming to room temperature for 1 hour.  The reaction was quenched by the 
addition of water.  The organic portion was washed with saturated aqueous 
NaHCO3, then water.  The combined aqueous portions were washed with CH2Cl2.  
The combined organic extracts were then washed with brine, dried over Na2SO4, 
and concentrated in vacuo.  Purification by flash column chromatography (10% 
EtOAc/Hexanes) provided 4.94 g (95%) of the ketone as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 0.96 (d, J = 6.7 Hz, 3H), 1.07 (s, 21H), 1.53 (ddd, J = 5.3, 11.9, 
16.5 Hz, 1H), 1.77 (m, 1H), 1.84 (m, 1H), 1.95 (m, 1H), 2.23 (dd, J = 15.4, 9.1 Hz, 
1H), 2.87 (dd, J = 15.4, 4.6 Hz, 1H), 2.98 (m, 1H), 3.43 (m, 1H), 3.67 (dd, J = 10.0, 
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2.6 Hz, 1H), 3.77 (m, 1H), 3.79 (s, 3H), 3.83-3.89 (m, 3H), 4.03 (dd, J = 4.3, 2.7 Hz, 
1H), 4.42 (AB, , JAB = 11.8 Hz, ∆νAB = 46.5 Hz, 2H), 4.54 (AB, JAB = 12.3 Hz, ∆νAB = 
22.3 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 7.22 (d, J = 8.6 Hz, 2H), 7.24-7.35 (m, 5H); 
13C NMR (100 MHz, CDCl3) δ 11.8, 17.9, 23.7, 27.6, 36.3, 37.3, 48.8, 55.0, 59.8, 
69.6, 72.8, 73.3, 80.3, 80.8, 88.0, 113.6, 127.2, 127.3, 128.1, 129.1, 129.8, 138.0, 
159.0, 211.8; IR (film) 2940, 2865, 1699, 1514, 1457, 1248 cm-1; [α]23D = -33 (c = 2.6 
CH2Cl2); MS (electrospray ionization) calculated for C35H54O6SiNa [M + Na]+:  
621.36, found: 621.4. 
O
Me
OH
Me
H H
H
PMBO
OBn
TIPSO
H
 
Tertiary Alcohol.  Into a flask equipped with an addition funnel was added 
methylmagnesium chloride (3.0 M in THF, 13.75 mL, 41.24 mmol) and 200 mL of 
E2O.  The solution was cooled to –78 oC, and ketone 10 (4.94 g, 8.25 mmol) in 200 
mL of Et2O was added dropwise via addition funnel.  The mixture was allowed to stir 
for 20 minutes at –78 oC.  The reaction was quenched by the addition of saturated 
aqueous ammonium chloride and allowed to warm to room temperature.  The layers 
were separated and the aqueous portion was extracted twice with EtOAc.  The 
combined organic extracts were then washed with brine, dried over Na2SO4, and 
concentrated in vacuo.  Purification by flash column chromatography (10% 
EtOAc/Hexanes) provided 4.42 g (88%) of the alcohol as a colorless oil:  1H NMR 
(400 MHz, CDCl3) δ 1.04 (d, J = 6.4 Hz, 3H), 1.07 (s, 21H), 1.18 (s, 3H), 1.51-1.73 
(m, 3H), 1.83-1.95 (m, 3H), 2.03 (m, 1H), 3.22 (m, 1H), 3.28 (br s, 1H), 3.62-3.69 (m, 
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3H), 3.73-3.87 (m, 3H), 3.80 (s, 3H), 4.44 (AB, JAB = 11.1 Hz, ∆νAB = 74.9 Hz, 2H), 
4.52 (AB, JAB = 11.7 Hz, ∆νAB = 24.8 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 7.25 (d, J = 
8.4 Hz, 2H), 7.27-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 11.9, 18.0, 21.8, 27.0, 
27.6, 37.3, 41.5, 53.0, 55.1, 59.8, 70.7, 70.8, 73.6, 74.2, 82.0, 82.1, 82.9, 113.6, 
127.6, 127.8, 128.4, 129.2, 130.5, 137.3, 159.0; IR (film) 3481 (br), 2943, 2865, 
1613, 1514, 1463, 1249 cm-1; [α]22D = +42 (c = 1.9 CH2Cl2); MS (electrospray 
ionization) calculated for C36H58O6SiNa [M + Na]+:  637.39, found:  637.3.   
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Primary Alcohol.  To a solution containing tertiary alcohol (3.70 g, 6.01 
mmol) in 120 mL of EtOH was added Raney Nickel (2800 slurry in H2O, 18.76 mL).  
The reaction flask was fitted with a hydrogen filled balloon.  The flask was evacuated 
under vacuum and filled with hydrogen.  The procedure was repeated twice more, 
and the reaction mixture was allowed to stir under an atmosphere of H2 overnight.  
The hydrogen balloon was removed and the suspension was filtered through celite.  
The filtrate was washed several times with ethanol while ensuring that the solid was 
not allowed to become dry.  The solvent was concentrated in vacuo and the product 
was purified by flash column chromatography (30% EtOAc/Hexanes) to provide 2.98 
g (95%) of the diol as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 1.00 (d, J = 6.7 
Hz, 3H), 1.07 (s, 21H), 1.15 (s, 3H), 1.51 (m, 1H), 1.56 (d, J = 12.9 Hz, 1H), 1.72 (m, 
1H), 1.78-1.93 (m, 3H), 2.04 (m, 1H), 2.24 (br s, 1H), 3.17 (ddd, J = 8.4, 8.4, 2.7 Hz, 
1H), 3.64 (m, 1H), 3.72-3.80 (m, 3H), 3.78 (s, 3H), 3.80-3.91 (m, 2H), 4.41 (AB, JAB 
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= 11.2 Hz, ∆νAB = 72.7 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 7.22 (d, J = 8.6 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 11.9, 17.9, 21.7, 27.4, 27.5, 36.7, 41.0, 54.4, 55.1, 59.8, 
63.3, 70.4, 74.3, 81.4, 82.4, 86.0, 113.6, 129.2, 130.4, 159.0; IR (film) 3389 (br), 
2944, 2866, 1613, 1514, 1463, 1384, 1302, 1249 cm-1; [α]23D = +36 (c = 4.4 CH2Cl2); 
MS (electrospray ionization) calculated for C29H52O6SiNa [M + Na]+:  547.34, found: 
547.4.   
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B Ring Aldehyde.  To a solution of the diol (280 mg, 0.534 mmole) in 5 mL of 
CH2Cl2 was added Dess-Martin periodinane (339 mg, 0.800 mmol).  After stirring 1 
hour at room temperature, the reaction was quenched via the addition of a 5:1 
solution of saturated aqueous Na2S2O3/NaHCO3.  The layers were separated and 
the aqueous layer was washed twice with CH2Cl2.  The combined organic extracts 
were then dried over Na2SO4 and concentrated in vacuo.  Purification by flash 
column chromatography (25% EtOAc/Hexanes) provided 238 mg (85%) of the 
aldehyde 11 as a colorless oil.  1H NMR (500 MHz, C6D6) δ 9.88 (s, 1H), 7.22-7.19 
(band, 2H), 6.83-6.80 (band, 2H), 4.39 (d, J = 11.5 Hz, 1H), 4.16 (d, J = 11.5 Hz, 
1H), 4.05 (s, 1H), 3.93 (ddd, J = 5.0, 9.5, 9.5 Hz, 1H), 3.84 (ddd, J = 4.0, 7.0, 10.5 
Hz, 1H), 3.76 (ddd, J = 2.5, 7.0, 9.5 Hz, 1H), 3.29 (s, 3H), 3.17 (m, 1H), 2.40 (s, 1H), 
2.09 (dddd, J = 3.0, 7.0, 9.5, 9.5 Hz, 1H), 1.91-1.85 (band, 2H), 1.78 (ddd, J = 3.0, 
3.0, 15.5 Hz, 1H), 1.66 (dddd, J = 3.5, 5.0, 9.0, 13.5 Hz, 1H), 1.51-1.42 (band, 2H), 
1.17 (s, 3H), 1.12-1.04 (band, 21H), 0.89 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, 
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C6D6) δ 205.0, 159.7, 130.9, 129.41, 129.40, 128.5, 128.1, 127.9, 114.1, 89.9, 83.3, 
82.3, 74.4, 70.8, 60.1, 54.7, 53.2, 41.2, 37.4, 27.8, 27.1, 22.9, 18.3, 18.2, 12.3; IR 
(film) 3447, 2942, 2865, 1732, 1612, 1513, 1462, 1381, 1301, 1249, 1094 cm-1; 
[α]25D = +35 (c = 0.35, CH2Cl2); MS (electrospray ionization) calculated for 
C29H51O6Si [M + H]+:  523.35, found: 523.4. 
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BCDE Tetraaryl Ether.  Into a flask containing a stir bar was added the diol 
(87 mg, 0.13 mmol) in 3 mL of DMF.  The mixture was cooled to 0 oC prior to 
addition of sodium hydride (60% dispersion in mineral oil, 26 mg, 0.64 mmol).  
Freshly prepared p-methoxybenzyl bromide (57 µL, 0.38 mmol) was added to the 
solution.  After stirring for 10 minutes at 0 oC, the reaction mixture was warmed to 
room temperature and allowed to stir for 14 hours.  The reaction was quenched by 
the slow addition of saturated NH4Cl, and diluted with Et2O.  The layers were 
separated, and the aqueous portion was extracted three more times with Et2O.  The 
organic layers were combined, dried over Na2SO4, and concentrated in vacuo.  
Purification by flash column chromatography (25% EtOAc/Hexanes) provided 106 
mg (91%) of the ether as a colorless oil:  1H NMR (400 MHz, CDCl3) δ 0.95 (d, J = 
6.6 Hz, 3H), 1.12 (s, 6H), 1.32-1.69 (m, 6 H), 1.70-2.02 (m, 5H), 2.04-2.26 (m, 3H), 
2.33 (m, 1H), 2.44 (m, 2H), 2.56 (m, 1H), 2.87 (dd, J = 7.8, 7.8 Hz, 1H), 3.02 (dd, J = 
9.3, 9.3 Hz, 1H), 3.28-3.58 (m, 11 H), 3.74 (s, 6H), 4.22-4.60 (m, 8H), 5.66 (m, 2H), 
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6.82 (m, 4H), 7.14-7.36 (m, 14H); 13C NMR (100 MHz, CDCl3) δ 16.5, 21.0, 26.7, 
28.0, 33.6, 34.2, 34.4, 34.6, 34.9, 42.3, 54.1, 55.1, 64.6, 66.4, 66.6, 68.9, 70.6, 71.2, 
72.3, 72.7, 75.7, 80.7, 81.9, 82.1, 82.2, 82.3, 82.7, 82.9, 113.5, 113.6, 127.3, 127.4, 
127.5, 127.7, 128.17, 128.23, 129.2, 129.4, 130.2, 130.5, 138.1, 138.3, 158.9, 
159.0; IR (film) 2954, 2925, 1609, 1516 (str), 1455, 1242 (str) cm-1; [α]22D = -15 (c = 
0.73, CH2Cl2); MS (electrospray ionization) calculated for C57H74O10Na [M + Na]+:  
941.52, found: 941.6.   
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  BCDE Diol.  Preparation of LiDBB:  A reaction vessel was charged with 4,4’-
di-t-butylbiphenyl (3.17g, 11.9 mmol) and 10.8 mL of THF.  Freshly cut lithium metal 
(75 mg, 10.8 mmol) was added to the solution and the heterogenous mixture was 
placed in a sonicating bath.  The solution was sonicated at 0 oC for two hours to 
provide a 1.0 M solution of LiDBB. 
To a flask equipped with a stir bar was added the BCDE ether (106 mg, 0.12 mmol) 
and 5 mL of THF.  The mixture was cooled to -78 oC, and the solution of LiDBB (3.0 
mL, 3.0 mmol, 1.0 M in THF) was added.  After stirring for 10 minutes at -78 oC, the 
reaction was quenched by the addition of saturated NH4Cl, diluted with Et2O, and 
warmed to room temperature.  The layers were separated, and the aqueous portion 
was extracted three more times with Et2O.  The organic layers were combined, dried 
over Na2SO4, and concentrated in vacuo.  Purification by flash column 
chromatography (25% to 75% EtOAc/Hexanes) provided 75 mg (89%) of the diol as 
 203 
a colorless oil: 1H NMR (400 MHz, CDCl3) δ 0.99 (d, J = 7.0 Hz, 3H), 1.15 (s, 3H), 
1.18 (d, J = 7.4 Hz, 3H), 1.39-1.72 (m, 6 H), 1.73-2.02 (m, 5H), 2.10-2.27 (m, 3H), 
2.35-2.87 (m, 6H), 2.91 (ddd J = 15.7, 12.1, 4.3 Hz, 1H), 3.06 (dd, J = 10.6, 10.6 Hz, 
1H), 3.23-3.40 (m, 3H), 3.42-3.61 (m, 5H), 3.68-3.84 (m, 3 H), 3.784 (3, 3H), 3.789 
(s, 3H), 4.39 (AB, JAB = 11.0 Hz, ∆νAB = 72.3 Hz, 2H), 4.41 (AB, JAB = 11.2 Hz, ∆νAB = 
8.7 Hz, 2H), 5.73 (m, 2H), 6.85 (d, J = 2.9 Hz, 2H), 6.87 (d, J = 2.9 Hz, 2H), 7.22 (d, 
J = 8.6 Hz, 2H), 7.26 (d, J = 11.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 16.5, 21.4, 
26.8, 28.1, 33.7, 34.5, 35.9, 36.1, 36.6, 42.4, 54.1, 55.2, 59.3, 64.9, 66.7, 68.9, 70.8, 
72.4, 73.2, 75.9, 81.4, 82.05, 82.14, 82.3, 83.0, 86.4, 92.0, 113.6, 113.7, 127.7, 
128.0, 129.3, 129.6, 130.3, 130.6, 159.0, 159.1; IR (film) 3395 (br), 2929, 1612, 
1514 (str), 1458, 1303, 1249 (str) cm-1; [α]20D = 15 (c = 1.5, CH2Cl2); MS 
(electrospray ionization) calculated for C43H62O10Na [M + Na]+:  761.42, found: 
761.5.   
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 BCDE Bis Silyl Ether.  To a round-bottomed flask equipped with a stir bar 
was added the diol (62 mg, 0.092 mmol) in 5 mL CH2Cl2.  The solution was cooled to 
0 oC, and 2,6 lutidine (43 µL, 0.37 mmol) was added, followed by t-butyldimethylsilyl 
trifluoromethanesulfonate (64 µL, 0.28 mmol).  The solution was stirred for 1 hour, 
then quenched by the addition of saturated NH4Cl and warmed to room temperature.  
The layers were separated, and the aqueous portion was extracted three more times 
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with CH2Cl2.  The organic layers were combined, dried over Na2SO4, and 
concentrated in vacuo.  Purification by flash column chromatography (10% 
EtOAc/Hexanes) provided 79 mg (96%) of the ether as a colorless oil: 1H NMR (400 
MHz, CDCl3) δ 0.01 (s, 3H), 0.03 (s, 3H), 0.07 (s, 3H), 0.09 (s, 3H), 0.87 (s, 9H), 
0.90 (s, 9H), 1.00 (d, J = 7 Hz, 3H), 1.15 (s, 3H), 1.16 (d, J = 7.3 Hz, 3H), 1.38-1.73 
(m, 7H), 1.73-1.96 (m, 4H), 2.11-2.33 (m, 3H), 2.33-2.50 (m, 3H), 2.54 (m, 1H), 2.92 
(ddd, J = 12.0, 9.8, 4.0 Hz, 1H), 3.07 (dd, J = 10.6, 10.6 Hz, 1H), 3.34-3.68 (m, 11H), 
3.791 (s, 3H), 3.794 (s, 3H), 4.40 (AB, JAB = 11.0 Hz, ∆νAB = 72.6 Hz, 2H), 4.41 (AB, 
JAB = 11.4 Hz, ∆νAB = 0.0 Hz, 2H), 5.66 (m, 2H), 6.85 (d, J = 3.7 Hz, 2H), 6.87 (d, J = 
3.7 Hz, 2H), 7.22 (d, J = 9.4 Hz, 2H), 7.27 (d, J = 8.6 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ -5.54, -5.52, -4.9, -4.5, 16.5, 17.8, 18.0, 20.6, 25.67, 25.69, 26.7, 28.0, 
33.6, 34.0, 34.2, 34.7, 37.4, 42.3, 54.1, 55.1, 58.5, 66.6, 69.0, 70.6, 72.3, 75.6, 75.7, 
81.4, 82.1, 82.2, 82.9, 83.0, 113.5, 113.6, 126.1, 129.1, 129.2, 129.4, 130.2, 130.5, 
158.9, 159.0; IR (film) 2955, 2928, 2855, 2360, 1613, 1514 (str), 1462, 1361, 1306, 
1250 (str) cm-1; [α]20D = -14 (c = 1.5, CH2Cl2); MS (electrospray ionization) calculated 
for C55H90O10Si2Na [M + Na]+:  989.60, found: 989.7.   
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 BCDE Primary Alcohol.  A reaction vessel with a stir bar was charged with 
the bis silyl ether (66 mg, 0.068 mmol) in 3 mL of THF.  Hydrogen fluoride-pyridine 
(150 µL, 65% hydrogen fluoride in pyridine) was added, and the solution was stirred 
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for 1.5 hours at room temperature.  The reaction was quenched via the slow addition 
of saturated NaHCO3 and diluted with Et2O.  The layers were separated, and the 
aqueous portion was extracted three more times with Et2O.  The organic layers were 
combined, dried over Na2SO4, and concentrated in vacuo.  Purification by flash 
column chromatography (25% EtOAc/Hexanes) provided 50 mg (86%) of the alcohol 
as a colorless oil, along with 9 mg (14%) of the starting bis silyl ether: 1H NMR (400 
MHz, CDCl3) δ 0.04 (s, 3H), 0.09 (s, 3H), 0.88 (s, 9H), 0.98 (d, J = 6.7 Hz, 3H), 1.14 
(s, 3H), 1.19 (d, J = 7.5 Hz, 3H), 1.38-1.54 (m, 3H), 1.55-1.64 (m, 3H), 1.65-1.82 (m, 
4H), 1.83-1.98 (m, 3H), 2.14 (m, 1H), 2.19-2.36 (m, 4H), 2.50 (m, 1H), 2.62 (m, 1H), 
2.91 (dd, J = 8.6, 8.6 Hz, 1H), 3.06 (dd, J = 9.6, 9.6 Hz, 1H), 3.36 (m, 2H), 3.42-3.49 
(m, 2H), 3.50-3.63 (m, 4h), 3.71 (m, 1H), 3.792 (s, 3H), 3.796 (s, 3H), 3.82 (m, 2H), 
4.39 (AB, JAB = 11.0 Hz, ∆νAB = 74.0 Hz, 2H), 4.41 (AB, JAB = 11.5 Hz, ∆νAB = 7.5 Hz, 
2H), 5.68 (m, 2H), 6.85 (d, J = 3.1 Hz, 2H), 6.87 (d, J = 3.1 Hz, 2H), 7.22 (d, J = 8.4 
Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ -4.8, -4.3, 16.6, 
17.9, 21.3, 25.8, 26.8, 28.1, 33.7, 34.7, 35.1, 35.5, 42.4, 54.2, 55.23, 55.24, 60.0, 
66.8, 69.0, 70.8, 72.4, 73.8, 75.8, 82.2, 82.3, 82.4, 82.6, 83.0, 85.6, 113.6, 113.7, 
126.8, 128.7, 129.3, 129.6, 130.3, 130.7, 159.0, 159.1; IR (film) 2956, 2929, 2853, 
1613, 1514 (str), 1463, 1303, 1250 (str), 1173 cm-1; [α]20D = 1.8 (c = 0.84, CH2Cl2); 
MS (electrospray ionization) calculated for C55H94NO10Si2 [M + NH4]+:  870.56, 
found: 870.6.   
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 BCDE Silyl Protected Phosphine Oxide.  The previously prepared alcohol 
(26 mg, 0.030 mmol) in 1 mL CH2Cl2 was added to a flask with a stir bar.  The 
solution was cooled to 0 oC, and triethylamine (17 µL, 0.12 mmol) was added, 
followed by methanesulfonyl chloride (5.0 µL, 0.061 mmol).  The solution was stirred 
for 15 minutes, then quenched by the addition of saturated NH4Cl and warmed to 
room temperature.  The layers were separated, and the aqueous portion was 
extracted three more times with CH2Cl2.  The organic layers were combined, dried 
over Na2SO4, and concentrated in vacuo.  Purification by flash column 
chromatography (25% EtOAc/Hexanes) provided 28 mg (100%) of the mesylate as a 
colorless oil. 
Prepartion of lithium diphenylphosphide:  To a reaction vessel with a stir bar was 
added diphenylphosphine (165 µL, 0.948 mmol) in 2.5 mL of THF.  The solution was 
cooled to 0 oC, and n-butyllithium (652 µL, 1.043 mmol, 1.6 M in hexanes) was 
added, resulting in a bright red solution.  The mixture was warmed to room 
temperature and stirred for 30 minutes. 
The previously prepared mesylate (28 mg, 0.030 mmol) was added to a flask in 1 
mL of THF and 50 µL of hexamethylphosphoramide.  The solution was cooled to 0 
oC, and the lithium diphenylphosphide (800 µL, 0.304 mmol, 0.38 M in THF) was 
added until a red color persisted for several minutes.  The reaction was quenched 
via the addition of 1 mL of water, then 100 µL of 30% H2O2 were added to the 
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solution and warmed to room temperature.  After dilution with Et2O, 10% Na2S2O3 
was used to wash the organic layer.  The aqueous layer was extracted five times 
further with Et2O.  The organic layers were combined, dried over Na2SO4, and 
concentrated in vacuo.  Purification by flash column chromatography (50% 
EtOAc/Hexanes) provided 29 mg (94%) of the phosphine oxide as a colorless semi-
solid: 1H NMR (400 MHz, CDCl3) δ -0.05 (s, 3H), 0.04 (s, 3H), 0.83 (s, 9H), 0.97 (d, J 
= 7.4 Hz, 3H), 0.98 (s, 3H), 1.14 (s, 3H), 1.26 (dd, J = 6.4, 6.4 Hz, 1H), 1.38-1.56 (m, 
4 H), 1.56-1.73 (m, 3H), 1.74-1.95 (m, 6H), 2.08-2.37 (m, 5H), 2.44 (m, 1H), 2.61 (m, 
1H), 2.89 (dd, J = 7.8 Hz, 1H), 3.06 (dd J = 10.4 Hz, 1H), 3.24-3.40 (m, 4H), 3.44 (dd 
J = 11.0, 4.5 Hz, 1H), 3.50-3.61 (m, 3H), 3.68 (br s, 1H), 3.79 (s, 6H), 4.39 (AB, JAB = 
11.0 Hz, ∆νAB = 72.3 Hz, 2H), 4.41 (AB, JAB = 12.7 Hz, ∆νAB = 0.0 Hz, 2H), 5.67 (m, 
2H), 6.86 (d, J = 7.9 Hz, 4H), 7.23 (d, J = 7.7 Hz, 2H), 7.26 (d, J = 6.7 Hz, 2H), 7.41-
7.55 (m, 6H), 7.73 (m, 4H); 13C NMR (100 MHz, CDCl3) δ -4.7, -4.3, 16.5, 17.9, 21.2, 
24.7, 24.8, 25.8, 26.9, 28.1, 33.7, 34.7, 35.2, 36.0, 42.5, 54.2, 55.23, 55.25, 66.7, 
69.0, 70.8, 72.4, 73.4, 75.9, 82.2, 82.36, 82.39, 83.0, 113.6, 113.7, 127.0, 128.48, 
128.54, 128.6, 128.7, 129.3, 129.6, 130.3, 130.7, 130.8, 130.9, 131.0, 131.6, 131.7, 
159.0, 159.1; IR (film) 2952, 2925, 2855, 1516 (str), 1451, 1245 (str) cm-1; [α]20D = 
5.8 (c = 0.68, CH2Cl2); MS (electrospray ionization) calculated for C61H86O10PSi [M + 
1]+:  1037.57, found: 1037.6.   
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 BCDE Acetal Protected Phosphine Oxide.  A reaction vessel with a stir bar 
was charged with the silyl protected phosphine oxide (56 mg, 0.055 mmol) in 2 mL 
of THF.  Tetrabutylammonium fluoride (163 µL, 0.163 mmol, 1.0 M in THF) was 
added, and the solution was stirred for three hours at room temperature.  The 
reaction was then concentrated in vacuo. 
The crude hydroxyphosphine oxide from the previous step was dissolved in 3 mL of 
2-methoxypropene in a reaction vessel with a stir bar at 0 oC.  Pyridinium p-
toluenesulfonate (50 mg, 0.20 mmol) was added, and the mixture was stirred for 1 
hour.  The reaction was quenched via the slow addition of saturated NaHCO3, then 
warmed to room temperature.  The mixture was extracted five times with CH2Cl2, 
dried over Na2SO4, and concentrated in vacuo.  Purification by flash column 
chromatography (100% EtOAc then 100% Acetone) provided 48 mg (90%) of the 
phosphine oxide as a pale white semi-solid: 1H NMR (400 MHz, C6D6) δ 0.96 (d, J = 
7.4 Hz, 3H), 1.08 (d, J = 7.4 Hz, 3H), 1.22 (s, 3H), 1.27 (s, 3H), 1.28 (s, 3H), 1.38 
(m, 1H), 1.52 (m, 1H), 1.65-1.90 (m, 8H), 1.98 (m, 2H), 2.12 (m, 2H), 2.26-2.55 (m, 
6H), 2.62 (dd, J = 12.3, 12.3 Hz, 1H), 2.79 (ddd, J = 12.1, 9.1, 4.3 Hz, 1H), 2.96-3.09 
(m, 2H), 3.13 (s, 3H), 3.29 (s, 3H), 3.31 (s, 3H), 3.42-3.57 (m, 4H), 3.58-3.76 (m, 
4H), 3.96 (dd, J = 4.4, 4.4 Hz, 1H), 4.31 (AB, JAB = 11.4 Hz, ∆νAB = 100.0 Hz, 2H), 
4.36 (s, 2H), 5.89 (ddd, J = 10.5, 10.5, 6.5 Hz, 1H), 6.00 (ddd, J = 10.8, 10.8, 7.3 Hz, 
1H), 6.78 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 7.02 (m, 6H), 7.20 (d, J = 8.5 
Hz, 2H), 7.34 (d, J = 8.5 Hz, 2H), 7.81 (m, 4H); 13C NMR (100 MHz, C6D6) δ 16.8, 
22.4, 25.2, 25.4, 27.1, 28.3, 29.4, 29.5, 34.5, 35.2, 36.1, 37.0, 42.7, 49.2, 54.7, 54.9, 
66.8, 69.7, 70.8, 72.8, 73.4, 75.9, 82.0, 82.3, 82.4, 82.7, 83.5, 127.2, 127.9, 128.1, 
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128.3, 128.5, 128.6, 128.66, 128.75, 129.66, 129.70, 131.0, 131.08, 131.10, 131.15, 
131.19, 131.3, 131.4; IR (film) 2929, 2862, 1514, 1463, 1439, 1249, 1180 cm-1; 
[α]20D = 18 (c = 0.61, CH2Cl2); MS (electrospray ionization) calculated for 
C59H79O11PNa [M + Na]+:  1017.53, found: 1017.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 210 
References 
 (1) Bernardelli, P.; Paquette, L. A. Heterocycles 1998, 49, 531-556. 
 
(2) Stierle, D. B.; Carte, B.; Faulkner, D. J.; Tagle, B.; Clardy, J. J. Am. 
Chem. Soc. 1980, 102, 5088-5092. 
 
(3) Bowden, B. F.; Coll, J. C.; Dai, M. C. Aust. J. Chem. 1989, 42, 665-
673. 
 
(4) Nicolaou, K. C.; Xu, J. Y.; Kim, S.; Ohshima, T.; Hosokawa, S.; 
Pfefferkorn, J. J. Am. Chem. Soc. 1997, 119, 11353-11354. 
 
(5) Nicolaou, K. C.; van Delft, F.; Ohshima, T.; Vourloumis, D.; Xu, J.; 
Hosokawa, S.; Pfefferkorn, J.; Kim, S.; Li, T. Ang. Chem., Int. Ed. Engl. 
1997, 36, 2520-2524. 
 
(6) Kennard, O.; Watson, D. G.; Riva di Sanseverino, L.; Tursch, B.; 
Bosmans, R.; Djerassi, C. Tetrahedron Lett. 1968, 2879-2884. 
 
 (7) Rodriguez, A. D.; Cobar, O. M. Tetrahedron 1995, 51, 6869-6880. 
 
 (8) Ortega, M. J.; Zubia, E.; Salva, J. J. Nat. Prod. 1994, 57, 1584-1586. 
 
(9) Sharma, P.; Alam, M. J. Chem. Soc., Perkin Trans. 1 1988, 2537-
2540. 
 
 (10) Rodriguez, A. D.; Cobar, O. M. Tetrahedron 1992, 49, 319-328. 
 
(11) Morales, J. J.; Lorenzo, D.; Rodriguez, A. D. J. Nat. Prod. 1991, 54, 
1368-1382. 
 
(12) Selover, S. J.; Crews, P.; Tagle, B.; Clardy, J. J. Org. Chem. 1981, 46, 
964-970. 
 
(13) Park, Y.-H.; Chang, S.-K.; Kim, I.-K.; Seo, Y.-W.; Shin, J.-H. Yakhak 
Hoechi 1997, 41, 345-351. 
 
(14) Uchio, Y.; Kodama, M.; Usui, S.; Fukazawa, Y. Tetrahedron Lett. 1992, 
33, 1317-1320. 
 
(15) MacMillan, D. W. C.; Overman, L. E. J. Am. Chem. Soc. 1995, 117, 
10391-10392. 
 
(16) Hopkins, M. H.; Overman, L. E.; Rishton, G. M. J. Am. Chem. Soc. 
1991, 113, 5354-5365. 
 211 
 
 (17) Ireland, R. E.; Bey, P. Org. Synth. 1973, 53, 63-65. 
 
 (18) McMurry, J. E.; Scott, W. J. Tetrahedron Lett. 1983, 24, 979-982. 
 
(19) Wulff, W. D.; Peterson, G. A.; Bauta, W. E.; Chan, K.-S.; Faron, K. L.; 
Gilbertson, S. R.; Kaesler, R. W.; Yang, D. C.; Murray, C. K. J. Org. 
Chem. 1986, 51, 277-279. 
 
 (20) Seyferth, D. J. Am. Chem. Soc. 1957, 79, 2133-2136. 
 
 (21) Molander, G. A.; Bobbitt, K. L. J. Org. Chem. 1992, 57, 5031-5034. 
 
 (22) Reetz, M. T. Ang. Chem. 1984, 96, 542-555. 
 
(23) Cremer, D.; Gauss, J.; Childs, R. F.; Blackburn, C. J. Am. Chem. Soc. 
1985, 107, 2435-2441. 
 
(24) Baggiolini, E.; Hamlow, H. P.; Schaffner, K. J. Am. Chem. Soc. 1970, 
92, 4906-4921. 
 
 (25) Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5974-5976. 
 
 (26) Hanson, R. M.; Sharpless, K. B. J. Org. Chem. 1986, 51, 1922-1925. 
 
 (27) Finan, J. M.; Kishi, Y. Tetrahedron Lett. 1982, 23, 2719-2722. 
 
(28) Ma, P.; Martin, V. S.; Masamune, S.; Sharpless, K. B.; Viti, S. M. J. 
Org. Chem. 1982, 47, 1378-1380. 
 
 (29) Viti, S. M. Tetrahedron Lett. 1982, 23, 4541-4544. 
 
(30) Hara, S.; Dojo, H.; Takinami, S.; Suzuki, A. Tetrahedron Lett. 1983, 24, 
731-734. 
 
 (31) Griffith, W. P.; Ley, S. V. Aldrichimica Acta 1990, 23, 13-19. 
 
(32) Jin, H.; Uenishi, J.; Christ, W. J.; Kishi, Y. J. Am. Chem. Soc. 1986, 
108, 5644-5646. 
 
(33) Takai, K.; Kimura, K.; Kuroda, T.; Hiyama, T.; Nozaki, H. Tetrahedron 
Lett. 1983, 24, 5281-5284. 
 
(34) Alam, M.; Sharma, P.; Zektzer, A. S.; Martin, G. E.; Ji, X.; Van der 
Helm, D. J. Org. Chem. 1989, 54, 1896-1900. 
 
 212 
(35) Hochlowski, J. E.; Faulkner, D. J. Tetrahedron Lett. 1980, 21, 4055-
4056. 
 
 (36) Chen, J.; Wang, T.; Zhao, K. Tetrahedron Lett. 1994, 35, 2827-2828. 
 
 (37) Overman, L. E.; Pennington, L. D. Org. Lett. 2000, 2, 2683-2686. 
 
(38) MacMillan, D. W. C.; Overman, L. E.; Pennington, L. D. J. Am. Chem. 
Soc. 2001, 123, 9033-9044. 
 
(39) Takai, K.; Oshima, K.; Nozaki, H. Tetrahedron Lett. 1980, 21, 1657-
1660. 
 
 (40) Bordwell, F. G.; Douglass, M. L. J. Am. Chem. Soc. 1966, 88, 993-999. 
 
(41) Marshall, J. A.; Hochstetler, A. R. J. Am. Chem. Soc. 1969, 91, 648-
657. 
 
 (42) Kropp, P. J. Org. Photochem. 1979, 4, 1-142. 
 
 (43) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155-4156. 
 
(44) Paquette, L. A.; Moradei, O. M.; Bernardelli, P.; Lange, T. Org. Lett. 
2000, 2, 1875-1878. 
 
(45) Kinney, W. A.; Coghlan, M. J.; Paquette, L. A. J. Am. Chem. Soc. 
1985, 107, 7352-7360. 
 
(46) De Jong, J. C.; Van Bolhuis, F.; Feringa, B. L. Tetrahedron: 
Asymmetry 1991, 2, 1247-1262. 
 
(47) De Jong, J. C.; Jansen, J. F. G. A.; Feringa, B. L. Tetrahedron Lett. 
1990, 31, 3047-3050. 
 
 (48) Vorndam, P. E. J. Org. Chem. 1990, 55, 3693-3695. 
 
 (49) Gemal, A. L.; Luche, J. L. J. Am. Chem. Soc. 1981, 103, 5454-5459. 
 
 (50) Bernardelli, P.; Paquette, L. A. J. Org. Chem. 1997, 62, 8284-8285. 
 
(51) Brueckner, C.; Holzinger, H.; Reissig, H. U. J. Org. Chem. 1988, 53, 
2450-2456. 
 
(52) Brueckner, C.; Lorey, H.; Reissig, H. U. Ang. Chem. 1986, 98, 559-
560. 
 
 213 
 (53) Tsuji, J. Synthesis 1984, 369-384. 
 
 (54) Koert, U. Tetrahedron Lett. 1994, 35, 2517-2520. 
 
(55) Le Borgne, J. F.; Cuvigny, T.; Larcheveque, M.; Normant, H. Synthesis 
1976, 238-240. 
 
 (56) Koert, U.; Stein, M.; Harms, K. Tetrahedron Lett. 1993, 34, 2299-2302. 
 
(57) Hikota, M.; Sakurai, Y.; Horita, K.; Yonemitsu, O. Tetrahedron Lett. 
1990, 31, 6367-6370. 
 
(58) Hikota, M.; Tone, H.; Horita, K.; Yonemitsu, O. Tetrahedron 1990, 46, 
4613-4628. 
 
 (59) Pine, S. H. Org. React. 1993, 43, 1-91. 
 
 (60) Kobayashi, S.; Hachiya, I. J. Org. Chem. 1994, 59, 3590-3596. 
 
(61) Harding, K. E.; Marman, T. H.; Nam, D.-H. Tetrahedron Lett. 1988, 29, 
1627-1630. 
 
(62) Grieco, P. A.; Gilman, S.; Nishizawa, M. J. Org. Chem. 1976, 41, 1485-
1486. 
 
(63) Friedrich, D.; Doskotch, R. W.; Paquette, L. A. Org. Lett. 2000, 2, 
1879-1882. 
 
(64) Gallou, F.; MacMillan, D. W. C.; Overman, L. E.; Paquette, L. A.; 
Pennington, L. D.; Yang, J. Org. Lett. 2001, 3, 135-137. 
 
(65) Bernardelli, P.; Moradei, O. M.; Friedrich, D.; Yang, J.; Gallou, F.; 
Dyck, B. P.; Doskotch, R. W.; Lange, T.; Paquette, L. A. J. Am. Chem. 
Soc. 2001, 123, 9021-9032. 
 
 (66) Frigerio, M.; Santagostino, M. Tetrahedron Lett. 1994, 35, 8019-8022. 
 
(67) Sharpless, K. B.; Michaelson, R. C. J. Am. Chem. Soc. 1973, 95, 
6136-6137. 
 
(68) Kusumi, T.; Uchida, H.; Ishitsuka, M. O.; Yamamoto, H.; Kakisawa, H. 
Chem. Lett. 1988, 1077-1078. 
 
(69) Corminboeuf, O.; Overman, L. E.; Pennington, L. D. Org. Lett. 2003, 5, 
1543-1546. 
 
 214 
 (70) Giner, J.-L.; Faraldos, J. A. J. Org. Chem. 2002, 67, 2717-2720. 
 
 (71) Faraldos, J. A.; Giner, J.-L. J. Org. Chem. 2002, 67, 4659-4666. 
 
(72) Brown, H. C.; Kulkarni, S. U. J. Organomet. Chem. 1979, 168, 281-
293. 
 
(73) Kabalka, G. W.; Shoup, T. M.; Goudgaon, N. M. J. Org. Chem. 1989, 
54, 5930-5933. 
 
(74) Schwarz, H.; Schiebel, H. M. The Chemistry of Peroxides 1983, 105-
127. 
 
 (75) Liu, J.; Zeng, L.; Wu, D. Chin. Sci. Bull. 1992, 37, 1627-1630. 
 
(76) Yamada, K.; Ogata, N.; Ryu, K.; Miyamoto, T.; Komori, T.; Higuchi, R. 
J. Nat. Prod. 1997, 60, 393-396. 
 
(77) He, Y. F.; Wang, R. M.; Liu, Y. Y.; Chang, Y.; Wang, Y. P.; Xia, C. G.; 
Suo, J. S. J. of Mol. Cat. A: Chem. 2000, 159, 109-113. 
 
(78) Ospina, C. A.; Rodriguez, A. D.; Ortega-Barria, E.; Capson, T. L. J. 
Nat. Prod. 2003, 66, 357-363. 
 
(79) Rodriguez, A. D.; Cobar, O. M. Chem. Pharm. Bull. 1995, 43, 1853-
1858. 
 
(80) Corminboeuf, O.; Overman, L. E.; Pennington, L. D. J. Am. Chem. 
Soc. 2003, 125, 6650-6652. 
 
 (81) Frater, G. Helv. Chim. Acta 1979, 62, 641-643. 
 
(82) Patel, D. V.; VanMiddlesworth, F.; Donaubauer, J.; Gannett, P.; Sih, C. 
J. J. Am. Chem. Soc. 1986, 108, 4603-4614. 
 
 (83) Comins, D. L.; Dehghani, A. Tetrahedron Lett. 1992, 33, 6299-6302. 
 
(84) Takai, K.; Oshima, K.; Nozaki, H. Bull. Chem. Soc. Jpn. 1983, 56, 
3791-3795. 
 
(85) Orita, A.; Sakamoto, K.; Hamada, Y.; Mitsutome, A.; Otera, J. 
Tetrahedron 1999, 55, 2899-2910. 
 
 (86) Sharma, S.; Oehlschlager, A. C. J. Org. Chem. 1989, 54, 5064-5073. 
 
 215 
(87) Orita, A.; Tanahashi, C.; Kakuda, A.; Otera, J. J. Org. Chem. 2001, 66, 
8926-8934. 
 
(88) Molander, G. A.; St. Jean, D. J., Jr.; Haas, J. J. Am. Chem. Soc. 2004, 
126, 1642-1643. 
 
 (89) Molander, G. A.; Jeffrey, S. C. Tetrahedron Lett. 2002, 43, 359-362. 
 
(90) Molander, G. A.; Cameron, K. O. J. Am. Chem. Soc. 1993, 115, 830-
846. 
 
 (91) Snider, B. B.; Hui, R. A. H. F. J. Org. Chem. 1985, 50, 5167-5176. 
 
(92) Chen, X.-T.; Zhou, B.; Bhattacharya, S. K.; Gutteridge, C. E.; Pettus, T. 
R. R.; Danishefsky, S. J. Ang. Chem, Int. Ed. 1998, 37, 789-792. 
 
(93) Umbricht, G.; Hellman, M. D.; Hegedus, L. S. J. Org. Chem. 1998, 63, 
5173-5178. 
 
(94) Pirrung, M. C.; Chang, V. K.; DeAmicis, C. V. J. Am. Chem. Soc. 1989, 
111, 5824-5831. 
 
 (95) Krapcho, A. P. Synthesis 1982, 805-822. 
 
(96) Orban, J.; Turner, J. V.; Twitchin, B. Tetrahedron Lett. 1984, 25, 5099-
5102. 
 
 (97) Hernandez, A.; Rapoport, H. J. Org. Chem. 1994, 59, 1058-1066. 
 
(98) Wollenberg, R. H.; Albizati, K. F.; Peries, R. J. Am. Chem. Soc. 1977, 
99, 7365-7367. 
 
 (99) Schlosser, M.; Wei, H.-x. Tetrahedron 1997, 53, 1735-1742. 
 
(100) Mitsunobu, O.; Yamada, M. Bull. Chem. Soc. Jpn. 1967, 40, 2380-
2382. 
 
(101) Sharpless, K. B.; Umbreit, M. A.; Nieh, M. T.; Flood, T. C. J. Am. 
Chem. Soc. 1972, 94, 6538-6540. 
 
(102) Molander, G. A.; Burkhardt, E. R.; Weinig, P. J. Org. Chem. 1990, 55, 
4990-4991. 
 
(103) Kim, H.; Lee, H.; Kim, J.; Kim, S.; Kim, D. J. Am. Chem. Soc. 2006, 
128, 15851-15855. 
 
 216 
(104) Kim, H.; Choi, W. J.; Jung, J.; Kim, S.; Kim, D. J. Am. Chem. Soc. 
2003, 125, 10238-10240. 
 
(105) Lee, H.; Kim, H.; Baek, S.; Kim, S.; Kim, D. Tetrahedron Lett. 2003, 44, 
6609-6612. 
 
(106) Baek, S.; Jo, H.; Kim, H.; Kim, H.; Kim, S.; Kim, D. Org. Lett. 2005, 7, 
75-77. 
 
(107) Crimmins, M. T.; Brown, B. H. J. Am. Chem. Soc. 2004, 126, 10264-
10266. 
 
(108) Crimmins, M. T.; Brown, B. H.; Plake, H. R. J. Am. Chem. Soc. 2006, 
128, 1371-1378. 
 
(109) Crimmins, M. T.; Ellis, J. M. J. Am. Chem. Soc. 2005, 127, 17200-
17201. 
 
(110) Davidson, J. E. P.; Gilmour, R.; Ducki, S.; Davies, J. E.; Green, R.; 
Burton, J. W.; Holmes, A. B. Synlett 2004, 1434-1436. 
 
(111) Evans, D. A.; Bartroli, J.; Shih, T. L. J. Am. Chem. Soc. 1981, 103, 
2127-2109. 
 
(112) Jones, T. K.; Mills, S. G.; Reamer, R. A.; Askin, D.; Desmond, R.; 
Volante, R. P.; Shinkai, I. J. Am. Chem. Soc. 1989, 111, 1157-1159. 
 
 (113) Kraus, G. A.; Kim, J. Org. Lett. 2004, 6, 3115-3117. 
 
(114) Oikawa, Y.; Yoshioka, T.; Yonemitsu, O. Tetrahedron Lett. 1982, 23, 
885-888. 
 
(115) Umbreit, M. A.; Sharpless, K. B. J. Am. Chem. Soc. 1977, 99, 5526-
5528. 
 
 (116) Hooz, J.; Gilani, S. S. H. Can. J. Chem. 1968, 46, 86-87. 
 
 (117) Kim, S.; Ahn, K. H. J. Org. Chem. 1984, 49, 1717-1724. 
 
 (118) Corey, E. J.; Enders, D.; Bock, M. G. Tetrahedron Lett. 1976, 7-10. 
 
(119) Barrett, A. G. M.; Godfrey, C. R. A.; Hollinshead, D. M.; Prokopiou, P. 
A.; Barton, D. H. R.; Boar, R. B.; Joukhadar, L.; McGhie, J. F.; Misra, 
S. C. J. Chem. Soc., Perkin Trans. 1 1981, 1501-1509. 
 
 217 
(120) Seo, Y.; Rho, J.-R.; Cho, K. W.; Shin, J. J. Nat. Prod. 1997, 60, 171-
174. 
 
(121) Uchio, Y.; Nakatani, M.; Hase, T.; Kodama, M.; Usui, S.; Fukazawa, Y. 
Tetrahedron Lett. 1989, 30, 3331-3332. 
 
 (122) Kang, S. H.; Lee, J. H.; Lee, S. B. Tetrahedron Lett. 1998, 39, 59-62. 
 
(123) Bowden, B. F.; Coll, J. C.; Vasilescu, I. M. Aust. J. Chem. 1989, 42, 
1705-1726. 
 
(124) Burgess, E. M.; Penton, H. R., Jr.; Taylor, E. A. J. Org. Chem. 1973, 
38, 26-31. 
 
(125) Clark, J. S.; Hayes, S. T.; Wilson, C.; Gobbi, L. Ang. Chem, Int. Ed. 
2007, 46, 437-440. 
 
(126) Su, J.-H.; Huang, H.-C.; Chao, C.-H.; Yan, L.-Y.; Wu, Y.-C.; Wu, C.-C.; 
Sheu, J.-H. Bull. Chem. Soc. Jpn. 2005, 78, 877-879. 
 
(127) Williams, D. R.; Meyer, K. G.; Shamim, K.; Patnaik, S. Can. J. Chem. 
2004, 82, 120-130. 
 
 (128) Winterfeldt, E. Chem. Ber. 1964, 97, 1952-1958. 
 
 (129) Winterfeldt, E.; Preuss, H. Chem. Ber. 1966, 99, 450-458. 
 
(130) Mancuso, A. J.; Huang, S.-L.; Swern, D. J. Org. Chem. 1978, 43, 
2480-2482. 
 
 (131) Matsuo, G.; Kadohama, H.; Nakata, T. Chem. Lett. 2002, 148-149. 
 
(132) Pirrung, M. C.; Werner, J. A. J. Am. Chem. Soc. 1986, 108, 6060-
6062. 
 
(133) Roskamp, E. J.; Johnson, C. R. J. Am. Chem. Soc. 1986, 108, 6062-
6063. 
 
(134) Clark, J. S.; Dossetter, A. G.; Whittingham, W. G. Tetrahedron Lett. 
1996, 37, 5605-5608. 
 
(135) Clark, S. J.; Dossetter, A. G.; Blake, A. J.; Li, W.-S.; Whittingham, W. 
G. Chem. Comm. 1999, 749-750. 
 
(136) Kwon, H. B.; McKee, B. H.; Stille, J. K. J. Org. Chem. 1990, 55, 3114-
3118. 
 218 
 
(137) Nowakowski, M.; Hoffmann, H. M. R. Tetrahedron 1997, 53, 4331-
4338. 
 
 (138) Stohrer, I.; Hoffmann, H. M. R. Helv. Chim. Acta 1993, 76, 2194-2209. 
 
 (139) Molander, G. A.; Etter, J. B. J. Org. Chem. 1986, 51, 1778-1786. 
 
(140) Balasubramanian, V.; Robinson, C. H. Tetrahedron Lett. 1981, 22, 
501-504. 
 
 (141) Gringore, O. H.; Rouessac, F. P. Org. Synth. 1985, 63, 121-126. 
 
(142) Ravid, U.; Silverstein, R. M.; Smith, L. R. Tetrahedron 1978, 34, 1449-
1452. 
 
 (143) Aurich, H. G.; Biesemeier, F. Synthesis 1995, 1171-1178. 
 
(144) Adams, J.; Poupart, M. A.; Grenier, L.; Schaller, C.; Ouimet, N.; 
Frenette, R. Tetrahedron Lett. 1989, 30, 1749-1752. 
 
(145) Nicolaou, K. C.; Duggan, M. E.; Hwang, C. K. J. Am. Chem. Soc. 1989, 
111, 6666-6675. 
 
(146) Chai, Y.; Vicic David, A.; McIntosh Matthias, C. Org. Lett. 2003, 5, 
1039-1042. 
 
 (147) Martin, S. F.; White, J. B. Tetrahedron Lett. 1982, 23, 23-26. 
 
(148) Burk, R. M.; Gac, T. S.; Roof, M. B. Tetrahedron Lett. 1994, 35, 8111-
8112. 
 
(149) Majetich, G.; Condon, S.; Hull, K.; Ahmad, S. Tetrahedron Lett. 1989, 
30, 1033-1036. 
 
 (150) Harapanhalli, R. S. J. Chem. Soc., Perkin Trans. 1 1988, 3149-3154. 
 
 (151) Greco, M. N.; Maryanoff, B. E. Tetrahedron Lett. 1992, 33, 5009-5012. 
 
 (152) Chu, M.; Coates, R. M. J. Org. Chem. 1992, 57, 4590-4597. 
 
(153) Fusetani, N.; Nagata, H.; Hirota, H.; Tsuyuki, T. Tetrahedron Lett. 
1989, 30, 7079-7082. 
 
 (154) Rubottom, G. M.; Gruber, J. M. J. Org. Chem. 1978, 43, 1599-1602. 
 
 219 
(155) Hutchison, J. M.; Lindsay, H. A.; Dormi, S. S.; Jones, G. D.; Vicic, D. 
A.; McIntosh, M. C. Org. Lett. 2006, 8, 3663-3665. 
 
(156) Lindsay, H. A.; Salisbury, C. L.; Cordes, W.; McIntosh, M. C. Org. Lett. 
2001, 3, 4007-4010. 
 
(157) Hong, S.-P.; Lindsay, H. A.; Yaramasu, T.; Zhang, X.; McIntosh, M. C. 
J. Org. Chem. 2002, 67, 2042-2055. 
 
 (158) Paquette, L. A.; Stirling, C. J. M. Tetrahedron 1992, 48, 7383-7423. 
 
 (159) Trost, B. M.; Klun, T. P. J. Org. Chem. 1980, 45, 4256-4257. 
 
(160) Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 
1994, 94, 2483-2547. 
 
(161) Jacob, J.; Espenson, J. H.; Jensen, J. H.; Gordon, M. S. 
Organometallics 1998, 17, 1835-1840. 
 
 (162) Morrill, C.; Grubbs, R. H. J. Am. Chem. Soc. 2005, 127, 2842-2843. 
 
 (163) Jung, M. E.; Pontillo, J. Tetrahedron 2003, 59, 2729-2736. 
 
(164) Bunn, B. J.; Cox, P. J.; Simpkins, N. S. Tetrahedron 1993, 49, 207-
218. 
 
 (165) Valls, J.; Toromanoff, E. Bull. Soc. Chim. Fr. 1961, 758-764. 
 
(166) Negishi, E.; Luo, F. T.; Pecora, A. J.; Silveira, A., Jr. J. Org. Chem. 
1983, 48, 2427-2430. 
 
 (167) Negishi, E.; Chatterjee, S. Tetrahedron Lett. 1983, 24, 1341-1344. 
 
 (168) Kabalka, G. W.; Yu, S.; Li, N.-S. Can. J. Chem. 1998, 76, 800-805. 
 
(169) Cooper, M. S.; Heaney, H.; Newbold, A. J.; Sanderson, W. R. Synlett 
1990, 533-535. 
 
(170) Van Boeckel, C. A. A.; Beetz, T. Tetrahedron Lett. 1983, 24, 3775-
3778. 
 
 (171) Molander, G. A.; Harris, C. R. Chem. Rev. 1996, 96, 307-338. 
 
(172) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-
956. 
 
 220 
(173) Anderson, E. A.; Davidson, J. E. P.; Harrison, J. R.; O'Sullivan, P. T.; 
Burton, J. W.; Collins, I.; Holmes, A. B. Tetrahedron 2002, 58, 1943-
1971. 
 
(174) Congreve, M. S.; Holmes, A. B.; Hughes, A. B.; Looney, M. G. J. Am. 
Chem. Soc. 1993, 115, 5815-5816. 
 
(175) Recondo, E. F.; Rinderknecht, H. Helv. Chim. Acta 1959, 42, 1171-
1173. 
 
(176) Goff, D. A.; Harris, R. N., III; Bottaro, J. C.; Bedford, C. D. J. Org. 
Chem. 1986, 51, 4711-4714. 
 
(177) Castaneda, A.; Kucera, D. J.; Overman, L. E. J. Org. Chem. 1989, 54, 
5695-5707. 
 
 (178) Baudat, R.; Petrzilka, M. Helv. Chim. Acta 1979, 62, 1406-1410. 
 
 (179) Petrzilka, M. Helv. Chim. Acta 1978, 61, 3075-3078. 
 
 (180) Petasis, N. A.; Bzowej, E. I. J. Am. Chem. Soc. 1990, 112, 6392-6394. 
 
(181) Burton, J. W.; Clark, J. S.; Derrer, S.; Stork, T. C.; Bendall, J. G.; 
Holmes, A. B. J. Am. Chem. Soc. 1997, 119, 7483-7498. 
 
(182) Kuroda, H.; Hanaki, E.; Izawa, H.; Kano, M.; Itahashi, H. Tetrahedron 
2004, 60, 1913-1920. 
 
(183) Magid, R. M.; Fruchey, O. S.; Johnson, W. L. Tetrahedron Lett. 1977, 
2999-3002. 
 
 (184) Guss, C. O.; Rosenthal, R. J. Am. Chem. Soc. 1955, 77, 2549. 
 
 (185) Kupchik, E. J.; Connolly, R. E. J. Org. Chem. 1961, 26, 4747-4748. 
 
 (186) Noltes, J. G.; van der Kerk, G. J. M. Chem. Ind. 1959, 294. 
 
(187) Hoefle, G.; Steglich, W.; Vorbrueggen, H. Ang. Chem. 1978, 90, 602-
615. 
 
 (188) Finkelstein, H. Ber. 1910, 43, 1528-1532. 
 
 (189) Molander, G. A.; Etter, J. B. Tetrahedron Lett. 1984, 25, 3281-3284. 
 
 (190) Broka, C. A.; Lin, Y. T. J. Org. Chem. 1988, 53, 5876-5885. 
 
 221 
(191) Ivin, K. J.; Mol, I. C.; Editors Olefin Metathesis and Metathesis 
Polymerization, Second Edition, 1996. 
 
(192) Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; 
O'Regan, M. J. Am. Chem. Soc. 1990, 112, 3875-3886. 
 
(193) Bazan, G. C.; Khosravi, E.; Schrock, R. R.; Feast, W. J.; Gibson, V. C.; 
O'Regan, M. B.; Thomas, J. K.; Davis, W. M. J. Am. Chem. Soc. 1990, 
112, 8378-8387. 
 
(194) Grubbs, R. H.; Miller, S. J.; Fu, G. C. Acc. Chem. Res. 1995, 28, 446-
452. 
 
(195) Schwab, P.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 
100-110. 
 
(196) Stewart, I. C.; Ung, T.; Pletnev, A. A.; Berlin, J. M.; Grubbs, R. H.; 
Schrodi, Y. Org. Lett. 2007, 9, 1589-1592. 
 
(197) Kingsbury, J. S.; Harrity, J. P. A.; Bonitatebus, P. J., Jr.; Hoveyda, A. 
H. J. Am. Chem. Soc. 1999, 121, 791-799. 
 
 (198) Clark, J. S.; Kettle, J. G. Tetrahedron Lett. 1997, 38, 127-130. 
 
 (199) Clark, J. S.; Kettle, J. G. Tetrahedron Lett. 1997, 38, 123-126. 
 
 (200) Delgado, M.; Martin, J. D. Tetrahedron Lett. 1997, 38, 6299-6300. 
 
(201) Miller, S. J.; Kim, S.-H.; Chen, Z.-R.; Grubbs, R. H. J. Am. Chem. Soc. 
1995, 117, 2108-2109. 
 
(202) Visser, M. S.; Heron, N. M.; Didiuk, M. T.; Sagal, J. F.; Hoveyda, A. H. 
J. Am. Chem. Soc. 1996, 118, 4291-4298. 
 
 (203) Wolfe, S. Acc. Chem. Res. 1972, 5, 102-111. 
 
 (204) Crimmins, M. T.; She, J. Synlett 2004, 1371-1374. 
 
 (205) Crimmins, M. T.; Choy, A. L. J. Org. Chem. 1997, 62, 7548-7549. 
 
 (206) Crimmins, M. T.; She, J. J. Am. Chem. Soc. 2004, 126, 12790-12791. 
 
 (207) Crimmins, M. T.; Tabet, E. A. J. Am. Chem. Soc. 2000, 122, 5473-476. 
 
(208) Crimmins, M. T.; Emmitte, K. A.; Katz, J. D. Org. Lett. 2000, 2, 2165-
2167. 
 222 
 
 (209) Crimmins, M. T.; DeBaillie, A. C. Org. Lett. 2003, 5, 3009-3011. 
 
(210) Crimmins, M. T.; Emmitte, K. A. J. Am. Chem. Soc. 2001, 123, 1533-
1534. 
 
 (211) Crimmins, M. T.; Emmitte, K. A. Synthesis 2000, 899-903. 
 
 (212) Crimmins, M. T.; Emmitte, K. A. Org. Lett. 1999, 1, 2029-2032. 
 
(213) Crimmins, M. T.; Choy, A. L. J. Am. Chem. Soc. 1999, 121, 5653-
5660. 
 
(214) Crimmins, M. T.; McDougall, P. J.; Ellis, J. M. Org. Lett. 2006, 8, 4079-
4082. 
 
(215) Crimmins, M. T.; King, B. W.; Tabet, E. A.; Chaudhary, K. J. Org. 
Chem. 2001, 66, 894-902. 
 
(216) Crimmins, M. T.; King, B. W.; Tabet, E. A. J. Am. Chem. Soc. 1997, 
119, 7883-7884. 
 
(217) Alcaraz, L.; Harnett, J. J.; Mioskowski, C.; Martel, J. P.; Le Gall, T.; 
Shin, D.-S.; Falck, J. R. Tetrahedron Lett. 1994, 35, 5449-5452. 
 
(218) Nicolaou, K. C.; Xu, J. Y.; Kim, S.; Pfefferkorn, J.; Ohshima, T.; 
Vourloumis, D.; Hosokawa, S. J. Am. Chem. Soc. 1998, 120, 8661-
8673. 
 
(219) Hunt, D. F.; Rodeheaver, G. T. J. Chem. Soc., Chem. Comm. 1971, 
818-819. 
 
 (220) Moussebois, C.; Dale, J. J. Chem. Soc., Org. 1966, 260-264. 
 
(221) Orita, A.; Tanahashi, C.; Kakuda, A.; Otera, J. Ang. Chem, Int. Ed. 
2000, 39, 2877-2879. 
 
(222) Kato, N.; Wu, X.; Tanaka, S.; Takeshita, H. Bull. Chem. Soc. Jpn. 
1990, 63, 1729-1734. 
 
(223) Clive, D. L. J.; Chittattu, G.; Curtis, N. J.; Menchen, S. M. J. Chem. 
Soc., Chem. Comm. 1978, 770-771. 
 
(224) Rodriguez, A. D.; Cobar, O. M.; Martinez, N. J. Nat. Prod. 1994, 57, 
1638-1655. 
 
 223 
(225) Lachance, H.; Lu, X.; Gravel, M.; Hall, D. G. J. Am. Chem. Soc. 2003, 
125, 10160-10161. 
 
(226) Hubbs, J. L.; Heathcock, C. H. J. Am. Chem. Soc. 2003, 125, 12836-
12843. 
 
 (227) Kim, S.; Kim, Y. C. Tetrahedron Lett. 1990, 31, 2901-2904.  
 
(228) Fettes, K.; McQuire, L.; Murray, A. W. J. Chem. Soc., Perkin Trans. 1 
1995, 2123-2127. 
 
(229) Guiney, D.; Gibson, C. L.; Suckling, C. J. Org. Biomol. Chem. 2003, 1, 
664-675. 
 
 (230) Nelson, T. D.; Crouch, R. D. Synthesis 1996, 1031-1069. 
 
(231) Mulzer, J.; Mantoulidis, A.; Ohler, E. J. Org. Chem. 2000, 65, 7456-
7467. 
 
(232) Larcheveque, M.; Sanner, C.; Azerad, R.; Buisson, D. Tetrahedron 
1988, 44, 6407-6418. 
 
 (233) Kozikowski, A. P.; Chen, Y. Y. J. Org. Chem. 1981, 46, 5248-5250. 
 
 (234) White, J. D.; Jeffrey, S. C. J. Org. Chem. 1996, 61, 2600-2601. 
 
 (235) Lam, H. W.; Pattenden, G. Ang. Chem, Int. Ed. 2002, 41, 508-511. 
 
(236) Crimmins, M. T.; Caussanel, F. J. Am. Chem. Soc. 2006, 128, 3128-
3129. 
 
(237) Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. 
Chem. Soc. 2003, 125, 11360-11370. 
 
(238) Chow, S. Y.; Williams, H. J.; Huang, Q.; Nanda, S.; Scott, A. I. J. Org. 
Chem. 2005, 70, 9997-10003. 
 
(239) Schinzer, D.; Boehm, O. M.; Altmann, K.-H.; Wartmann, M. Synlett 
2004, 1375-1378. 
 
(240) Cheng, D.; Zhu, S.; Yu, Z.; Cohen, T. J. Am. Chem. Soc. 2001, 123, 
30-34. 
 
(241) Ebel, H.; Polborn, K.; Steglich, W. Eur. J. Org. Chem. 2002, 2905-
2912. 
 
 224 
(242) Miyaoka, H.; Honda, D.; Mitome, H.; Yamada, Y. Tetrahedron Lett. 
2002, 43, 7773-7775. 
 
(243) Crimmins, M. T.; Zuccarello, J. L.; Cleary, P. A.; Parrish, J. D. Org. 
Lett. 2006, 8, 159-162. 
 
(244) Crimmins, M. T.; McDougall, P. J.; Emmitte, K. A. Org. Lett. 2005, 7, 
4033-4036. 
 
 (245) Thummel, R. P.; Rickborn, B. J. Am. Chem. Soc. 1970, 92, 2064-2067. 
 
 (246) Corey, E. J.; Chaykovsky, M. J. Am. Chem. Soc. 1965, 87, 1353-1364. 
 
 (247) Corey, E. J.; Chaykovsky, M. J. Am. Chem. Soc. 1962, 84, 866-867. 
 
(248) Caballero, E.; Guilhot, F.; Lopez, J. L.; Medarde, M.; Sahaguin, H.; 
Tome, F. Tetrahedron Lett. 1996, 37, 6951-6954. 
 
(249) Brown, H. C.; Desai, M. C.; Jadhav, P. K. J. Org. Chem. 1982, 47, 
5065-5069. 
 
(250) Masamune, S.; Lu, L. D. L.; Jackson, W. P.; Kaiho, T.; Toyoda, T. J. 
Am. Chem. Soc. 1982, 104, 5523-5526. 
 
(251) Di Grandi, M. J.; Coburn, C. A.; Isaacs, R. C. A.; Danishefsky, S. J. J. 
Org. Chem. 1993, 58, 7728-7731. 
 
(252) Vishwakarma, L. C.; Stringer, O. D.; Davis, F. A. Org. Synth. 1988, 66, 
203-210. 
 
(253) Davis, F. A.; Chattopadhyay, S.; Towson, J. C.; Lal, S.; Reddy, T. J. 
Org. Chem. 1988, 53, 2087-2089. 
 
 (254) Inoue, M. Chem. Rev. 2005, 105, 4379-4405. 
 
 (255) Lin, Y.-Y.; Risk, M.; Ray, S. M.; Van Engen, D.; Clardy, J.; Golik, J.; J
  James, J. C.; Nakanishi, K. J. Am. Chem. Soc. 1981, 103, 6773-6775. 
 
(256) Prasad, A. V. K.; Shimizu, Y. J. Am. Chem. Soc. 1989, 111, 6476-
6477. 
 
(257) Murata, M.; Naoki, H.; Matsunaga, S.; Satake, M.; Yasumoto, T. J. Am. 
Chem. Soc. 1994, 116, 7098-7107. 
 
 (258) Nakanishi, K. Toxicon 1985, 23, 473-479. 
 
 225 
 (259) Yasumoto, T. Chem. Rec. 2001, 1, 228-242. 
 
 (260) Scheuer, P. J. Tetrahedron 1994, 50, 3-18. 
 
 (261) Lewis, R. J. Toxicon 2001, 39, 97-106. 
 
(262) Poli, M. A.; Mende, T. J.; Baden, D. G. Mol. Pharmacol. 1986, 30, 129-
135. 
 
(263) Morohashi, A.; Satake, M.; Nagai, H.; Oshima, Y.; Yasumoto, T. 
Tetrahedron 2000, 56, 8995-9001. 
 
(264) Satake, M.; Shoji, M.; Oshima, Y.; Naoki, H.; Fujita, T.; Yasumoto, T. 
Tetrahedron Lett. 2002, 43, 5829-5832. 
 
(265) Konishi, M.; Yang, X.; Li, B.; Fairchild, C. R.; Shimizu, Y. J. Nat. Prod. 
2004, 67, 1309-1313. 
 
(266) Fuwa, H.; Ebine, M.; Bourdelais, A. J.; Baden, D. G.; Sasaki, M. J. Am. 
Chem. Soc. 2006, 128, 16989-16999. 
 
 (267) Rainier, J. D.; Allwein, S. P. Tetrahedron Lett. 1998, 39, 9601-9604. 
 
 (268) Cox, J. M.; Rainier, J. D. Org. Lett. 2001, 3, 2919-2922. 
 
 (269) Majumder, U.; Cox, J. M.; Rainier, J. D. Org. Lett. 2003, 5, 913-916. 
 
(270) Satake, M.; Murata, M.; Yasumoto, T. J. Am. Chem. Soc. 1993, 115, 
361-362. 
 
(271) Takai, K.; Kakiuchi, T.; Kataoka, Y.; Utimoto, K. J. Org. Chem. 1994, 
59, 2668-2670. 
 
(272) Hayashi, N.; Fujiwara, K.; Murai, A. Tetrahedron 1997, 53, 12425-
12468. 
 
(273) Valentine, J. C.; McDonald, F. E.; Neiwert, W. A.; Hardcastle, K. I. J. 
Am. Chem. Soc. 2005, 127, 4586-4587. 
 
(274) Simpson, G. L.; Heffron, T. P.; Merino, E.; Jamison, T. F. J. Am. Chem. 
Soc. 2006, 128, 1056-1057. 
 
 (275) Warren, J. D.; Shi, Y. J. Org. Chem. 1999, 64, 7675-7677. 
 
(276) Bourdelais, A. J.; Campbell, S.; Jacocks, H.; Naar, J.; Wright, J. L. C.; 
Carsi, J.; Baden, D. G. Cell. Mol. Neurobiol. 2004, 24, 553-563. 
 226 
 
(277) Sayer, A.; Hu, Q.; Bourdelais, A. J.; Baden, D. G.; Gibson, J. E. Arch. 
Toxicol. 2005, 79, 683-688. 
 
 (278) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457-2483. 
 
(279) Sasaki, M.; Ebine, M.; Takagi, H.; Takakura, H.; Shida, T.; Satake, M.; 
Oshima, Y.; Igarashi, T.; Yasumoto, T. Org. Lett. 2004, 6, 1501-1504. 
 
(280) Nicolaou, K. C.; Prasad, C. V. C.; Hwang, C. K.; Duggan, M. E.; Veale, 
C. A. J. Am. Chem. Soc. 1989, 111, 5321-5330. 
 
(281) Fuwa, H.; Ebine, M.; Sasaki, M. J. Am. Chem. Soc. 2006, 128, 9648-
9650. 
 
(282) Johnson, H. W. B.; Majumder, U.; Rainier, J. D. J. Am. Chem. Soc. 
2005, 127, 848-849. 
 
(283) Okazoe, T.; Takai, K.; Oshima, K.; Utimoto, K. J. Org. Chem. 1987, 52, 
4410-4412. 
 
(284) Alam, M.; Trieff, N. M.; Ray, S. M.; Hudson, J. E. J. Pharm. Sci. 1975, 
64, 865-867. 
 
(285) Shimizu, Y.; Chou, H. N.; Bando, H.; Van Duyne, G.; Clardy, J. J. Am. 
Chem. Soc. 1986, 108, 514-515. 
 
(286) Pawlak, J.; Tempesta, M. S.; Golik, J.; Zagorski, M. G.; Lee, M. S.; 
Nakanishi, K.; Iwashita, T.; Gross, M. L.; Tomer, K. B. J. Am. Chem. 
Soc. 1987, 109, 1144-1150. 
 
(287) Trainer, V. L.; Thomsen, W. J.; Catterall, W. A.; Baden, D. G. Mol. 
Pharmacol. 1991, 40, 988-994. 
 
(288) Rein, K. S.; Baden, D. G.; Gawley, R. E. J. Org. Chem. 1994, 59, 
2101-2106. 
 
(289) Gawley, R. E.; Rein, K. S.; Jeglitsch, G.; Adams, D. J.; Theodorakis, E. 
A.; Tiebes, J.; Nicolaou, K. C.; Baden, D. G. Chem. & Biol. 1995, 2, 
533-541. 
 
(290) Nicolaou, K. C.; Rutjes, F. P. J. T.; Theodorakis, E. A.; Tiebes, J.; 
Sato, M.; Untersteller, E. J. Am. Chem. Soc. 1995, 117, 1173-1174. 
 
 227 
(291) Nicolaou, K. C.; Theodorakis, E. A.; Rutjes, F. P. J. T.; Tiebes, J.; 
Sato, M.; Untersteller, E.; Xiao, X. Y. J. Am. Chem. Soc. 1995, 117, 
1171-1172. 
 
(292) Nicolaou, K. C.; Tiebes, J.; Theodorakis, E. A.; Rutjes, F. P. J. T.; 
Koide, K.; Sato, M.; Untersteller, E. J. Am. Chem. Soc. 1994, 116, 
9371-9372. 
 
(293) Nicolaou, K. C.; Hwang, C. K.; Duggan, M. E. J. Am. Chem. Soc. 1989, 
111, 6682-6690. 
 
(294) Nicolaou, K. C.; Duggan, M. E.; Hwang, C. K. J. Am. Chem. Soc. 1989, 
111, 6676-6682. 
 
(295) Nicolaou, K. C.; Hwang, C. K.; Nugiel, D. A. J. Am. Chem. Soc. 1989, 
111, 4136-4137. 
 
(296) Nicolaou, K. C.; Gunzner, J. L.; Shi, G.-Q.; Agrios, K. A.; Gartner, P.; 
Yang, Z. Chem. Eur. J. 1999, 5, 646-658. 
 
(297) Nicolaou, K. C.; Shi, G.-Q.; Gunzner, J. L.; Gartner, P.; Wallace, P. A.; 
Ouellette, M. A.; Shi, S.; Bunnage, M. E.; Agrios, K. A.; Veale, C. A.; 
Hwang, C.-K.; Hutchinson, J.; Prasad, C. V. C.; Ogilvie, W. W.; Yang, 
Z. Chem. Eur. J. 1999, 5, 628-645. 
 
(298) Nicolaou, K. C.; Wallace, P. A.; Shi, S.; Ouellette, M. A.; Bunnage, M. 
E.; Gunzner, J. L.; Agrios, K. A.; Shi, G.-Q.; Gartner, P.; Yang, Z. 
Chem. Eur. J. 1999, 5, 618-627. 
 
(299) Nicolaou, K. C.; Bunnage, M. E.; McGarry, D. G.; Shi, S.; Somers, P. 
K.; Wallace, P. A.; Chu, X.-J.; Agrios, K. A.; Gunzner, J. L.; Yang, Z. 
Chem. Eur. J. 1999, 5, 599-617. 
 
(300) Nicolaou, K. C.; Yang, Z.; Shi, G.-q.; Gunzner, J. L.; Agrios, K. A.; 
Gartner, P. Nature 1998, 392, 264-269. 
 
(301) Nicolaou, K. C.; Hwang, C. K.; Marron, B. E.; DeFrees, S. A.; 
Couladouros, E. A.; Abe, Y.; Carroll, P. J.; Snyder, J. P. J. Am. Chem. 
Soc. 1990, 112, 3040-3054. 
 
(302) Schreiber, J.; Maag, H.; Hashimoto, N.; Eschenmoser, A. Ang. Chem., 
Int. Ed. Engl. 1971, 10, 330-331. 
 
(303) Brown, H. C.; Randad, R. S.; Bhat, K. S.; Zaidlewicz, M.; Racherla, U. 
S. J. Am. Chem. Soc. 1990, 112, 2389-2392. 
 
 228 
 (304) Crimmins, M. T.; McDougall, P. J. Org. Lett. 2003, 5, 591-594. 
 
(305) Alvarez-Ibarra, C.; Arias, S.; Banon, G.; Fernandez, M. J.; Rodriguez, 
M.; Sinisterra, V. J. Chem. Soc., Chem. Comm. 1987, 1509-1511. 
 
 (306) Paterson, I.; Yeung, K. S.; Smaill, J. B. Synlett 1993, 774-776. 
 
 (307) Oishi, T.; Nakata, T. Acc. Chem. Res. 1984, 17, 338-344. 
 
(308) Crabtree, R. H.; Felkin, H.; Fillebeen-Khan, T.; Morris, G. E. J. 
Organomet. Chem. 1979, 168, 183-195. 
 
(309) Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 1993, 93, 1307-
1370. 
 
(310) Horita, K.; Yoshioka, T.; Tanaka, T.; Oikawa, Y.; Yonemitsu, O. 
Tetrahedron 1986, 42, 3021-3028. 
 
 (311) Ojima, I.; Kogure, T. Organometallics 1982, 1, 1390-1399. 
 
 (312) Crimmins, M. T.; Cleary, P. A. Heterocycles 2003, 61, 87-92. 
 
(313) Baden, D. G.; Bourdelais, A. J.; Jacocks, H.; Michelliza, S.; Naar, J. 
Environ. Health. Perspect. 2005, 113, 621-625. 
 
 (314) Stork, G.; Zhao, K. Tetrahedron Lett. 1989, 30, 287-290. 
 
